
<html lang="en"     class="pb-page"  data-request-id="d0f77344-fc23-497d-88a8-c71ff7fd2bf7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2014.57.issue-20;pageGroup:string:Publication Pages;article:article:10.1021/jm500660f;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity" /></meta><meta name="dc.Creator" content="Zhen  Liu" /></meta><meta name="dc.Creator" content="Yuan  Yao" /></meta><meta name="dc.Creator" content="Mari  Kogiso" /></meta><meta name="dc.Creator" content="Baisong  Zheng" /></meta><meta name="dc.Creator" content="Lisheng  Deng" /></meta><meta name="dc.Creator" content="Jihui J.  Qiu" /></meta><meta name="dc.Creator" content="Shuo  Dong" /></meta><meta name="dc.Creator" content="Hua  Lv" /></meta><meta name="dc.Creator" content="James M.  Gallo" /></meta><meta name="dc.Creator" content="Xiao-Nan  Li" /></meta><meta name="dc.Creator" content="Yongcheng  Song" /></meta><meta name="dc.Description" content="Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma. Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the reduction of α-ketoglu..." /></meta><meta name="Description" content="Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma. Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the reduction of α-ketoglu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 1, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500660f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500660f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500660f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500660f" /></link>
        
    
    

<title>Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500660f" /></meta><meta property="og:title" content="Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0009.jpeg" /></meta><meta property="og:description" content="Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma. Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the reduction of α-ketoglutaric acid to d-2-hydroxyglutaric acid (D2HG), leading to cancer initiation. Several 1-hydroxypyridin-2-one compounds were identified to be inhibitors of IDH1(R132H). A total of 61 derivatives were synthesized, and their structure–activity relationships were investigated. Potent IDH1(R132H) inhibitors were identified with Ki values as low as 140 nM, while they possess weak or no activity against WT IDH1. Activities of selected compounds against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular production of D2HG, with R2 of 0.83 and 0.73, respectively. Several inhibitors were found to be permeable through the blood–brain barrier in a cell-based model assay and exhibit potent and selective activity (EC50 = 0.26–1.8 μM) against glioma cells with the IDH1 R132H mutation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500660f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500660f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500660f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500660f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500660f&amp;href=/doi/10.1021/jm500660f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8307-8318</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500522y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500750b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen++Liu">Zhen Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Yao">Yuan Yao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mari++Kogiso">Mari Kogiso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Baisong++Zheng">Baisong Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisheng++Deng">Lisheng Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jihui+J.++Qiu">Jihui J. Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuo++Dong">Shuo Dong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Lv">Hua Lv</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++Gallo">James M. Gallo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Nan++Li">Xiao-Nan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongcheng++Song">Yongcheng Song</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pharmacology, <sup>⊥</sup>Department of Pediatrics-oncology, <sup>∥</sup>Department of Medicine, and <sup>‡</sup>Dan L. Duncan Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 713-798-7415. E-mail: <a href="/cdn-cgi/l/email-protection#433a302c2d240321202e6d262736"><span class="__cf_email__" data-cfemail="324b415d5c557250515f1c575647">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500660f&amp;href=/doi/10.1021%2Fjm500660f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8307–8318</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 1, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 April 2014</li><li><span class="item_label"><b>Published</b> online</span>1 October 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 October 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500660f" title="DOI URL">https://doi.org/10.1021/jm500660f</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500660f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6295</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500660f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhen&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Mari&quot;,&quot;last_name&quot;:&quot;Kogiso&quot;},{&quot;first_name&quot;:&quot;Baisong&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Lisheng&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Jihui&quot;,&quot;last_name&quot;:&quot;J. Qiu&quot;},{&quot;first_name&quot;:&quot;Shuo&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Lv&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. Gallo&quot;},{&quot;first_name&quot;:&quot;Xiao-Nan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yongcheng&quot;,&quot;last_name&quot;:&quot;Song&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;8307-8318&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500660f&quot;},&quot;abstract&quot;:&quot;Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma. Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the reduction of α-ketoglutaric acid to d-2-hydroxyglutaric acid (D2HG), leading to cancer initiation. Several 1-hydroxypyridin-2-one compounds were identified to be inhibitors of IDH1(R132H). A total of 61 derivatives were synthesized, and their structure–activity relationships were investigated. Potent IDH1(R132H) inhibitors were identified with Ki values as low as 140 nM, while they possess weak or no activity against WT IDH1. Activities of selected compounds against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular production of D2HG, with R2 of 0.83 and 0.73, respectively. Several inhibitors were found to be permeable through the blood–brain barrier in a cell-based model assay and exhibit potent and selective activity (EC50 = 0.26–1.8 μM) against glioma cells with the IDH1 &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500660f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500660f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500660f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500660f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500660f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500660f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500660f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500660f&amp;href=/doi/10.1021/jm500660f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500660f" /></input><a href="/doi/pdf/10.1021/jm500660f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26pmid%3D25271760%26genre%3Darticle%26aulast%3DLiu%26date%3D2014%26atitle%3DInhibition%2Bof%2BCancer-Associated%2BMutant%2BIsocitrate%2BDehydrogenases%253A%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2Band%2BSelective%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D20%26spage%3D8307%26epage%3D8318%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jmcmar.2014.57.issue-20/20141023/jmcmar.2014.57.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma. Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the reduction of α-ketoglutaric acid to <span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid (D2HG), leading to cancer initiation. Several 1-hydroxypyridin-2-one compounds were identified to be inhibitors of IDH1(R132H). A total of 61 derivatives were synthesized, and their structure–activity relationships were investigated. Potent IDH1(R132H) inhibitors were identified with <i>K</i><sub>i</sub> values as low as 140 nM, while they possess weak or no activity against WT IDH1. Activities of selected compounds against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular production of D2HG, with <i>R</i><sup>2</sup> of 0.83 and 0.73, respectively. Several inhibitors were found to be permeable through the blood–brain barrier in a cell-based model assay and exhibit potent and selective activity (EC<sub>50</sub> = 0.26–1.8 μM) against glioma cells with the IDH1 R132H mutation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77151" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77151" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Isocitrate dehydrogenase (IDH) is one of the key enzymes in the tricarboxylic acid cycle, which provides aerobic organisms the majority of energy by oxidation of the acetyl group derived from, for example, carbohydrates and fats. IDH catalyzes the oxidative decarboxylation of isocitric acid (ICT) to α-ketoglutaric acid (α-KG) using Mg<sup>2+</sup> and NADP<sup>+</sup> (or NAD<sup>+</sup>) as cofactors,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A. There are three IDH isozymes in humans, with IDH1 located in cytoplasm and IDH2 and 3 in mitochondria.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Moreover, α-KG, the product of the IDH catalyzed reaction, is used as a common cofactor by ∼60 dioxygenases, including important epigenetic enzymes such as the JmjD family of histone demethylases. Therefore, the function of IDH enzymes is of importance to normal physiology.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Reaction catalyzed by WT IDH enzymes in tricarboxylic acid cycle, (B) reaction catalyzed by mutant IDH enzymes, and (C) structures of current inhibitors of mutant IDH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent genetic studies have identified frequent mutations in IDH genes in several types of cancer.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> For example, IDH1 mutations are found in ∼75% of low-grade gliomas (grade II and III), as well as secondary glioblastoma multiforme, the grade IV glioma developed from the low-grade tumors.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The R132H mutation is predominant (>90%) in these gliomas. Mutations of IDH1 or IDH2 have also been found in ∼20% acute myeloid leukemia and many sarcomas.<a onclick="showRef(event, 'ref6 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10 ref11">(6, 9-11)</a> The IDH mutations occur at an early stage of these cancers, suggesting they could play important roles in cancer initiation. Of particular interest is that all characterized IDH mutant proteins, such as IDH1(R132H) and IDH1(R132C), almost lose the catalytic function of wild-type (WT) IDH, but obtain a new capability: they can catalyze the reduction of α-KG to <span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid (D2HG) using Mg<sup>2+</sup> and NADPH as cofactors,<a onclick="showRef(event, 'ref6 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref6 ref12 ref13">(6, 12, 13)</a> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B. These IDH mutant enzymes therefore cause elevated D2HG concentrations in cell and plasma. Further studies show a high level of D2HG is very harmful and could be the culprit for the initiation of the cancer. Due to its structural similarity to α-KG, D2HG is a broad inhibitor of α-KG-dependent dioxygenases including histone demethylases and the TET-family of 5-methylcytosine hydroxylases,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> which are important enzymes keeping a balanced histone and DNA methylation status. Overexpression of IDH1(R132H) can cause hypermethylation of histone and DNA and block cell differentiation.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> These findings suggest mutant IDH is a novel drug target for intervention,<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> and its inhibitors represent useful probes for the investigation of the biological functions of IDH mutation as well as potential therapeutics for this type of cancer.</div><div class="NLM_p">A series of diamide compounds, such as compound <b>1</b> shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C, were reported to be the first inhibitors of mutant IDH1 with IC<sub>50</sub> values as low as 70 nM.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Compound <b>1</b> is able to reduce the cellular D2HG concentration and slow the proliferation of IDH1 mutated cancer cells. We also reported several 1-hydroxypyridin-2-one compounds,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> such as compounds <b>2</b> and <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C), are potent inhibitors of mutant IDH1 with inhibition constant (<i>K</i><sub>i</sub>) values as low as 190 nM, which exhibit very weak activity against WT IDH1 showing a high selectivity of >60-fold. In addition, we determined the X-ray crystal structures of IDH1(R132H) in complex with inhibitors <b>2</b> and <b>3</b>, which reveal the exact binding mode of these two compounds as well as the structural basis for the high selectivity.</div><div class="NLM_p last">Here, we report the inhibitor discovery, design, synthesis, and structure–activity relationships (SAR) of several series of 1-hydroxypyridin-2-one compounds targeting cancer-associated mutant IDH1. Several inhibitors of mutant IDH1 show potent and selective activity against glioma cells with the IDH1 R132H mutation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Identification of the Initial Inhibitors of IDH1(R132H)</h3><div class="NLM_p">Our previous research in developing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> another reductase using Mg<sup>2+</sup> and NADPH as cofactors, provided an enriched source of compounds that could inhibit mutant IDH1. By screening this focused library of ∼130 compounds against recombinant human IDH1(R132H), the predominant mutation found in the majority of the gliomas, followed by validation, we found several 5- and 6-substituted 1-hydroxypyridin-2-one compounds to be low micromolar inhibitors. The structures and activities of these compounds are shown in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>, together with those of inactive analogs in the library that are useful for SAR analysis.</div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures and <i>K</i><sub>i</sub> Values of Initial Inhibitors of IDH1(R132H)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">5-Benzyl-1-hydroxypyridin-2-one (<b>4</b>) was found to be an inhibitor of IDH1(R132H) with a <i>K</i><sub>i</sub> value of 8.2 μM, while compound <b>5</b> with a 5-phenyl group has a very weak activity. Compound <b>6</b> with an -O- linkage exhibits a <i>K</i><sub>i</sub> of 46 μM, suggesting that an electron-rich core is not favored. Compounds <b>7</b> and <b>8</b> with a 6-substituent possess an improved activities (<i>K</i><sub>i</sub> = 5.9 and 4.5 μM) compared with that of <b>4</b>. Ciclopirox (<b>9</b>), an antifungal drug, with 4-methyl and 6-cyclohexyl substituents is inactive against IDH1(R132H).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Medicinal Chemistry To Find Potent IDH1(R132H) Inhibitors</h3><div class="NLM_p">With the identification of 5- and 6-substituted 1-hydroxypyridin-2-one compounds, that is, <b>4</b>, <b>7</b>, and <b>8</b>, as the lead inhibitors of IDH1(R132H), systematic medicinal chemistry studies were performed in an effort to find compounds with improved activity. Four series of compounds, including 5-, 6-, and 4-methyl-6- and 4-methyl-3-substituted 1-hydroxypyridin-2-one compounds, have been designed, synthesized, and tested against IDH1(R132H).</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows the structures and activities of 5- or 6-substituted 1-hydroxypyridin-2-one compounds. Compounds <b>10</b> and <b>11</b>, having 5-(2-phenylethyl) and 5-(3-phenylpropyl) substituents, respectively, lose the inhibitory activity. In addition, compounds <b>12</b>–<b>14</b> containing a 5-hydroxamate, amide, and reversed amide group, respectively, are also inactive. For 6-substituted 1-hydroxypyridin-2-one compounds, compounds <b>15</b> and <b>16</b> bearing a 6-phenyl and 6-(1-phenylethyl) group, respectively, are inactive against IDH1(R132H). Compound <b>17</b> with a 2-phenylethyl group exhibits less activity (<i>K</i><sub>i</sub> = 10 μM) compared with compound <b>7</b> with a 6-benzyl group. Compound <b>18</b>, which has an additional -CO<sub>2</sub>Me, is considerably less active than <b>17</b>. These results, together with those of compounds <b>4</b>–<b>7</b>, suggest that 6-benzyl is more favorable. In addition, despite the good activity of compound <b>8</b> with a 6-hydroxamic acid (<i>K</i><sub>i</sub> = 4.5 μM), we did not pursue this compound further due to the high polarity as well as poor pharmacokinetics of the hydroxamate group.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and <i>K</i><sub>i</sub> Values of 5- or 6-Substituted Compounds against IDH1(R132H)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sup>5</sup></th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">-Ph</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">∼50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">-OPh</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">-CONHOH</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">-CONHBn</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">-NHCOBn</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Ph</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)Ph</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-(CH<sub>2</sub>)<sub>2</sub>(4-CO<sub>2</sub>Me-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CONHOH</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>2</b>, obtained by replacing the 6-cyclohexyl group of the inactive compound <b>9</b> with a benzyl substituent, was found to be a potent inhibitor of IDH1(R132H) with a <i>K</i><sub>i</sub> value of 190 nM, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. It is ∼30× more active than the analogous compound <b>7</b> without a 4-methyl group, showing the 4-Me is important for the activity. Compound <b>19</b> with 4-methyl-6-phenoxymethyl substituents was found to inhibit IDH1(R132H) with a <i>K</i><sub>i</sub> of 870 nM, ∼4× less active than <b>2</b>. Compound <b>20</b> having 4,6-dimethyl substituents was found to be inactive. These results demonstrate that the combination of the 4-methyl and 6-benzyl substituents is needed to achieve a high inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and <i>K</i><sub>i</sub> Values of 3-, 4-, and 6-Substituted Compounds against IDH1(R132H)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-cyclohexyl</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OPh</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-OMe-Ph)</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-OH-Ph)</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="char" char=".">13.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-OH</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>OAc</td><td class="colsep0 rowsep0" align="left">-Bn</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(4-OMe-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(4-OH-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-OMe-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-OH-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(2-OMe-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(2-OH-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-F-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(penta-F-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(4-CN-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-CN-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-COOH-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-CONH<sub>2</sub>-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(4-CF<sub>3</sub>-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3,5-diMe-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(thiophen-3-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3-biphenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(4-OPh-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(naphth-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(6-OMe-naphth-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">40.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(6-OH-naphth-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">27.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(benzothiophen-2-yl)</td><td class="colsep0 rowsep0" align="char" char=".">22.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>[4-(4-OMe-Ph)-Ph]</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>[4-(4-OH-Ph)-Ph]</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>[4-(3-OMe-Ph)-Ph]</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>[4-(3-OH-Ph)-Ph]</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-Me</td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>(3,5-diPh-Ph)</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td></tr></tbody></table></div></div><div class="NLM_p">With the potent inhibitor <b>2</b> in hand, efforts were next made to optimize the 1-hydroxypyridin-2-one core structure. Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a> shows the structures and activities of compounds <b>21–29</b>, each of which has a different aromatic core structure, while contains a benzyl substituent for SAR analysis. Compared with compound <b>4</b>, lack of activity for compound <b>21</b> clearly indicates the importance of <i>N</i>-OH group. Greatly reduced activities for compounds <b>22</b>–<b>24</b> with a C-substituted -OH group suggest that the N-substituted -OH in compound <b>2</b> increases the binding affinity to IDH1(R132H). In addition, compared with compound <b>7</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), lack of activity for compounds <b>25</b> and <b>26</b> suggests the reversely positioned <i>N</i>-OH and carbonyl functionalities are disfavored. Furthermore, compared with compound <b>2</b>, a 20-fold activity reduction for compound <b>27</b> (<i>K</i><sub>i</sub> = 3.8 μM) with an <i>N</i>-NH<sub>2</sub> group again underscores the critical role of the <i>N</i>-OH group of the 1-hydroxypyridin-2-one core. Compounds <b>28</b> and <b>29</b> having a 2-pyrone and 2-thiopyrone ring, respectively, are also inactive. These SAR studies show that the 1-hydroxypyridin-2-one ring represents the most potent core structure for the inhibition of IDH1(R132H).</div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structures of <b>21</b>–<b>29</b> and Their <i>K</i><sub>i</sub> Values against IDH1(R132H)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> X-Ray Structure of Inhibitor Bound IDH1(R132H) and Structure Based Rationalization of SAR</h3><div class="NLM_p">We determined the X-ray structures of IDH1(R132H) in complex with NADPH and the potent inhibitors <b>2</b> and <b>3</b> at 3.3 Å,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> to a similar resolution as the previously reported structures.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Detailed structural information has been reported in our previous communication,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> while the interactions between the protein and <b>2</b> are briefly summarized to facilitate rationalization of SARs as well as inhibitor design described below. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a, the 4-methyl-1-hydroxypyridin-2-one ring of compound <b>2</b> is located in a pocket surrounded by Arg100, Ser94, Thr77, Asn96, Arg109, and NADPH. The planar -CONH<sub>2</sub> of Asn96 is located right underneath the pyridine ring of <b>2</b>, with the distance of ∼4.1 Å. The two O atoms of the 1-hydroxypyridin-2-one core form two H-bonds with the two N atoms of the guanidinium group of Arg100. The calculated p<i>K</i><sub>a</sub> of 6.1 for <b>2</b> suggests that the <i>N</i>-OH group may be deprotonated, which, together with the (partially negative) O atom of the 2-oxo group, also provides strong electrostatic interactions with the positively charged side chain of Arg100. This should explain why the core structures in compounds <b>21</b>–<b>24</b> and <b>27</b>–<b>29</b> with either a single O atom or a higher p<i>K</i><sub>a</sub> value are considerably less potent. The 4-methyl group is nicely fitted into a mainly hydrophobic cavity, ∼3.7–4.2 Å from -CH<sub>3</sub> of Thr77 and -CH<sub>2</sub>- and -O- of Ser94. Loss of these favorable interactions should account for the reduced activity of compound <b>7</b>. The phenyl ring of the 6-benzyl has favorable hydrophobic (as well as electrostatic) interactions with the nicotinamide ring of NADPH, while the other side of the phenyl ring is ∼5 Å away from the side chain of Arg109. In addition, the C4 atom of the phenyl ring is ∼11 Å away from Leu250′ (omitted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a for clarity) from the other monomeric protein. Therefore, Arg109, Leu250′, and NADPH form a relatively large pocket that could be explored for inhibitor design (described below). The crystal structures show compounds bearing a branched 6-substituent, such as <b>9</b>, <b>15</b>, and <b>16</b>, would cause severe steric conflicts with NADPH if their 4-methyl-1-hydroxypyridin-2-one ring maintains the favorable interactions with the protein. This should account for the loss of activity for <b>9</b>, <b>15</b>, and <b>16</b>.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal and docking structures of inhibitors of IDH1(R132H). (A) The close-up view of the active site of the crystal structure of IDH1(R132H)/<b>2</b>, with the backbone of one monomeric protein shown in blue lines and that of the other monomer in yellow. Compound <b>2</b> is shown as a ball and stick model. Only selected residues with the interactions with <b>2</b> are shown for clarity. (B) Ten docking structures of compound <b>30</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing that the 3-benzyl group of <b>30</b> is predicted to occupy an empty pocket. (C) Ten docking structures of compound <b>34</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing the 4-OH group of <b>34</b> is predicted to have favorable interactions with Thr77. (D) Ten docking structures of compound <b>39</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing the 6-(3-OMe-Ph) group of <b>39</b> is predicted to have favorable interactions with Arg109.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure Guided Inhibitor Development and SAR</h3><div class="NLM_p">In the structure of the IDH1(R132H)/<b>2</b> complex, there is a pocket near the 3-position of the 1-hydroxypyridin-2-one core, surrounded by Gly97, Lys93, Arg100, and Asn101. Compound <b>30</b>, having a 3-benzyl as well as the favorable 4-methyl group, was designed and synthesized. Although it can be docked into the structure of IDH1(R132H)/<b>2</b> with the binding pose of 1-hydroxypyridin-2-one core similar to that of <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b), compound <b>30</b> exhibits a moderate inhibitory activity with a <i>K</i><sub>i</sub> of 9.5 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), being 50× less active than compound <b>2</b>. Compounds <b>31</b> and <b>32</b> with additional meta-substituted -OMe and -OH are less active than <b>30</b>. These results indicate that a benzyl group at the 3-position of the 1-hydroxypyridin-2-one ring is considerably less favorable than that at the 6-position.</div><div class="NLM_p">We next sought to optimize the 4-position of the 1-hydroxypyridin-2-one ring. The IDH1(R132H)/<b>2</b> structure reveals that the 4-Me group has favorable interactions with the side chains of Thr77 and Ser94. Compared with <b>2</b>, compound <b>33</b> with a 4-isopropyl group was found to exhibit a 50-fold activity loss (<i>K</i><sub>i</sub> = 9.5 μM), indicating that isopropyl is too bulky for the pocket. Compound <b>34</b> with a 4-hydroxyl group was found to be also a potent inhibitor of IDH1(R132H) with a <i>K</i><sub>i</sub> of 380 nM, being comparable to compound <b>2</b>. Introducing the -OH was intended to have favorable interactions (e.g., H-bond) with the side chains of Thr77 (or Ser94), with the docking results of <b>34</b> shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c. However, the 4-OH in compound <b>34</b> is not superior to the 4-Me in <b>2</b>. In addition, the 4-methoxy group in compound <b>35</b> (<i>K</i><sub>i</sub> = 5.5 μM) considerably reduces the inhibitory activity. Compound <b>36</b> with a 4-hydroxymethyl, as well as its acetyl ester <b>37</b>, also have moderate potency with <i>K</i><sub>i</sub> values of 5.6 and 4.5 μM, respectively. These results show that only small substituents with a single heavy atom, such as -Me and -OH, are favorable for the 4-position of 1-hydroxypyridin-2-one ring. Because 1-hydroxypyridin-2-one compounds with a 4-methyl group is considerably easier to synthesize and might be more cell permeable than those with a 4-hydroxyl, we decided to keep the 4-Me for further SAR studies.</div><div class="NLM_p">The SAR studies for the 6-position of compound <b>2</b> were performed to find a substituent that can provide increased potency. First, we wanted to explore how electron density of the phenyl ring affects the activity. Compound <b>38</b> with a <i>para</i>-OMe group in its 6-benzyl group exhibits less activity than does its parent compound <b>2</b>, while <b>3</b> having a <i>para</i>-OH maintains a comparable activity (<i>K</i><sub>i</sub> = 290 nM). Of interest are the higher inhibitory potencies of compounds <b>39</b> and <b>40</b> (<i>K</i><sub>i</sub> = 150 and 140 nM) having a <i>meta</i>-substituted OMe and OH group, respectively, showing that these two groups are more favorable. Changing the OMe and OH groups to the <i>ortho</i>-position for compounds <b>41</b> and <b>42</b> resulted in ∼2× activity reductions with their <i>K</i><sub>i</sub> values of 490 and 650 nM, respectively. On the other hand, an electron-withdrawing fluoro substituent in <b>43</b> and <b>44</b> (<i>K</i><sub>i</sub> = 2.2 μM) was found to be highly disfavored, leading to ∼10-fold activity decrease. A similar trend can be observed for compounds <b>45</b>–<b>49</b> (<i>K</i><sub>i</sub> 1.6 to >50 μM) bearing electron-withdrawing -CN, -CO<sub>2</sub>H, -CONH<sub>2</sub>, and -CF<sub>3</sub> groups, showing that strongly electron-deficient phenyl ring can reduce the inhibitory activity of this series of compounds. Compound <b>50</b> having two <i>meta</i>-substituted methyl groups possesses a moderate activity of 3.1 μM. Compound <b>51</b> bearing a thiophenyl side chain was found to be a good inhibitor (<i>K</i><sub>i</sub> = 950 nM). The increased activity for compounds <b>39</b> and <b>40</b> might be due to increased interactions with Arg109, as show in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d for the docking results of <b>39</b>. Introducing strong electron-withdrawing groups (e.g., -F, -CF<sub>3</sub>, and -CN) for compounds <b>43</b>–<b>49</b> is disfavored because this could reduce the electrostatic interactions between the phenyl rings and the electron-deficient nicotinamide ring of NADPH.</div><div class="NLM_p last">Analogs with two or more aromatic rings at the 6-position of 1-hydroxypyridin-2-one were synthesized because of the relatively large pocket surrounded by NADPH, Arg109, and Leu250′ described above. Compounds <b>52</b>, <b>53</b>, and <b>54</b> having a <i>meta</i>-biphenyl, <i>para</i>-phenoxyphenyl, and 1-naphthyl group, respectively, were found to be strong inhibitors with <i>K</i><sub>i</sub> values of 600, 750, and 950 nM. However, compounds <b>55</b> and <b>56</b>, which are derivatives of <b>54</b> with a 6-OMe or -OH in the naphthyl ring, respectively, exhibit very weak activity (<i>K</i><sub>i</sub> > 25 μM). Similarly weak activity was observed for the benzothiophenyl derivative <b>57</b> (<i>K</i><sub>i</sub> = 22.5 μM). These three compounds are >23× less active than their parent compounds <b>54</b> and <b>51</b>. Compounds <b>58</b> and <b>59</b> with a <i>para</i>-OMe and <i>para</i>-OH substituted <i>para</i>-biphenyl group were, however, found to be potent inhibitors of IDH1(R132H) with <i>K</i><sub>i</sub> values of 340 and 250 nM, respectively. Moving the OMe and OH groups to the <i>meta</i>-position for compounds <b>60</b> and <b>61</b> resulted in more potent inhibition, with the <i>K</i><sub>i</sub> values of these two compounds being 140 and 270 nM, respectively. Finally, compound <b>62</b> bearing a <i>meta</i>-terphenyl group was found to be still a potent inhibitor (<i>K</i><sub>i</sub> = 300 nM). Activity data of these compounds show a large variety of substituents with different sizes can replace the phenyl moiety of compound <b>2</b> while maintaining comparable or having even improved activity. More modifications at this position could further improve the inhibitory activity.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Inhibition of IDH1(R132C) and WT IDH1</h3><div class="NLM_p">Although rare in glioma, Arg132 mutation to cysteine in IDH1 is frequently found in acute myeloid leukemia and sarcomas.<a onclick="showRef(event, 'ref6 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10 ref11">(6, 9-11)</a> The mutant protein IDH1(R132C) possesses the same enzymatic function as IDH1(R132H) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C) with comparable kinetic parameters.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The R132C mutation also causes elevated levels of D2HG in these cancer patients.</div><div class="NLM_p">We selected 10 representative IDH1(R132H) inhibitors, with <i>K</i><sub>i</sub> values ranging from 0.14 to 9.5 μM, and tested the activity of these compounds against recombinant IDH1(R132C), using our previous method.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The results, together with their <i>K</i><sub>i</sub> values against IDH1(R132H), are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. These compounds were found to also be inhibitors of IDH1(R132C) with <i>K</i><sub>i</sub> values ranging from 0.12 to 14.7 μM, which shows a good correlation with those for the R132H mutant enzyme, with <i>R</i><sup>2</sup> of 0.83 as well as slope of 1.04 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). These results suggest that the residue Cys132 seems to have a similar function as His132 does for catalyzing the reduction of α-KG to D2HG.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activity of Selected Inhibitors of Mutant IDH1</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IDH enzyme <i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">WT</th><th class="colsep0 rowsep0" align="center" char=".">R132H</th><th class="colsep0 rowsep0" align="center" char=".">R132C</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM) for inhibition of D2HG</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">12.3 ± 3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.19 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.12 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">2.4 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">16.8 ± 3.0</td><td class="colsep0 rowsep0" align="char" char=".">0.28 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.27 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">8.5 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">8.2 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">6.6 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">5.9 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">10.5 ± 3.2</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">4.5 ± 1.7</td><td class="colsep0 rowsep0" align="char" char=".">2.4 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">9.5 ± 2.9</td><td class="colsep0 rowsep0" align="char" char=".">14.7 ± 6.3</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.38 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">1.8 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">9.7 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.15 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.26 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">1.1 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.14 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.42 ± 0.11</td><td class="colsep0 rowsep0" align="char" char=".">3.8 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">14.0 ± 2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.34 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.80 ± 0.31</td><td class="colsep0 rowsep0" align="char" char=".">1.1 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">15.2 ± 5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.25 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.56 ± 0.24</td><td class="colsep0 rowsep0" align="char" char=".">3.2 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">13.0 ± 3.5</td><td class="colsep0 rowsep0" align="char" char=".">0.14 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.62 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">6.3 ± 0.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Not tested.</p></div></div></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlations between inhibition of IDH1(R132C) and that of (A) IDH1(R132H) and (B) cellular production of D2HG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, given that WT IDH1 plays an important role in normal physiology, an ideal inhibitor should have a good selectivity for the mutant IDH1 enzymes. The inhibitory activities of the above 10 compounds were tested against recombinant WT IDH1 and the results are also shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Compounds <b>2</b>, <b>3</b>, and <b>58</b>–<b>60</b> were found to have only weak inhibitory activities (<i>K</i><sub>i</sub> 12.3–16.8 μM) against WT IDH1, while compounds <b>7</b>, <b>33</b>, <b>34</b>, <b>39</b>, and <b>40</b> do not inhibit the enzyme. Selectivity of >41-fold was observed for these compounds, compared with their <i>K</i><sub>i</sub> values against IDH1(R132H),.</div><div class="NLM_p">The activities of these compounds against the three IDH1 enzymes indicate that Arg132 exhibits a drastically different role from His132 or Cys132. Previous structural studies of WT and R132H mutant IDH1 show IDH1(R132H) has two ligand binding sites, I and II (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1A),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with the site II being the catalytic site ∼6.5 Å away from site I, while WT IDH1 only has the binding site II. ICT binds to site I in IDH1(R132H), while α-KG occupies the catalytically active, binding site II.<a onclick="showRef(event, 'ref12 ref25'); return false;" href="javascript:void(0);" class="ref ref12 ref25">(12, 25)</a> His132 is not involved in the binding of either ICT or α-KG. ICT is located in site II in WT IDH1. The function of Arg132 is to have two H-bonds as well as an electrostatic interaction with the two carboxyl groups of ICT, which can enhance the binding of ICT in site II as well as stabilize the overall structure of the IDH1/ICT complex. Due to the shorter length as well as the chemical nature of the side chain, His132 (as well as Cys132) cannot play the same role as Arg132. This explains why R132H and R132C mutant proteins have the similar function, while WT IDH1 having Arg132 is a different enzyme. It is noted that the two binding sites I and II do not coexist in IDH1(R132H). With ligand induced protein conformational changes, IDH1(R132H) exhibits either its binding site I or II.</div><div class="NLM_p last">Our X-ray crystallographic studies showed that compounds <b>2</b> and <b>3</b> are located in the ligand binding site I of IDH1(R132H) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Figure S1B,C).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The R132H (as well as R132C) mutation causes the mutant protein to bind ICT/<b>2</b>/<b>3</b> in the binding site I, while R132 in WT IDH1 can induce protein conformational changes and stabilize the binding of ICT/α-KG in the site II. Our modeling studies show that the distinct environment for binding site I represents the structural basis for the high selectivity of inhibitors <b>2</b> and <b>3</b> for mutant IDH1.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition of Cellular Production of D2HG</h3><div class="NLM_p last">The hallmark of IDH mutated cancer is the significantly elevated D2HG concentrations in cancer cells as well as in plasma. We next measured the ability of the 10 inhibitors in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> to reduce the cellular production of D2HG. Human fibrosarcoma HT1080 cells, which harbor the IDH1 R132C mutation,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> were treated with increasing concentrations of these compounds for 48 h. No significant cytotoxicity to HT1080 cells was observed for up to 30 μM. D2HG concentrations of the cells were quantitatively determined by using HPLC-MS. Are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, except for the weak inhibitors <b>7</b> and <b>33</b> (used as negative controls), inhibitors of IDH1(R132C) were able to inhibit the production of D2HG in HT1080 with the IC<sub>50</sub> values of 1.1–9.7 μM. In addition, the cell activities of these compounds also exhibit a good correlation with their enzyme activity, showing a <i>R</i><sup>2</sup> value of 0.73 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In vitro Blood–Brain Barrier (BBB) Permeability</h3><div class="NLM_p">Since inhibitors of mutant IDH1 are required to penetrate the blood–brain barrier (BBB) for glioma treatment, a cell-based model system using MDCK-MDR1 cells<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> was used to determine the BBB permeability potential for selected compounds <b>2</b> and <b>39</b>, as well as for the known inhibitor <b>1</b> as a comparison. The cells are grown on polycarbonate supports separating two chambers to allow compound flux in either direction, apical [A] to basolateral [B] and vice versa, to be measured. The cells are highly confluent to approximate the tight junctions characteristic of endothelial cells that comprise the BBB. In addition, the multidrug resistance 1 (<i>MDR1</i>) gene is overexpressed in the cell, producing a high level of P-glycoprotein (the product of <i>MDR1</i>), a known BBB efflux pump, on the apical side that limits brain distribution for many low molecular weight drugs.</div><div class="NLM_p">As can be seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, 1-hydroxy-pyridin-2-one compounds <b>2</b> and <b>39</b> were both found to have analogous cell permeability values of 5.45 and 5.39, respectively, in the A → B direction, and possessed comparable rates of 6.34 and 8.88 for the reverse direction. The low efflux ratios (1.3 and 1.7) due to the comparable directional permeability rates suggest that these two compounds are not likely substrates for P-glycoprotein. On the other hand, compound <b>1</b> exhibited a low rate of cell permeability (0.15) in the A → B direction and much higher rate of 10.4 in the B → A direction leading to a high efflux ratio of 72.6, suggesting that compound <b>1</b> is a substrate of P-glycoprotein and likely BBB impermeable.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cell Permeability Rates (10<sup>–6</sup> cm/s) for Mutant IDH1 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">rate (apical to basolateral)</th><th class="colsep0 rowsep0" align="center" char=".">rate (basolateral to apical)</th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">72.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">5.45</td><td class="colsep0 rowsep0" align="char" char=".">6.34</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">5.39</td><td class="colsep0 rowsep0" align="char" char=".">8.88</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Measured as rate<sup>(B→A)</sup>/rate<sup>(A→B)</sup>.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Selective Activity against Glioma Stem-Like Cells with IDH1 R132H Mutation</h3><div class="NLM_p">Next, we examined the activity of the IDH1(R132H) inhibitors against BT-142 glioma cells having the R132H IDH1 mutation,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> as well as two glioma cells, BXD-4687 and -3752, without an IDH1 mutation as controls.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Unlike normal cell culture conditions under which cells are grown as a monolayer attached to a plate, these glioma cells were cultured in serum-free media and grown as neurospheres, colonies of glioma cells with a diameter of 30–300 μm. The so-called cancer stem cells (CSC) are enriched in these neurospheres.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> CSCs represent a small fraction of cancer cells with a distinct phenotype that can form new tumors when transplanted into immunocompromised mice.<a onclick="showRef(event, 'ref30 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref35 ref36 ref37">(30, 35-37)</a> While proliferating rapidly, the bulk non-stem cancer cells fail to do so. CSCs possess certain key traits as normal stem cells, including the ability to unlimitedly self-renew and differentiate. It has now well documented that CSCs play important roles in antitumor-drug resistance, cancer relapse, and metastasis. It is therefore important to find compounds having selective activity against CSCs.</div><div class="NLM_p">The most potent IDH1(R132H) inhibitors <b>2</b>, <b>39</b>, <b>40</b>, <b>58</b>, and <b>59</b> were tested to inhibit the formation of neurospheres of the three glioma cells. Also included in the assay are compound <b>1</b> and temozolomide, the first-line chemotherapy for glioblastoma. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, all of the three clinical glioblastoma cells are resistant to temozolomide (EC<sub>50</sub> > 50 μM), suggesting that these cells overexpress <i>MDR1</i>, which is the main cause for temozolomide resistance. Compound <b>1</b> exhibits no activity against BXD-4687 and -3752 (without an IDH1 mutation) and normal fibroblast WI-38 cells. For BT-142 glioma cells with the IDH1 R132H mutation, <b>1</b> was found to inhibit neurosphere formation by ∼40% at 2 μM, but increase of the concentration of <b>1</b> to 20 μM did not result in higher inhibition, presumably due to the high efflux or poor permeability of <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Consistent with the results in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, activity of compound <b>2</b> (as well as other 1-hydroxypyridin-2-one analogs) is not affected by these factors. Compound <b>2</b> exhibited potent activity against IDH1(R132H)-containing BT-142 cells with an EC<sub>50</sub> of 370 nM, while it had significantly weaker activity against BXD-4687 and -3752 without an IDH1 mutation (EC<sub>50</sub> 6.8 and 5.9 μM, respectively), showing a high selectivity of ∼16-fold. In addition, compound <b>2</b> possesses negligible cytotoxicity against the proliferation of normal fibroblast WI-38 cells (EC<sub>50</sub> > 50 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These results show that potent IDH1(R132H) inhibitor <b>2</b> possesses selective activity against the proliferation of CSCs of BT-142, which is dependent upon the cellular environment caused by a high concentration of D2HG. The moderate activity of <b>2</b> against BXD-4687 and -3752 suggests the compound could have nonspecific activity against the proliferation of these two glioma cells. Indeed, while inactive against IDH1(R132H), compound <b>9</b> (ciclopirox) was reported to have similar (low micromolar) antiproliferative activity against, for example, breast cancer and leukemia cells.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> This suggests compound <b>2</b> exerts dual activities on BT-142 cells, that is, by inhibiting IDH1(R132H) and blocking rapid proliferation simultaneously, which could provide a synergistic (or additive) effect. This could explain the high potency of the dual-role compound. Similarly, compounds <b>39</b>, <b>40</b>, <b>58</b>, and <b>59</b> exhibited selective activity against BT-142 glioma cells, with compound <b>58</b> being the most potent. It inhibited neurosphere formation of BT-142 with an EC<sub>50</sub> of 260 nM, while it showed >10-fold less activity against the two glioma cells without an IDH1 mutation. Moreover, none of these compounds possess significant cytotoxicity against the proliferation of normal fibroblast WI-38 cells, showing potentially low toxicity. Given temozolomide resistance in a significant portion of glioma/glioblastoma as well as poor BBB permeability and weak antiglioma activity of compound <b>1</b>, these results demonstrate the importance for further development of these 1-hydroxypyridin-2-one inhibitors as potential therapeutics for IDH1 mutated glioma.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. EC<sub>50</sub> Values (μM) of Selected Inhibitors against Glioma and Normal Fibroblast WI-38 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="​" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="​">BT-142</th><th class="colsep0 rowsep0" align="center" char=".">BXD-4687</th><th class="colsep0 rowsep0" align="center" char=".">BXD-3752</th><th class="colsep0 rowsep0" align="center" char=".">WI-38</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">temozolomide</td><td class="colsep0 rowsep0" align="char" char="​">>50</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#tbl5-fn1" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="​">>20<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="​">0.37 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">6.8 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">5.9 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char="​">0.63 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char="​">1.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">7.5 ± 3.1</td><td class="colsep0 rowsep0" align="char" char=".">6.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char="​">0.26 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">7.6 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">2.8 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char="​">0.69 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">16 ± 2.0</td><td class="colsep0 rowsep0" align="char" char=".">5.1 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">EC<sub>50</sub> of <b>1</b> cannot be accurately determined; <b>1</b> (2 μM) exhibited ∼40% of inhibition, but increasing to 20 μM still showed ∼40% inhibition.</p></div><div class="footnote" id="tbl5-fn1"><sup>b</sup><p class="last">Not tested.</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> shows the general methods for the synthesis of the 4-methyl-6-substituted 1-hydroxypyridin-2-one and related compounds, which include the most active inhibitors (e.g., <b>2</b> and <b>39</b>) of mutant IDH1. An acyl chloride was reacted with ethyl 3-methyl-2-butenate in the presence of AlCl<sub>3</sub> to produce a mixture of stereoisomeric esters, which without purification were cyclized under acidic conditions to generate a single compound, pyron-2-one <b>63</b>, with a yield of 50–85% from the acyl chloride. Because the reaction of <b>63</b> with hydroxylamine occurred in a very poor yield (0–20%), compound <b>63</b> was converted to more reactive pyron-2-thione <b>64</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> which reacted readily with hydroxylamine or hydrazine to give 4-methyl-6-substituted 1-hydroxy (or amino)-pyridin-2-one compounds in 67–73% yield. We found that compound <b>63a</b> with a 6-chloromethyl group is a useful common intermediate, which can undergo a mild Suzuki coupling reaction to give <b>63b</b>. With this route, compounds <b>3</b> and <b>38</b>–<b>62</b> were synthesized without each starting from a different acyl chloride. In addition, strong acid sensitive R-groups, for example, thiophenyl in <b>51</b>, can be introduced.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis for 4-Methyl-6-substituted 1-Hydroxypyridin-2-one and Related Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) AlCl<sub>3,</sub> CH<sub>2</sub>Cl<sub>2,</sub> reflux; (ii) H<sub>2</sub>SO<sub>4</sub>/HOAc; (iii) P<sub>4</sub>S<sub>10</sub>, benzene, reflux; (iv) NH<sub>2</sub>OH or NH<sub>2</sub>NH<sub>2</sub>, pyridine, reflux; (v) R-B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, dioxane, reflux.</p></p></figure><div class="NLM_p">The majority of the mono-5- or 6-substituted 1-hydroxypyridin-2-one compounds were synthesized using a palladium catalyzed coupling reaction starting from a bromo-substituted 2-methoxypyridine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). By our previous methods,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> the 2-methoxypyridine moiety of the coupling products was converted to the 1-hydroxypyridin-2-one core by oxidation with 3-chloroperoxybenzoic acid followed by treatment with acetyl chloride. To synthesize compounds <b>36</b> and <b>37</b>, 2,6-dihydroxyisonicotinic acid was heated with POBr<sub>3</sub> followed by methanolysis to give 2,6-dibromo ester <b>65</b>, which was reduced, protected with a methoxymethyl (MOM) group, and treated with NaOMe to produce compound <b>66</b> with the desired 2-OMe and 6-Br. Treatment with BuLi followed by benzaldehyde afforded a secondary alcohol, whose -OH was reduced by the reaction with Et<sub>3</sub>SiH and trifluoroacetic acid<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> to give compound <b>67</b>. Deprotection of MOM as well as conversion to 1-hydroxypyridin-2-one led to the formation of compound <b>37</b>. Hydrolysis of <b>37</b> with NaOH produced compound <b>36</b>. Compounds <b>34</b> and <b>35</b> were prepared from 2,6-dibromopyridine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The oxidation of the pyridine ring facilitated the nitration at the 4-position of 2,6-dibromopyridine to give compound <b>68</b>. Upon reduction of the pyridine-oxide, treatment with NaOMe resulted in double substitutions of the 2-Br and 4-NO<sub>2</sub> groups to give 6-bromo-2,4-dimethoxypyridine (<b>70</b>). A palladium catalyzed reaction to introduce the 6-benzyl group followed by conversion to 1-hydroxypyridin-2-one gave rise to compound <b>35</b>, whose -Me was removed by treatment with BBr<sub>3</sub> to produce compound <b>34</b>.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis for Other Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) a Pd-catalyzed coupling reaction, for example, Suzuki or Heck reaction; (ii) 3-chloroperoxybenzoic acid; (iii) AcCl, reflux, then MeOH; (iv) POBr<sub>3</sub>, 130 °C, then MeOH; (v) NaBH<sub>4</sub>, reflux; (vi) MOMCl, Et<sub>3</sub>N; (vii) NaOMe, reflux; (viii) BuLi, −78 °C, then PhCHO, 25 °C; (ix) Et<sub>3</sub>SiH, trifluoroacetic acid, 50 °C; (x) 3 N HCl; (xi) NaOH; (xii) H<sub>2</sub>O<sub>2</sub>, TFA, reflux; (xiii) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>; 60 °C; (xiv) PBr<sub>3</sub>; (xv) NaOMe, MeOH/THF, 40 °C; (xvi) BnZnBr, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; (xvii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">IDH1 mutations at the residue Arg132 are frequently found in low grade gliomas/secondary glioblastomas (∼75%), AML (∼20%), and certain sarcomas. Studies have shown that these mutant proteins acquire a new enzyme function, that is, the reduction of α-KG to D2HG, causing D2HG accumulation in the patients. High concentrations (in millimolar levels) of D2HG can inhibit a broad range of α-KG-dependent dioxygenases, including histone demethylases and DNA hydroxylases, leading to abnormal levels of histone/DNA methylation, which block cell differentiation and eventually cause cancer initiation. Mutant IDH1 proteins are therefore drug targets for these types of cancer. Upon screening of compounds targeting another Mg<sup>2+</sup>/NADPH-dependent enzyme, 1-hydroxypyridin-2-one compounds <b>4</b> and <b>7</b> were identified to be low micromolar inhibitors of IDH1(R132H). Guided by SAR as well as the X-ray structure of the IDH1(R132H)/<b>2</b> complex, a total of 61 derivatives were designed and synthesized, among which several potent inhibitors were identified with <i>K</i><sub>i</sub> values of 140–270 nM. SAR analysis shows that (1) the 1-hydroxypyridin-2-one core structure is required to be active, (2) a very small group such as -Me or -OH at the 4-position of the core is needed to achieve a submicromolar potency, (3) a (substituted) benzyl group at the 6-position of 1-hydroxypyridin-2-one is more favored compared with a phenyl or other groups at the 3- and 5-positions, and (4) strongly electron-withdrawing groups are disfavored as a substituent for the 6-benzyl, while -OMe or -OH, for example, that in compounds <b>39</b>, <b>40</b>, and <b>60</b>, provides an improved activity. Ten selected compounds were tested for their activity in inhibiting IDH1(R132C), as well as the production of D2HG in HT1080 fibrosarcoma cells, and the results indicate that there are good correlations between these inhibitory activities. In addition, these compounds exhibit potent and selective activity in inhibiting the proliferation of BT-142 glioma cells with the R132H IDH1 mutation, with the most potent compound <b>58</b> having EC<sub>50</sub> of 0.26 μM, while it is considerably less active against two glioma cells without an IDH1 mutation (EC<sub>50</sub> 2.8 and 7.6 μM), showing a selectivity of >10-fold. Low cytotoxicity (EC<sub>50</sub> > 50 μM) of these compounds against normal fibroblast WI-38 cells was observed. Moreover, using a cell based BBB model assay, 1-hydroxypyridin-2-one inhibitors were found to be BBB permeable, while inhibitor <b>1</b> with another chemo-type has a high efflux ratio, which might be responsible for the observed weak activity of <b>1</b> (EC<sub>50</sub> > 20 μM) against BT-142 glioma cells. All these results suggest that this work could lead to a new treatment for IDH1 mutated glioma and further development of 1-hydroxypyridin-2-one inhibitors is warranted.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were purchased from Alfa Aesar (Ward Hill, MA) or Aldrich (Milwaukee, WI). Compounds were characterized by <sup>1</sup>H NMR on a Varian (Palo Alto, CA) 400-MR spectrometer, and the purities monitored by a Shimadzu Prominence HPLC with a Phenomenex C18 column (4.6 mm × 250 mm, methanol/H<sub>2</sub>O 60:40, monitored at 254 and 280 nm). The purities of all compounds were found to be >95%.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis and Characterization of Compounds <b>2</b>–<b>62</b></h3><div class="NLM_p last">Details of compound synthesis and characterization can be found in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Experimental Section.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Expression and Purification of Human WT and R132H Mutant IDH1</h3><div class="NLM_p">The wild-type IDH1 gene was cloned using 5′-GATCCGAATTCGATGTCCAAAAAAATCAGTG-3′ and 5′-TGGTGCTCGAGTAAGTTTGGCCTGAGCTAG-3′ as forward and reverse primers, respectively, and inserted into pET-24b vector. Correctness of the inset was verified by sequencing. <i>Escherichia coli</i> BL21-CodonPlus strain (Agilent) was transformed with the plasmid and cultured at 37 °C in LB medium containing kanamycin (50 μg/mL) and chloramphenicol (34 μg/mL). Upon reaching an optical density of ∼0.6 at 600 nm, IDH1 expression was induced by addition of 0.1 mM isopropylthiogalactoside at 18 °C for 20 h. Cells were harvested, lysed, and centrifuged at 20000 rpm for 20 min, and the supernatant was collected and purified using Ni-affinity (HisTrap HP, GE Healthcare) followed by Superdex 75 (GE Healthcare) column chromatography. WT-IDH1 was obtained with ∼90% purity (SDS-PAGE).</div><div class="NLM_p last">R132H and R132C mutant IDH1 genes were generated from the wild-type IDH1 plasmid, using QuikChange site-directed mutagenesis kit (Agilent) following the manufacturer’s protocol. Correctness of the gene sequences was verified. The mutant genes were then transferred to pGEX-KG vector for better expression. Expression of mutant IDH1 enzymes were performed similarly to that for the wild-type protein. Cells were harvested, lysed, and centrifuged at 20000 rpm for 20 min, the supernatant was collected, and the recombinant protein was trapped in glutathione sepharose resin (GE Healthcare). The GST-IDH1 fusion protein was eluted with 10 mM glutathione solution, and the GST tag was removed by thrombin digestion overnight at 4 °C. IDH1(R132H) and IDH1(R132C) were obtained in ∼90% purity (SDS-PAGE) using a glutathione sepharose column followed by Superdex 75 gel filtration column chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Enzyme Inhibition Assays</h3><div class="NLM_p">Determination of the activity and inhibition of IDH1(R132H) and IDH1(R132C) is based on the initial linear consumption of NADPH in the reaction. The enzyme activity assay was performed in a 96-well microplate using the purified IDH1 mutant (100 nM), 4 mM MgCl<sub>2</sub>, 1 mM α-KG, and 100 μM NADPH (≫<i>K</i><sub>m</sub> for NADPH) in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (pH = 7.5) containing 0.1 mg/mL bovine serum albumin. For inhibition assays, triplicate samples of compounds were incubated with the protein for 5 min before addition of α-KG to initiate the reaction. The optical absorbance of each well was monitored every 30 s at 340 nm, where NADPH has maximum absorption, using a Beckman DTX-880 microplate reader. The data were imported into Prism (version 5.0, GraphPad), and the IC<sub>50</sub> values were calculated with a standard dose–response curve fitting. For compounds with IC<sub>50</sub> values much greater than the enzyme concentration, <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>), where [S] is the concentration of α-KG (1 mM) and <i>K</i><sub>m</sub> is the literature value of 0.965 mM for R132H<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and 0.295 mM for R132C.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> For compounds with IC<sub>50</sub> < 1 μM, <i>K</i><sub>i</sub> values were calculated using the Morrison tight inhibition modeling in Prism.</div><div class="NLM_p last">Determination of the activity/inhibition of WT-IDH1 is based on the initial linear production of NADPH. In brief, the enzyme activity assay was performed in a 96-well microplate using the purified IDH1 (15 nM), 4 mM MgCl<sub>2</sub>, 200 μM sodium <span class="smallcaps smallerCapital">d</span>-isocitrate (<i>K</i><sub>m</sub> = 65 μM),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and 1 mM NADP<sup>+</sup> (≫<i>K</i><sub>m</sub> for NADP) in 50 mM HEPES buffer (pH = 7.5). The reaction can be readily monitored by an increase in optical absorbance at 340 nm. Activity and compound inhibition can be determined similarly as described for mutant IDH1 using Prism 5.0.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Docking</h3><div class="NLM_p last">Docking studies were performed with our previous methods<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> using the Schrödinger suite (version 2013, Schrödinger, LLC, New York, NY, 2013), which includes all of the programs described below. The crystal structure of IDH1(R132H)/<b>2</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L">4I3L</a>) was prepared using the module “protein preparation wizard” in Maestro (version 9.5) using default protein parameters, with all water molecules removed, hydrogens added, inhibitor extracted, and NADPH retained in the protein structure for docking. H-bonds were then optimized, and the protein was energy-minimized using OPLS-2005 force field. A receptor grid, which is large enough to contain the whole active site, was generated using Glide (version 5.5) without constraints. Compounds were built, minimized using OPLS-2005 force field in Maestro, and then docked into the prepared protein structure using Glide (docking parameters: standard-precision and dock flexibly).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Growth Inhibition</h3><div class="NLM_p last">The cytotoxicity assay was done using our previous method.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In brief, 10<sup>5</sup> WI-38 fibroblast cells were inoculated into each well of a 96-well plate and cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum at 37 °C in a 5% CO<sub>2</sub> atmosphere with 100% humidity overnight for cell attachment. After addition of compounds (from 1 to 50 μM), plates were incubated for 48 h, after which cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, using a commercially available kit (Sigma). IC<sub>50</sub> value of each compound was calculated from dose–response curves by Prism 5.0.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> D2HG Production Inhibition in HT1080 Cells</h3><div class="NLM_p last">The HT1080 fibrosarcoma cell line, which harbors an IDH1(R132C) mutation, was obtained from ATCC (Manassas, VA). The D2HG production inhibition assay followed our previous protocol.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In brief, 10<sup>5</sup> cells/well were seeded into wells of a six-well plate and cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% dialyzed fetal bovine serum at 37 °C in a 5% CO<sub>2</sub> atmosphere with 100% humidity overnight for cell attachment. Cells were treated with an increasing concentration of compounds in 2 mL of culture medium for 48 h. Medium was collected and diluted with 8 mL of MeOH. After shaking, the mixture was centrifuged to remove any precipitate, and the supernatant was subjected to HPLC-MS to separate and quantitate the amount of D2HG. HPLC was run using a Phenomenex C18 column (250 mm × 4.6 mm, 5 μm) with 50% tributylamine buffer/50% MeOH as an eluent at a flow rate of 0.5 mL/min (tributylamine buffer: 10 mM tributylamine, 15 mM acetic acid, 3% MeOH in water). A single ion monitoring (SIM) for 147 Da was used to detect and quantitate the amount of D2HG (parameters: interface voltage, −4.2 kV; detector voltage, 1.3 kV; nebulizing gas, 1.5 L/min; drying gas, 15 L/min; desolvation line temperature, 250 °C; heat block temperature, 200 °C; Pirani gauge vacuum, 102 Pa; ion gauge vacuum: 5 × 10<sup>–4</sup> Pa). Authentic D2HG purchased from Sigma-Aldrich (St Louis, MO) was used to validate and calibrate the HPLC-MS assay conditions before measuring the D2HG concentrations secreted by the HT1080 cells untreated or treated with <b>2</b>. EC<sub>50</sub> was calculated from the dose–response curve by Prism 5.0.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vitro Blood–Brain Barrier (BBB) Permeability Assay</h3><div class="NLM_p">MDCK-MDR1 cells were obtained from NIH (Bethesda, MD) and maintained in DMEM with 10% standard fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 80 ng/mL colchicine. For transport experiments, cells with passage numbers of 24–33 were seeded at a density of 60000 cells/cm<sup>2</sup> on Transwell plates (pore size 0.4 μm; diameter 6.5 mm; insert growth area 0.33 cm<sup>2</sup>; Costar, Pittston, PA) and maintained in culture as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In brief, confluent MDCK-MDR1 monolayers expressing P-glycoprotein were obtained 3–4 days postseeding, and their integrity was assessed by measurement of the transepithelial electrical resistance (TEER, Ω·cm<sup>2</sup>) with a volt–ohm meter (Millicell-ERS, Millipore Corpration, Billerica, MA). After subtraction of the background TEER (i.e., the resistance exhibited by the filter alone), only MDCK-MDR1 cell monolayers that exhibited a TEER > 1000 Ω·cm<sup>2</sup> throughout [measured before and after the study] the experiments were used.</div><div class="NLM_p">Drug transport across the cell monolayers was measured in both apical to basolateral (A-B) and basolateral to apical (B-A) directions. Experiments were performed in HBSS (Hank’s balanced salt solution containing 50 mM HEPES buffer, pH ≈ 7.4) at 37 °C using monolayers that were preincubated for 30 min with prewarmed HBSS. At the start of the experiment, fresh HBSS was added to the receiver compartments, and the compounds were independently added to the donor compartments at an initial concentration of 10 μM (diluted from 10 mM DMSO stock to a final DMSO concentration of 0.1%) and then incubated at 37 °C for 90 min, after which samples were collected from both the receiver and donor compartments.</div><div class="NLM_p">Detection and quantification of the compounds were performed with an LC/MS/MS system (HPLC, Shimadzu, Kyoto, Japan; MS, QTrap 5500, Applied Biosystems, Foster City, California) using an electrospray ionization (ESI) interface and operated in positive ion mode. Instrument control, data acquisition, and processing for both chromatography and MS were performed using the Analyst 1.5.1 software (Applied Biosystems MDS Sciex, Ontario, Canada). The chromatographic separation system consisted of a guard cartridge (C18, 4.0 × 2.0 mm<sup>2</sup>; Phenomenex, Torrance, California), an analytic column (Luna C18, 3 μm particle size, 50 × 2.0 mm<sup>2</sup>; Phenomenex), and a mobile phase of acetonitrile/10 mM ammonium formate (65:35, v/v), delivered isocratically at a flow rate of 0.2 mL/min. To 10 μL samples from both the apical or basolateral sides, 40 μL of cold acetonitrile was added; samples were mixed and centrifuged at 15000 rpm for 5 min; 10 μL of the resultant supernatant was injected into the LC/MS-MS system. Compound quantification was performed by ESI-selected reaction monitoring. The column effluent was monitored at the following precursor–product ion transitions: <i>m</i>/<i>z</i> 214.9 → 197.1 for compound <b>2</b>, <i>m</i>/<i>z</i> 244.9 → 212.3 for <b>39</b>, and <i>m</i>/<i>z</i> 463.2 → 123.0 for <b>1</b> with a dwell time of 100 ms for each ion transition.</div><div class="NLM_p last">The apparent permeability, <i>P</i><sub>app</sub> (cm/s) was calculated as <i>P</i><sub>app</sub> = d<i>Q</i>/(d<i>t</i> × 1/(<i>A</i><i>C</i><sub>0</sub>)), where d<i>Q</i>/d<i>t</i> is the transport rate of the compound (mol/s), <i>A</i> is the area of the cell monolayer (cm<sup>2</sup>), and <i>C</i><sub>0</sub> is the initial donor concentration (mol/L).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Inhibition of the Proliferation of Glioma Cells</h3><div class="NLM_p last">Two glioma neurosphere cultures, Baylor xenograft derived BXD-4687 and BXD-3752, were initiated from patient tumor-derived orthotopic xenograft mouse models.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> These cells were cultured in serum-free cell growth medium consisting of neurobasal media, N2 and B27 supplements (Life Technologies, Grand Island, NY), recombinant human bFGF and EGF (50 ng/mL each; R&D Systems Inc., Minneapolis, MN), 200 units/mL penicillin, and 200 μg/mL streptomycin at 37 °C in a 5% CO<sub>2</sub> atmosphere with 100% humidity as we described previously.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> BT-142 glioma cells,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which have an endogenous R132H mutation in IDH1, aggressive tumor-initiating capacity, and 2-hydroxyglutarate (2-HG) production, were obtained from ATCC (Manassas, VA) and maintained in above-mentioned serum-free stem cell growth medium with additional supplements, including 100 ng/mL recombinant human platelet-derived growth factor-AA, 25 μg/mL insulin, 100 μg/mL transferrin, 15 μM putrescine, 30 nM selenite, 2 μg/mL heparan sulfate, 0.9% glucose, 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 20 nM progesterone. To measure antiproliferative activity, 2000 cells/well were seeded into 96-well plates and treated with 0.002, 0.02, 0.2, 2, and 20 μM of the selected compounds in 100 μL of culture medium for up to 13 days. Cell viability was measured at days 4, 7, 10, and 13 by Cell Counting Kit-8 (Dojindo Molecular Technologies, Rockville, MD) according to the manufacturer’s instructions as we described previously.<a onclick="showRef(event, 'ref31 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref35">(31, 35)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/jm500660f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Alignments of crystal structures of IDH1 forms bound to substrates and inhibitors and experimental procedures providing details of compound synthesis and characterization. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500660f/suppl_file/jm500660f_si_001.pdf">jm500660f_si_001.pdf (834.35 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500660f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongcheng Song</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e198928e8f86a183828ccf848594"><span class="__cf_email__" data-cfemail="78010b17161f381a1b15561d1c0d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen Liu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Yao</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mari Kogiso</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baisong Zheng</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisheng Deng</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jihui J. Qiu</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuo Dong</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Lv</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. Gallo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Nan Li</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacology, ⊥Department of Pediatrics-oncology, ∥Department of Medicine, and ‡Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.L. and Y.Y. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2973e3687-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant (R01NS080963) from National Institute of Neurological Disorders and Stroke (NINDS/NIH) and a grant (RP140469) from Cancer Prevention and Research Institute of Texas (CPRIT) to Y.S., as well as a grant (R01CA127963) to J.M.G.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> Abbrevations</h2><tr><td class="NLM_term">α-KG</td><td class="NLM_def"><p class="first last">α-ketoglutaric acid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">D2HG</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid</p></td></tr><tr><td class="NLM_term">ICT</td><td class="NLM_def"><p class="first last">isocitric acid</p></td></tr><tr><td class="NLM_term">IDH</td><td class="NLM_def"><p class="first last">isocitrate hydrogenase</p></td></tr><tr><td class="NLM_term"><i>MDR1</i></td><td class="NLM_def"><p class="first last">multidrug resistance 1</p></td></tr><tr><td class="NLM_term">R132H</td><td class="NLM_def"><p class="first last">Arg132 mutation to His</p></td></tr><tr><td class="NLM_term">R132C</td><td class="NLM_def"><p class="first last">Arg132 mutation to Cys</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">33946</span><span class="NLM_x">–</span> <span class="NLM_lpage">33957</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1074%2Fjbc.M404298200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=15173171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33946-33957&author=X.+Xuauthor=J.+Zhaoauthor=Z.+Xuauthor=B.+Pengauthor=Q.+Huangauthor=E.+Arnoldauthor=J.+Ding&title=Structures+of+human+cytosolic+NADP-dependent+isocitrate+dehydrogenase+reveal+a+novel+self-regulatory+mechanism+of+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity</span></div><div class="casAuthors">Xu, Xiang; Zhao, Jingyue; Xu, Zhen; Peng, Baozhen; Huang, Qiuhua; Arnold, Eddy; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33946-33957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate, and regulation of the enzymic activity of IDHs is crucial for their biol. functions.  Bacterial IDHs are reversibly regulated by phosphorylation of a strictly conserved serine residue at the active site.  Eukaryotic NADP-dependent IDHs (NADP-IDHs) have been shown to have diverse important biol. functions; however, their regulatory mechanism remains unclear.  Structural studies of human cytosolic NADP-IDH (HcIDH) in complex with NADP and in complex with NADP, isocitrate, and Ca2+ reveal three biol. relevant conformational states of the enzyme that differ substantially in the structure of the active site and in the overall structure.  A structural segment at the active site that forms a conserved α-helix in all known NADP-IDH structures assumes a loop conformation in the open, inactive form of HcIDH; a partially unraveled α-helix in the semi-open, intermediate form; and an α-helix in the closed, active form.  The side chain of Asp279 of this segment occupies the isocitrate-binding site and forms hydrogen bonds with Ser94 (the equiv. of the phosphorylation site in bacterial IDHs) in the inactive form and chelates the metal ion in the active form.  The structural data led us to propose a novel self-regulatory mechanism for HcIDH that mimics the phosphorylation mechanism used by the bacterial homologs, consistent with biochem. and biol. data.  This mechanism might be applicable to other eukaryotic NADP-IDHs.  The results also provide insights into the recognition and specificity of substrate and cofactor by eukaryotic NADP-IDHs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJaUxoQoMZ7Vg90H21EOLACvtfcHk0li_6An-GqsXCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D&md5=79474e467a8cca43c26551c86745b3e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404298200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520cytosolic%2520NADP-dependent%2520isocitrate%2520dehydrogenase%2520reveal%2520a%2520novel%2520self-regulatory%2520mechanism%2520of%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33946%26epage%3D33957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Haselbeck, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlister-Henn, L.</span><span> </span><span class="NLM_article-title">Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">12116</span><span class="NLM_x">–</span> <span class="NLM_lpage">12122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=12116-12122&author=R.+J.+Haselbeckauthor=L.+McAlister-Henn&title=Function+and+expression+of+yeast+mitochondrial+NAD-+and+NADP-specific+isocitrate+dehydrogenases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaselbeck%26aufirst%3DR.%2BJ.%26aulast%3DMcAlister-Henn%26aufirst%3DL.%26atitle%3DFunction%2520and%2520expression%2520of%2520yeast%2520mitochondrial%2520NAD-%2520and%2520NADP-specific%2520isocitrate%2520dehydrogenases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D12116%26epage%3D12122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jennings, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckey, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmelee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlister-Henn, L.</span><span> </span><span class="NLM_article-title">Cytosolic NADP(+)-dependent isocitrate dehydrogenase. Isolation of rat cDNA and study of tissue-specific and developmental expression of mRNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2689</span><span class="NLM_x">, </span> <span class="NLM_fpage">23128</span><span class="NLM_x">–</span> <span class="NLM_lpage">23134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2689&publication_year=1994&pages=23128-23134&author=G.+T.+Jenningsauthor=S.+Sechiauthor=P.+M.+Stevensonauthor=R.+C.+Tuckeyauthor=D.+Parmeleeauthor=L.+McAlister-Henn&title=Cytosolic+NADP%28%2B%29-dependent+isocitrate+dehydrogenase.+Isolation+of+rat+cDNA+and+study+of+tissue-specific+and+developmental+expression+of+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DG.%2BT.%26aulast%3DSechi%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DP.%2BM.%26aulast%3DTuckey%26aufirst%3DR.%2BC.%26aulast%3DParmelee%26aufirst%3DD.%26aulast%3DMcAlister-Henn%26aufirst%3DL.%26atitle%3DCytosolic%2520NADP%2528%252B%2529-dependent%2520isocitrate%2520dehydrogenase.%2520Isolation%2520of%2520rat%2520cDNA%2520and%2520study%2520of%2520tissue-specific%2520and%2520developmental%2520expression%2520of%2520mRNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D2689%26spage%3D23128%26epage%3D23134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenendt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallia, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busam, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekleab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strausberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karchin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">An integrated genomic analysis of human glioblastoma multiforme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1126%2Fscience.1164382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=18772396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1807-1812&author=D.+W.+Parsonsauthor=S.+Jonesauthor=X.+Zhangauthor=J.+C.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=I.+M.+Siuauthor=G.+L.+Galliaauthor=A.+Oliviauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=S.+Keirauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=D.+A.+Busamauthor=H.+Tekleabauthor=L.+A.+Diazauthor=J.+Hartiganauthor=D.+R.+Smithauthor=R.+L.+Strausbergauthor=S.+K.+Marieauthor=S.+M.+Shinjoauthor=H.+Yanauthor=G.+J.+Rigginsauthor=D.+D.+Bignerauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=An+integrated+genomic+analysis+of+human+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrated genomic analysis of human glioblastoma multiforme</span></div><div class="casAuthors">Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Siu, I.-Mei; Gallia, Gary L.; Olivi, Alessandro; McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Nikolskaya, Tatiana; Nikolsky, Yuri; Busam, Dana A.; Tekleab, Hanna; Diaz, Luis A., Jr.; Hartigan, James; Smith, Doug R.; Strausberg, Robert L.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Yan, Hai; Riggins, Gregory J.; Bigner, Darell D.; Karchin, Rachel; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1807-1812</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review based on author's research.  Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer.  To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, detd. the presence of amplifications and deletions using high-d. oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples.  This comprehensive anal. led to the discovery of a variety of genes that were not known to be altered in GBMs.  Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients.  Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were assocd. with an increase in overall survival.  These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFSe-eB8psp7Vg90H21EOLACvtfcHk0lgtIwceV8q5pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE&md5=88c9e87c4b9dc8ebedcaa2b5d9f3ce13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164382%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%2BC.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DOlivi%26aufirst%3DA.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DKeir%26aufirst%3DS.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DBusam%26aufirst%3DD.%2BA.%26aulast%3DTekleab%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DMarie%26aufirst%3DS.%2BK.%26aulast%3DShinjo%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAn%2520integrated%2520genomic%2520analysis%2520of%2520human%2520glioblastoma%2520multiforme%26jtitle%3DScience%26date%3D2008%26volume%3D321%26spage%3D1807%26epage%3D1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ccr.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=17-30&author=W.+Xuauthor=H.+Yangauthor=Y.+Liuauthor=Y.+Yangauthor=P.+Wangauthor=S.+H.+Kimauthor=S.+Itoauthor=C.+Yangauthor=M.+T.+Xiaoauthor=L.+X.+Liuauthor=W.+Q.+Jiangauthor=J.+Liuauthor=J.+Y.+Zhangauthor=B.+Wangauthor=S.+Fryeauthor=Y.+Zhangauthor=Y.+H.+Xuauthor=Q.+Y.+Leiauthor=K.+L.+Guanauthor=S.+M.+Zhaoauthor=Y.+Xiong&title=Oncometabolite+2-hydroxyglutarate+is+a+competitive+inhibitor+of+alpha-ketoglutarate-dependent+dioxygenases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases</span></div><div class="casAuthors">Xu, Wei; Yang, Hui; Liu, Ying; Yang, Ying; Wang, Ping; Kim, Se-Hee; Ito, Shinsuke; Yang, Chen; Wang, Pu; Xiao, Meng-Tao; Liu, Li-xia; Jiang, Wen-qing; Liu, Jing; Zhang, Jin-ye; Wang, Bin; Frye, Stephen; Zhang, Yi; Xu, Yan-hui; Lei, Qun-ying; Guan, Kun-Liang; Zhao, Shi-min; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: IDH1 and IDH2 mutations occur frequently in gliomas and acute myeloid leukemia, leading to simultaneous loss and gain of activities in the prodn. of α-ketoglutarate (α-KG) and 2-hydroxyglutarate (2-HG), resp.  Here we demonstrate that 2-HG is a competitive inhibitor of multiple α-KG-dependent dioxygenases, including histone demethylases and the TET family of 5-methylcytosine (5mC) hydroxylases. 2-HG occupies the same space as α-KG does in the active site of histone demethylases.  Ectopic expression of tumor-derived IDH1 and IDH2 mutants inhibits histone demethylation and 5mC hydroxylation.  In glioma, IDH1 mutations are assocd. with increased histone methylation and decreased 5-hydroxylmethylcytosine (5hmC).  Hence, tumor-derived IDH1 and IDH2 mutations reduce α-KG and accumulate an α-KG antagonist, 2-HG, leading to genome-wide histone and DNA methylation alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpry-WZlrav7Vg90H21EOLACvtfcHk0lgtIwceV8q5pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D&md5=27f1e2d50b9dc1dd30bcc576d6318662</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26aulast%3DJiang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFrye%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DLei%26aufirst%3DQ.%2BY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DOncometabolite%25202-hydroxyglutarate%2520is%2520a%2520competitive%2520inhibitor%2520of%2520alpha-ketoglutarate-dependent%2520dioxygenases%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D17%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0lgpaYubAlk4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19554337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+A+study+of+1%2C010+diffuse+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span></div><div class="casAuthors">Hartmann Christian; Meyer Jochen; Balss Jorg; Capper David; Mueller Wolf; Christians Arne; Felsberg Jorg; Wolter Marietta; Mawrin Christian; Wick Wolfgang; Weller Michael; Herold-Mende Christel; Unterberg Andreas; Jeuken Judith W M; Wesseling Peter; Reifenberger Guido; von Deimling Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Somatic mutations in the IDH1 gene encoding cytosolic NADP+-dependent isocitrate dehydrogenase have been shown in the majority of astrocytomas, oligodendrogliomas and oligoastrocytomas of WHO grades II and III.  IDH2 encoding mitochondrial NADP+-dependent isocitrate dehydrogenase is also mutated in these tumors, albeit at much lower frequencies.  Preliminary data suggest an importance of IDH1 mutation for prognosis showing that patients with anaplastic astrocytomas, oligodendrogliomas and oligoastrocytomas harboring IDH1 mutations seem to fare much better than patients without this mutation in their tumors.  To determine mutation types and their frequencies, we examined 1,010 diffuse gliomas.  We detected 716 IDH1 mutations and 31 IDH2 mutations.  We found 165 IDH1 (72.7%) and 2 IDH2 mutations (0.9%) in 227 diffuse astrocytomas WHO grade II, 146 IDH1 (64.0%) and 2 IDH2 mutations (0.9%) in 228 anaplastic astrocytomas WHO grade III, 105 IDH1 (82.0%) and 6 IDH2 mutations (4.7%) in 128 oligodendrogliomas WHO grade II, 121 IDH1 (69.5%) and 9 IDH2 mutations (5.2%) in 174 anaplastic oligodendrogliomas WHO grade III, 62 IDH1 (81.6%) and 1 IDH2 mutations (1.3%) in 76 oligoastrocytomas WHO grade II and 117 IDH1 (66.1%) and 11 IDH2 mutations (6.2%) in 177 anaplastic oligoastrocytomas WHO grade III.  We report on an inverse association of IDH1 and IDH2 mutations in these gliomas and a non-random distribution of the mutation types within the tumor entities.  IDH1 mutations of the R132C type are strongly associated with astrocytoma, while IDH2 mutations predominantly occur in oligodendroglial tumors.  In addition, patients with anaplastic glioma harboring IDH1 mutations were on average 6 years younger than those without these alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtaE6XzJLN_6xYuD7tu2XfW6udTcc2ea2ca4wJMafQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D&md5=cf2e0709bbe2f6d49d466b7083f2e486</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520A%2520study%2520of%25201%252C010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Marcucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radmacher, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrózek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margeson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzeler, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolitz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, C. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2348</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1200%2FJCO.2009.27.3730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20368543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2348-2355&author=G.+Marcucciauthor=K.+Maharryauthor=Y.-Z.+Wuauthor=M.+D.+Radmacherauthor=K.+Mr%C3%B3zekauthor=D.+Margesonauthor=K.+B.+Hollandauthor=S.+P.+Whitmanauthor=H.+Beckerauthor=S.+Schwindauthor=K.+H.+Metzelerauthor=B.+L.+Powellauthor=T.+H.+Carterauthor=J.+E.+Kolitzauthor=M.+Wetzlerauthor=A.+J.+Carrollauthor=M.+R.+Baerauthor=M.+A.+Caligiuriauthor=R.+A.+Larsonauthor=C.+D.+Bloomfield&title=IDH1+and+IDH2+gene+mutations+identify+novel+molecular+subsets+within+de+novo+cytogenetically+normal+acute+myeloid+leukemia%3A+A+cancer+and+leukemia+group+B+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study</span></div><div class="casAuthors">Marcucci, Guido; Maharry, Kati; Wu, Yue-Zhong; Radmacher, Michael D.; Mrozek, Krzysztof; Margeson, Dean; Holland, Kelsi B.; Whitman, Susan P.; Becker, Heiko; Schwind, Sebastian; Metzeler, Klaus H.; Powell, Bayard L.; Carter, Thomas H.; Kolitz, Jonathan E.; Wetzler, Meir; Carroll, Andrew J.; Baer, Maria R.; Caligiuri, Michael A.; Larson, Richard A.; Bloomfield, Clara D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2348-2355</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To analyze the frequency and assocns. with prognostic markers and outcome of mutations in IDH genes encoding isocitrate dehydrogenases in adult de novo cytogenetically normal acute myeloid leukemia (CN-AML).  Patients and Methods: Diagnostic bone marrow or blood samples from 358 patients were analyzed for IDH1 and IDH2 mutations by DNA polymerase chain reaction amplification/sequencing.  FLT3, NPM1, CEBPA, WT1, and MLL mutational analyses and gene- and microRNA-expression profiling were performed centrally.  Results: IDH mutations were found in 33% of the patients.  IDH1 mutations were detected in 49 patients (14%; 47 with R132).  IDH2 mutations, previously unreported in AML, were detected in 69 patients (19%; 13 with R172 and 56 with R140).  R172 IDH2 mutations were mutually exclusive with all other prognostic mutations analyzed.  Younger age (< 60 years), mol. low-risk (NPM1-mutated/FLT3-internal tandem duplication-neg.) IDH1-mutated patients had shorter disease-free survival than mol. low-risk IDH1/IDH2-wild-type (wt) patients (P = .046).  R172 IDH2-mutated patients had lower complete remission rates than IDH1/IDH2wt patients (P = .007).  Distinctive microarray gene- and microRNA-expression profiles accurately predicted R172 IDH2 mutations.  The highest expressed gene and microRNAs in R172 IDH2-mutated patients compared with the IDH1/IDH2wt patients were APP (previously assocd. with complex karyotype AML) and miR-1 and miR-133 (involved in embryonal stem-cell differentiation), resp.  Conclusion: IDH1 and IDH2 mutations are recurrent in CN-AML and have an unfavorable impact on outcome.  The R172 IDH2 mutations, previously unreported in AML, characterize a novel subset of CN-AML patients lacking other prognostic mutations and assoc. with unique gene- and microRNA-expression profiles that may lead to the discovery of novel, therapeutically targetable leuke-mogenic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiEtSm6jNn6LVg90H21EOLACvtfcHk0ljNARSpn2HW6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFOntr0%253D&md5=7f3d00b921e52fdc10e75ab2fbac3ae9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.3730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.3730%26sid%3Dliteratum%253Aachs%26aulast%3DMarcucci%26aufirst%3DG.%26aulast%3DMaharry%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.-Z.%26aulast%3DRadmacher%26aufirst%3DM.%2BD.%26aulast%3DMr%25C3%25B3zek%26aufirst%3DK.%26aulast%3DMargeson%26aufirst%3DD.%26aulast%3DHolland%26aufirst%3DK.%2BB.%26aulast%3DWhitman%26aufirst%3DS.%2BP.%26aulast%3DBecker%26aufirst%3DH.%26aulast%3DSchwind%26aufirst%3DS.%26aulast%3DMetzeler%26aufirst%3DK.%2BH.%26aulast%3DPowell%26aufirst%3DB.%2BL.%26aulast%3DCarter%26aufirst%3DT.%2BH.%26aulast%3DKolitz%26aufirst%3DJ.%2BE.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DA.%2BJ.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DBloomfield%26aufirst%3DC.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520gene%2520mutations%2520identify%2520novel%2520molecular%2520subsets%2520within%2520de%2520novo%2520cytogenetically%2520normal%2520acute%2520myeloid%2520leukemia%253A%2520A%2520cancer%2520and%2520leukemia%2520group%2520B%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D2348%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasanthakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paietta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löwenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span> </span><span class="NLM_article-title">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ccr.2010.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21130701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=553-567&author=M.+E.+Figueroaauthor=O.+Abdel-Wahabauthor=C.+Luauthor=P.+S.+Wardauthor=J.+Patelauthor=A.+Shihauthor=Y.+Liauthor=N.+Bhagwatauthor=A.+Vasanthakumarauthor=H.+F.+Fernandezauthor=M.+S.+Tallmanauthor=Z.+Sunauthor=K.+Wolniakauthor=J.+K.+Peetersauthor=W.+Liuauthor=S.+E.+Choeauthor=V.+R.+Fantinauthor=E.+Paiettaauthor=B.+L%C3%B6wenbergauthor=J.+D.+Lichtauthor=L.+A.+Godleyauthor=R.+Delwelauthor=P.+J.+Valkauthor=C.+B.+Thompsonauthor=R.+L.+Levineauthor=A.+Melnick&title=Leukemic+IDH1+and+IDH2+mutations+result+in+a+hypermethylation+phenotype%2C+disrupt+TET2+function%2C+and+impair+hematopoietic+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span></div><div class="casAuthors">Figueroa, Maria E.; Abdel-Wahab, Omar; Lu, Chao; Ward, Patrick S.; Patel, Jay; Shih, Alan; Li, Yushan; Bhagwat, Neha; Vasanthakumar, Aparna; Fernandez, Hugo F.; Tallman, Martin S.; Sun, Zhuoxin; Wolniak, Kristy; Peeters, Justine K.; Liu, Wei; Choe, Sung E.; Fantin, Valeria R.; Paietta, Elisabeth; Loewenberg, Bob; Licht, Jonathan D.; Godley, Lucy A.; Delwel, Ruud; Valk, Peter J. M.; Thompson, Craig B.; Levine, Ross L.; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-567</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Cancer-assocd. IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate (2HG) prodn.  Mutational and epigenetic profiling of a large acute myeloid leukemia (AML) patient cohort revealed that IDH1/2-mutant AMLs display global DNA hypermethylation and a specific hypermethylation signature.  Furthermore, expression of 2HG-producing IDH alleles in cells induced global DNA hypermethylation.  In the AML cohort, IDH1/2 mutations were mutually exclusive with mutations in the α-ketoglutarate-dependent enzyme TET2, and TET2 loss-of-function mutations were assocd. with similar epigenetic defects as IDH1/2 mutants.  Consistent with these genetic and epigenetic data, expression of IDH mutants impaired TET2 catalytic function in cells.  Finally, either expression of mutant IDH1/2 or Tet2 depletion impaired hematopoietic differentiation and increased stem/progenitor cell marker expression, suggesting a shared proleukemogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5mMhJR64Z4rVg90H21EOLACvtfcHk0ljNARSpn2HW6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ&md5=f058c7dbd2efd6a25f4044506b5a2ef3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DN.%26aulast%3DVasanthakumar%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%2BF.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWolniak%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DJ.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChoe%26aufirst%3DS.%2BE.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGodley%26aufirst%3DL.%2BA.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DValk%26aufirst%3DP.%2BJ.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DLeukemic%2520IDH1%2520and%2520IDH2%2520mutations%2520result%2520in%2520a%2520hypermethylation%2520phenotype%252C%2520disrupt%2520TET2%2520function%252C%2520and%2520impair%2520hematopoietic%2520differentiation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D553%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Amary, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berisha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskandarpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogendoorn, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirabosco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, A. M.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1002%2Fpath.2913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21598255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2011&pages=334-343&author=M.+F.+Amaryauthor=K.+Bacsiauthor=F.+Maggianiauthor=S.+Damatoauthor=D.+Halaiauthor=F.+Berishaauthor=R.+Pollockauthor=P.+O%E2%80%99Donnellauthor=A.+Grigoriadisauthor=T.+Dissauthor=M.+Eskandarpourauthor=N.+Presneauauthor=P.+C.+Hogendoornauthor=A.+Futrealauthor=R.+Tiraboscoauthor=A.+M.+Flanagan&title=IDH1+and+IDH2+mutations+are+frequent+events+in+central+chondrosarcoma+and+central+and+periosteal+chondromas+but+not+in+other+mesenchymal+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumors</span></div><div class="casAuthors">Amary, M. Fernanda; Bacsi, Krisztian; Maggiani, Francesca; Damato, Stephen; Halai, Dina; Berisha, Fitim; Pollock, Robin; O'Donnell, Paul; Grigoriadis, Anita; Diss, Tim; Eskandarpour, Malihe; Presneau, Nadege; Hogendoorn, Pancras C.; Futreal, Andrew; Tirabosco, Roberto; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-343</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 occur in gliomas and acute myeloid leukemia (AML).  Since patients with multiple enchondromas have occasionally been reported to have these conditions, we hypothesized that the same mutations would occur in cartilaginous neoplasms.  Approx. 1200 mesenchymal tumors, including 220 cartilaginous tumors, 222 osteosarcomas and another ∼750 bone and soft tissue tumors, were screened for IDH1 R132 mutations, using Sequenom mass spectrometry.  Cartilaginous tumors and chondroblastic osteosarcomas, wild-type for IDH1 R132, were analyzed for IDH2 (R172, R140) mutations.  Validation was performed by capillary sequencing and restriction enzyme digestion.  Heterozygous somatic IDH1/IDH2 mutations, which result in the prodn. of a potential oncometabolite, 2-hydroxyglutarate, were only detected in central and periosteal cartilaginous tumors, and were found in at least 56% of these, ∼40% of which were represented by R132C.  IDH1 R132H mutations were confirmed by immunoreactivity for this mutant allele.  The ratio of IDH1:IDH2 mutation was 10.6 : 1.  No IDH2 R140 mutations were detected.  Mutations were detected in enchondromas through to conventional central and dedifferentiated chondrosarcomas, in patients with both solitary and multiple neoplasms.  No germline mutations were detected.  No mutations were detected in peripheral chondrosarcomas and osteochondromas.  In conclusion, IDH1 and IDH2 mutations represent the first common genetic abnormalities to be identified in conventional central and periosteal cartilaginous tumors.  As in gliomas and AML, the mutations appear to occur early in tumorigenesis.  We speculate that a mosaic pattern of IDH-mutation-bearing cells explains the reports of diverse tumors (gliomas, AML, multiple cartilaginous neoplasms, haemangiomas) occurring in the same patient.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnKlczQQ1mLVg90H21EOLACvtfcHk0ljNARSpn2HW6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D&md5=59128645aa54d08a4251d8f763ccb28e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpath.2913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2913%26sid%3Dliteratum%253Aachs%26aulast%3DAmary%26aufirst%3DM.%2BF.%26aulast%3DBacsi%26aufirst%3DK.%26aulast%3DMaggiani%26aufirst%3DF.%26aulast%3DDamato%26aufirst%3DS.%26aulast%3DHalai%26aufirst%3DD.%26aulast%3DBerisha%26aufirst%3DF.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DDiss%26aufirst%3DT.%26aulast%3DEskandarpour%26aufirst%3DM.%26aulast%3DPresneau%26aufirst%3DN.%26aulast%3DHogendoorn%26aufirst%3DP.%2BC.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520events%2520in%2520central%2520chondrosarcoma%2520and%2520central%2520and%2520periosteal%2520chondromas%2520but%2520not%2520in%2520other%2520mesenchymal%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2011%26volume%3D224%26spage%3D334%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+van+der+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0ljjPHaAa65miw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3Dvan%2Bder%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coller, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=225-234&author=P.+S.+Wardauthor=J.+Patelauthor=D.+R.+Wiseauthor=O.+Abdel-Wahabauthor=B.+D.+Bennettauthor=H.+A.+Collerauthor=J.+R.+Crossauthor=V.+R.+Fantinauthor=C.+V.+Hedvatauthor=A.+E.+Perlauthor=J.+D.+Rabinowitzauthor=M.+Carrollauthor=S.+M.+Suauthor=K.+A.+Sharpauthor=R.+L.+Levineauthor=C.+B.+Thompson&title=The+common+feature+of+leukemia-associated+IDH1+and+IDH2+mutations+is+a+neomorphic+enzyme+activity+converting+alpha-ketoglutarate+to+2-hydroxyglutarate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DHedvat%26aufirst%3DC.%2BV.%26aulast%3DPerl%26aufirst%3DA.%2BE.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520common%2520feature%2520of%2520leukemia-associated%2520IDH1%2520and%2520IDH2%2520mutations%2520is%2520a%2520neomorphic%2520enzyme%2520activity%2520converting%2520alpha-ketoglutarate%2520to%25202-hydroxyglutarate%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D225%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Rourke, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnature10860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=22343901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=474-478&author=C.+Luauthor=P.+S.+Wardauthor=G.+S.+Kapoorauthor=D.+Rohleauthor=S.+Turcanauthor=O.+Abdel-Wahabauthor=C.+R.+Edwardsauthor=R.+Khaninauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=K.+E.+Wellenauthor=D.+M.+O%E2%80%99Rourkeauthor=S.+L.+Bergerauthor=T.+A.+Chanauthor=R.+L.+Levineauthor=I.+K.+Mellinghoffauthor=C.+B.+Thompson&title=IDH+mutation+impairs+histone+demethylation+and+results+in+a+block+to+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span></div><div class="casAuthors">Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">474-478</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukemias (AML) and chondrosarcomas, and share a novel enzymic property of producing 2-hydroxyglutarate (2HG) from α-ketoglutarate.  Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells.  In tumor samples from glioma patients, IDH mutations were assocd. with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was assocd. with increased histone methylation.  To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro.  Introduction of either mutant IDH or cell-permeable 2HG was assocd. with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation.  This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation.  Gliomas were found to have elevated levels of similar histone repressive marks.  Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation.  Of the marks examd., increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture.  Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation.  Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxj9sZYgiJH7Vg90H21EOLACvtfcHk0ljjPHaAa65miw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D&md5=d5bb18c8ef2bbd1d28540cf7dabc9b57</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature10860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10860%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DKhanin%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DD.%2BM.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DIDH%2520mutation%2520impairs%2520histone%2520demethylation%2520and%2520results%2520in%2520a%2520block%2520to%2520cell%2520differentiation%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D474%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yilmaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabius, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span> </span><span class="NLM_article-title">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=479-483&author=S.+Turcanauthor=D.+Rohleauthor=A.+Goenkaauthor=L.+A.+Walshauthor=F.+Fangauthor=E.+Yilmazauthor=C.+Camposauthor=A.+W.+Fabiusauthor=C.+Luauthor=P.+S.+Wardauthor=C.+B.+Thompsonauthor=A.+Kaufmanauthor=O.+Guryanovaauthor=R.+Levineauthor=A.+Heguyauthor=A.+Vialeauthor=L.+G.+Morrisauthor=J.+T.+Huseauthor=I.+K.+Mellinghoffauthor=T.+A.+Chan&title=IDH1+mutation+is+sufficient+to+establish+the+glioma+hypermethylator+phenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DGoenka%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DL.%2BA.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYilmaz%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DFabius%26aufirst%3DA.%2BW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKaufman%26aufirst%3DA.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DL.%2BG.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BA.%26atitle%3DIDH1%2520mutation%2520is%2520sufficient%2520to%2520establish%2520the%2520glioma%2520hypermethylator%2520phenotype%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Prensner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Metabolism unhinged: IDH mutations in cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnm0311-291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21383741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=291-293&author=J.+R.+Prensnerauthor=A.+M.+Chinnaiyan&title=Metabolism+unhinged%3A+IDH+mutations+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism unhinged: IDH mutations in cancer</span></div><div class="casAuthors">Prensner, John R.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-293</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently characterized IDH1 and IDH2 mutations in leukemia and glioblastoma have introduced a fascinating cancer-specific role for metabolic genes essential to cellular respiration.  Studies also link aberrant IDH1 and IDH2 activity to an altered metabolite profile, an observation that may have broad implications for both cancer epigenetics and clin. management of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopuegY-UsALVg90H21EOLACvtfcHk0lhrkMeugVxlvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D&md5=6df1b41aab0341769974251276ba6dec</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm0311-291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0311-291%26sid%3Dliteratum%253Aachs%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMetabolism%2520unhinged%253A%2520IDH%2520mutations%2520in%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D291%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">IDH mutations in glioma and acute myeloid leukemia</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=387-397&author=L.+Dangauthor=S.+Jinauthor=S.+M.+Su&title=IDH+mutations+in+glioma+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DIDH%2520mutations%2520in%2520glioma%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1093%2Fjnci%2Fdjq262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20576929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=926-928&author=K.+Garber&title=Oncometabolite%3F+IDH1+discoveries+raise+possibility+of+new+metabolism+targets+in+brain+cancers+and+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite? IDH1 Discoveries Raise Possibility of New Metabolism Targets in Brain Cancers and Leukemia</span></div><div class="casAuthors">Garber, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">926-928</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Compared with normal cells, which primarily generate energy aerobically in mitochondria, most tumor cells rely more heavily on glycolysis (the anaerobic conversion of glucose to lactate) to generate energy.  Tumors also display other unique metabolic features.  But the discovery of a mutated metabolic enzyme was strong evidence that metabolic abnormalities play an important role in oncogenesis, and it set off a frantic effort to understand what the mutation was doing in such common and lethal cancers.  Answers have proven just as surprising as the initial discovery.  And the revelations, although incomplete and still controversial, are paving the way for drugs targeting mutant isocitrate dehydrogenase (IDH) and for diagnostic tests to identify patients likely to benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUWv5GxNnQqrVg90H21EOLACvtfcHk0lhrkMeugVxlvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D&md5=66fe53c6c537f459144c907a59e47d90</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq262%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DOncometabolite%253F%2520IDH1%2520discoveries%2520raise%2520possibility%2520of%2520new%2520metabolism%2520targets%2520in%2520brain%2520cancers%2520and%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D926%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0lgeJ3Ftwt1cKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaskas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grommes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldrini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komisopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kernytsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0lgeJ3Ftwt1cKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anglin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0lgeJ3Ftwt1cKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundriyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-<span class="smallcaps smallerCapital">d</span>-xylulose-5-phosphate reductoisomerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6539</span><span class="NLM_x">–</span> <span class="NLM_lpage">6542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012592" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6539-6542&author=L.+Dengauthor=S.+Sundriyalauthor=V.+Rubioauthor=Z.+Shiauthor=Y.+Song&title=Coordination+chemistry+based+approach+to+lipophilic+inhibitors+of+1-deoxy-d-xylulose-5-phosphate+reductoisomerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm9012592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012592%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSundriyal%26aufirst%3DS.%26aulast%3DRubio%26aufirst%3DV.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCoordination%2520chemistry%2520based%2520approach%2520to%2520lipophilic%2520inhibitors%2520of%25201-deoxy-d-xylulose-5-phosphate%2520reductoisomerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6539%26epage%3D6542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Structures of 1-Deoxy-<span class="smallcaps smallerCapital">d</span>-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100243r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=165-170&author=L.+Dengauthor=K.+Endoauthor=M.+Katoauthor=G.+Chengauthor=S.+Yajimaauthor=Y.+Song&title=Structures+of+1-Deoxy-d-Xylulose-5-Phosphate+Reductoisomerase%2FLipophilic+Phosphonate+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml100243r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100243r%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DYajima%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DStructures%2520of%25201-Deoxy-d-Xylulose-5-Phosphate%2520Reductoisomerase%252FLipophilic%2520Phosphonate%2520Complexes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D165%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300419r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=278-282&author=J.+Xueauthor=J.+Diaoauthor=G.+Caiauthor=L.+Dengauthor=B.+Zhengauthor=Y.+Yaoauthor=Y.+Song&title=Antimalarial+and+Structural+Studies+of+Pyridine-containing+Inhibitors+of+1-Deoxyxylulose-5-phosphate+Reductoisomerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300419r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300419r%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DG.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DAntimalarial%2520and%2520Structural%2520Studies%2520of%2520Pyridine-containing%2520Inhibitors%2520of%25201-Deoxyxylulose-5-phosphate%2520Reductoisomerase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D278%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132H</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%9Coff-on+switch%E2%80%9D+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0ljR3ZLW-S33Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%259Coff-on%2520switch%25E2%2580%259D%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirozzi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasojevic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span> </span><span class="NLM_article-title">Mutant IDH1 is required for IDH1 mutated tumor cell growth</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=774-782&author=G.+Jinauthor=C.+J.+Pirozziauthor=L.+H.+Chenauthor=G.+Y.+Lopezauthor=C.+G.+Duncanauthor=J.+Fengauthor=I.+Spasojevicauthor=D.+D.+Bignerauthor=Y.+Heauthor=H.+Yan&title=Mutant+IDH1+is+required+for+IDH1+mutated+tumor+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DG.%26aulast%3DPirozzi%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DLopez%26aufirst%3DG.%2BY.%26aulast%3DDuncan%26aufirst%3DC.%2BG.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DH.%26atitle%3DMutant%2520IDH1%2520is%2520required%2520for%2520IDH1%2520mutated%2520tumor%2520cell%2520growth%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D774%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hellinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veszelka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duy, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, M.</span><span> </span><span class="NLM_article-title">Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ejpb.2012.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=22906709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCiur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=340-351&author=E.+Hellingerauthor=S.+Veszelkaauthor=A.+E.+Tothauthor=F.+Walterauthor=A.+Kittelauthor=M.+L.+Bakkauthor=K.+Tihanyiauthor=V.+Hadaauthor=S.+Nakagawaauthor=T.+D.+Duyauthor=M.+Niwaauthor=M.+A.+Deliauthor=M.+Vastag&title=Comparison+of+brain+capillary+endothelial+cell-based+and+epithelial+%28MDCK-MDR1%2C+Caco-2%2C+and+VB-Caco-2%29+cell-based+surrogate+blood-brain+barrier+penetration+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models</span></div><div class="casAuthors">Hellinger, Eva; Veszelka, Szilvia; Toth, Andrea E.; Walter, Fruzsina; Kittel, Agnes; Bakk, Monika Laura; Tihanyi, Karoly; Hada, Viktor; Nakagawa, Shinsuke; Dinh Ha Duy, Thuy; Niwa, Masami; Deli, Maria A.; Vastag, Monika</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">340-351</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An accurate means of predicting blood-brain barrier (BBB) penetration and blood-brain partitioning of NCEs (new chem. entities) would fulfill a major need in pharmaceutical research.  Currently, an industry-std. BBB drug penetration model is not available.  Primary brain capillary endothelial cells, optionally co-cultured with astrocytes and/or pericytes, are the most valued models of BBB.  For routine use, establishing and maintaining a co-culture system is too costly and labor intensive.  Alternatively, non-cerebral cell lines such as MDCK-MDR1 are used, and most recently, the suitability of native and modified Caco-2 for predicting brain penetration has also come under investigation.  This study provides comparative data on the morphol. and functionality of the high integrity brain capillary endothelial BBB model (EPA: triple culture of brain capillary endothelial cells with pericytes and astrocytes) and the epithelial cell-based (native Caco-2, high P-glycoprotein expressing vinblastine-treated VB-Caco-2 and MDCK-MDR1) surrogate BBB models.  Using a panel of 10 compds. VB-Caco-2 and MDCK-MDR1 cell lines show restrictive paracellular pathway and BBB-like selective passive permeability that makes them comparable to the rat brain BBB model, which gave correlation with the highest r2 value with in vivo permeability data.  In bidirectional assay, the VB-Caco-2 and the MDCK-MDR1 models identified more P-glycoprotein drug substrates than the rat brain BBB model.  While the complexity and predictive value of the BBB model is the highest, for the screening of NCEs to det. whether they are efflux substrates or not, the VB-Caco-2 and the MDCK-MDR1 models may provide a simple and inexpensive tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPCN0_k1e4XrVg90H21EOLACvtfcHk0ljoqPhaPXWwxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCiur7F&md5=25215c5216a31136644eff7fe1cff273</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2012.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2012.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DHellinger%26aufirst%3DE.%26aulast%3DVeszelka%26aufirst%3DS.%26aulast%3DToth%26aufirst%3DA.%2BE.%26aulast%3DWalter%26aufirst%3DF.%26aulast%3DKittel%26aufirst%3DA.%26aulast%3DBakk%26aufirst%3DM.%2BL.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DHada%26aufirst%3DV.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DDuy%26aufirst%3DT.%2BD.%26aulast%3DNiwa%26aufirst%3DM.%26aulast%3DDeli%26aufirst%3DM.%2BA.%26aulast%3DVastag%26aufirst%3DM.%26atitle%3DComparison%2520of%2520brain%2520capillary%2520endothelial%2520cell-based%2520and%2520epithelial%2520%2528MDCK-MDR1%252C%2520Caco-2%252C%2520and%2520VB-Caco-2%2529%2520cell-based%2520surrogate%2520blood-brain%2520barrier%2520penetration%2520models%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2012%26volume%3D82%26spage%3D340%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetic-driven approach to screen candidate anticancer drugs for brain tumor chemotherapy</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=250-257&author=H.+Lvauthor=X.+Zhangauthor=J.+Sharmaauthor=M.+V.+R.+Reddyauthor=E.+P.+Reddyauthor=J.+M.+Gallo&title=Integrated+pharmacokinetic-driven+approach+to+screen+candidate+anticancer+drugs+for+brain+tumor+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSharma%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26atitle%3DIntegrated%2520pharmacokinetic-driven%2520approach%2520to%2520screen%2520candidate%2520anticancer%2520drugs%2520for%2520brain%2520tumor%2520chemotherapy%26jtitle%3DAAPS%2520J.%26date%3D2013%26volume%3D15%26spage%3D250%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Luchman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stechishin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnelong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weljie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S.</span><span> </span><span class="NLM_article-title">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=184-191&author=H.+A.+Luchmanauthor=O.+D.+Stechishinauthor=N.+H.+Dangauthor=M.+D.+Bloughauthor=C.+Chesnelongauthor=J.+J.+Kellyauthor=S.+A.+Nguyenauthor=J.+A.+Chanauthor=A.+M.+Weljieauthor=J.+G.+Cairncrossauthor=S.+Weiss&title=An+in+vivo+patient-derived+model+of+endogenous+IDH1-mutant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuchman%26aufirst%3DH.%2BA.%26aulast%3DStechishin%26aufirst%3DO.%2BD.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DBlough%26aufirst%3DM.%2BD.%26aulast%3DChesnelong%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DWeljie%26aufirst%3DA.%2BM.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%26atitle%3DAn%2520in%2520vivo%2520patient-derived%2520model%2520of%2520endogenous%2520IDH1-mutant%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2012%26volume%3D14%26spage%3D184%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antalffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauser, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1414</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1414-1424&author=Q.+Shuauthor=K.+K.+Wongauthor=J.+M.+Suauthor=A.+M.+Adesinaauthor=L.+T.+Yuauthor=Y.+T.+Tsangauthor=B.+C.+Antalffyauthor=P.+Baxterauthor=L.+Perlakyauthor=J.+Yangauthor=R.+C.+Dauserauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=C.+C.+Lauauthor=X.+N.+Li&title=Direct+orthotopic+transplantation+of+fresh+surgical+specimen+preserves+CD133%2B+tumor+cells+in+clinically+relevant+mouse+models+of+medulloblastoma+and+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DQ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DL.%2BT.%26aulast%3DTsang%26aufirst%3DY.%2BT.%26aulast%3DAntalffy%26aufirst%3DB.%2BC.%26aulast%3DBaxter%26aufirst%3DP.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DDauser%26aufirst%3DR.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DDirect%2520orthotopic%2520transplantation%2520of%2520fresh%2520surgical%2520specimen%2520preserves%2520CD133%252B%2520tumor%2520cells%2520in%2520clinically%2520relevant%2520mouse%2520models%2520of%2520medulloblastoma%2520and%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2008%26volume%3D26%26spage%3D1414%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idamakanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Police, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenbeck, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1173-1185&author=Z.+Liuauthor=X.+Zhaoauthor=H.+Maoauthor=P.+A.+Baxterauthor=Y.+Huangauthor=L.+Yuauthor=L.+Wadhwaauthor=J.+M.+Suauthor=A.+Adesinaauthor=L.+Perlakyauthor=M.+Hurwitzauthor=N.+Idamakantiauthor=S.+R.+Policeauthor=P.+L.+Hallenbeckauthor=R.+L.+Hurwitzauthor=C.+C.+Lauauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=X.+N.+Li&title=Intravenous+injection+of+oncolytic+picornavirus+SVV-001+prolongs+animal+survival+in+a+panel+of+primary+tumor-based+orthotopic+xenograft+mouse+models+of+pediatric+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWadhwa%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DHurwitz%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DPolice%26aufirst%3DS.%2BR.%26aulast%3DHallenbeck%26aufirst%3DP.%2BL.%26aulast%3DHurwitz%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DIntravenous%2520injection%2520of%2520oncolytic%2520picornavirus%2520SVV-001%2520prolongs%2520animal%2520survival%2520in%2520a%2520panel%2520of%2520primary%2520tumor-based%2520orthotopic%2520xenograft%2520mouse%2520models%2520of%2520pediatric%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2013%26volume%3D15%26spage%3D1173%26epage%3D1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, T.</span><span> </span><span class="NLM_article-title">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20331619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=877-889&author=F.+Wanauthor=S.+Zhangauthor=R.+Xieauthor=B.+Gaoauthor=B.+Camposauthor=C.+Herold-Mendeauthor=T.+Lei&title=The+utility+and+limitations+of+neurosphere+assay%2C+CD133+immunophenotyping+and+side+population+assay+in+glioma+stem+cell+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span></div><div class="casAuthors">Wan, Feng; Zhang, Suojun; Xie, Ruifan; Gao, Baocheng; Campos, Benito; Herold-Mende, Christel; Lei, Ting</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-889</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic "blueprints" of GSCs.  To identify the true "stemness" signatures, pure GSC populations are primarily needed.  Reliable in vitro methods enriching for GSCs and thereby identifying the key stem-like characteristics constitute the preliminary step forward.  We discuss in this review the current widely used methods for enriching and isolating GSCs, namely neurosphere assay, CD133 Immunophenotyping and side population assay, and detail their limitations and potential pitfalls that could complicate interpretation of corresponding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrleaZxkJUBc7Vg90H21EOLACvtfcHk0lhoMtmmDURJvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN&md5=09f9ae3b110b21a2bb65baa0d831c09c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLei%26aufirst%3DT.%26atitle%3DThe%2520utility%2520and%2520limitations%2520of%2520neurosphere%2520assay%252C%2520CD133%2520immunophenotyping%2520and%2520side%2520population%2520assay%2520in%2520glioma%2520stem%2520cell%2520research%26jtitle%3DBrain%2520Pathol.%26date%3D2010%26volume%3D20%26spage%3D877%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterman-Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visnyei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenieux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazareff, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Neurosphere formation is an independent predictor of clinical outcome in malignant glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=980-987&author=D.+R.+Laksauthor=M.+Masterman-Smithauthor=K.+Visnyeiauthor=B.+Angenieuxauthor=N.+M.+Orozcoauthor=I.+Foranauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=L.+M.+Liauauthor=J.+A.+Lazareffauthor=P.+S.+Mischelauthor=T.+F.+Cloughesyauthor=S.+Horvathauthor=H.+I.+Kornblum&title=Neurosphere+formation+is+an+independent+predictor+of+clinical+outcome+in+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DMasterman-Smith%26aufirst%3DM.%26aulast%3DVisnyei%26aufirst%3DK.%26aulast%3DAngenieux%26aufirst%3DB.%26aulast%3DOrozco%26aufirst%3DN.%2BM.%26aulast%3DForan%26aufirst%3DI.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DLazareff%26aufirst%3DJ.%2BA.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DNeurosphere%2520formation%2520is%2520an%2520independent%2520predictor%2520of%2520clinical%2520outcome%2520in%2520malignant%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2009%26volume%3D27%26spage%3D980%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Chaichana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Berridi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara-Quintana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinones-Hinojosa, A.</span><span> </span><span class="NLM_article-title">Neurosphere assays: Growth factors and hormone differences in tumor and nontumor studies</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2851</span><span class="NLM_x">–</span> <span class="NLM_lpage">2857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2851-2857&author=K.+Chaichanaauthor=G.+Zamora-Berridiauthor=J.+Camara-Quintanaauthor=A.+Quinones-Hinojosa&title=Neurosphere+assays%3A+Growth+factors+and+hormone+differences+in+tumor+and+nontumor+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaichana%26aufirst%3DK.%26aulast%3DZamora-Berridi%26aufirst%3DG.%26aulast%3DCamara-Quintana%26aufirst%3DJ.%26aulast%3DQuinones-Hinojosa%26aufirst%3DA.%26atitle%3DNeurosphere%2520assays%253A%2520Growth%2520factors%2520and%2520hormone%2520differences%2520in%2520tumor%2520and%2520nontumor%2520studies%26jtitle%3DStem%2520Cells%26date%3D2006%26volume%3D24%26spage%3D2851%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voicu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurusiddappa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=580-594&author=L.+Yuauthor=P.+A.+Baxterauthor=H.+Voicuauthor=S.+Gurusiddappaauthor=Y.+Zhaoauthor=A.+Adesinaauthor=T.+K.+Manauthor=Q.+Shuauthor=Y.+J.+Zhangauthor=X.+M.+Zhaoauthor=J.+M.+Suauthor=L.+Perlakyauthor=R.+Dauserauthor=M.+Chintagumpalaauthor=C.+C.+Lauauthor=S.+M.+Blaneyauthor=P.+H.+Raoauthor=H.+C.+Leungauthor=X.+N.+Li&title=A+clinically+relevant+orthotopic+xenograft+model+of+ependymoma+that+maintains+the+genomic+signature+of+the+primary+tumor+and+preserves+cancer+stem+cells+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DVoicu%26aufirst%3DH.%26aulast%3DGurusiddappa%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DMan%26aufirst%3DT.%2BK.%26aulast%3DShu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BM.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DDauser%26aufirst%3DR.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DRao%26aufirst%3DP.%2BH.%26aulast%3DLeung%26aufirst%3DH.%2BC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DA%2520clinically%2520relevant%2520orthotopic%2520xenograft%2520model%2520of%2520ependymoma%2520that%2520maintains%2520the%2520genomic%2520signature%2520of%2520the%2520primary%2520tumor%2520and%2520preserves%2520cancer%2520stem%2520cells%2520in%2520vivo%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D580%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vormoor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres-Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span> </span><span class="NLM_article-title">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=645-648&author=T.+Lapidotauthor=C.+Sirardauthor=J.+Vormoorauthor=B.+Murdochauthor=T.+Hoangauthor=J.+Caceres-Cortesauthor=M.+Mindenauthor=B.+Patersonauthor=M.+A.+Caligiuriauthor=J.+E.+Dick&title=A+cell+initiating+human+acute+myeloid+leukaemia+after+transplantation+into+SCID+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DB.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DPaterson%26aufirst%3DB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26atitle%3DA%2520cell%2520initiating%2520human%2520acute%2520myeloid%2520leukaemia%2520after%2520transplantation%2520into%2520SCID%2520mice%26jtitle%3DNature%26date%3D1994%26volume%3D367%26spage%3D645%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Al Hajj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, M. F.</span><span> </span><span class="NLM_article-title">Therapeutic implications of cancer stem cells</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=43-47&author=M.+Al+Hajjauthor=M.+W.+Beckerauthor=M.+Wichaauthor=I.+Weissmanauthor=M.+F.+Clarke&title=Therapeutic+implications+of+cancer+stem+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BHajj%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DM.%2BW.%26aulast%3DWicha%26aufirst%3DM.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DClarke%26aufirst%3DM.%2BF.%26atitle%3DTherapeutic%2520implications%2520of%2520cancer%2520stem%2520cells%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2004%26volume%3D14%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">The antitumor activity of the fungicide ciclopirox</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1002%2Fijc.25255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20225320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=2467-2477&author=H.+Zhouauthor=T.+Shenauthor=Y.+Luoauthor=L.+Liuauthor=W.+Chenauthor=B.+Xuauthor=X.+Hanauthor=J.+Pangauthor=C.+A.+Riveraauthor=S.+Huang&title=The+antitumor+activity+of+the+fungicide+ciclopirox"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor activity of the fungicide ciclopirox</span></div><div class="casAuthors">Zhou, Hongyu; Shen, Tao; Luo, Yan; Liu, Lei; Chen, Wenxing; Xu, Baoshan; Han, Xiuzhen; Pang, Jia; Rivera, Chantal A.; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2467-2477</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Ciclopirox olamine (CPX) is a synthetic antifungal agent clin. used to treat mycoses of the skin and nails.  Here, we show that CPX inhibited tumor growth in human breast cancer MDA-MB-231 xenografts.  To unveil the underlying mechanism, we further studied the antitumor activity of CPX in cell culture.  The results indicate that CPX inhibited cell proliferation and induced apoptosis in human rhabdomyosarcoma (Rh30), breast carcinoma (MDA-MB231) and colon adenocarcinoma (HT-29) cells in a concn.-dependent manner.  By cell cycle anal., CPX induced accumulation of cells in G1/G0 phase of the cell cycle.  Concurrently, CPX downregulated cellular protein expression of cyclins (A, B1, D1 and E) and cyclin-dependent kinases (CDK2 and CDK4) and upregulated expression of the CDK inhibitor p21Cip1, leading to hypophosphorylation of retinoblastoma protein.  CPX also downregulated protein expression of Bcl-xL and survivin and enhanced cleavages of Bcl-2.  Z-VAD-FMK, a pan-caspase inhibitor, partially prevented CPX-induced cell death, suggesting that CPX-induced apoptosis of cancer cells is mediated at least in part through caspase-dependent mechanism.  The results indicate that CPX is a potential antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4oPUHIyDErVg90H21EOLACvtfcHk0lgVAyJQfIqNpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GqtLnN&md5=b470936945d36addb288929e0da4162a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fijc.25255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25255%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DC.%2BA.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DThe%2520antitumor%2520activity%2520of%2520the%2520fungicide%2520ciclopirox%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26spage%3D2467%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Eberhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antholine, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">3064</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eberhard%2C+Y.%3B+McDermott%2C+S.+P.%3B+Wang%2C+X.%3B+Gronda%2C+M.%3B+Venugopal%2C+A.%3B+Wood%2C+T.+E.%3B+Hurren%2C+R.%3B+Datti%2C+A.%3B+Batey%2C+R.+A.%3B+Wrana%2C+J.%3B+Antholine%2C+W.+E.%3B+Dick%2C+J.+E.%3B+Schimmer%2C+A.+D.Blood+2009%2C+114%2C+3064%E2%80%933073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEberhard%26aufirst%3DY.%26aulast%3DMcDermott%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGronda%26aufirst%3DM.%26aulast%3DVenugopal%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DT.%2BE.%26aulast%3DHurren%26aufirst%3DR.%26aulast%3DDatti%26aufirst%3DA.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DWrana%26aufirst%3DJ.%26aulast%3DAntholine%26aufirst%3DW.%2BE.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D3064%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Deodhar, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kekare, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pednekar, S. R.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of 2-Pyridones by Nucleophilic Reaction on Pyran2-thiones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1055%2Fs-1985-31201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADyaL28XlslCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=328-331&author=K.+D.+Deodharauthor=M.+B.+Kekareauthor=S.+R.+Pednekar&title=A+Facile+Synthesis+of+2-Pyridones+by+Nucleophilic+Reaction+on+Pyran2-thiones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of 2-pyridones by nucleophilic reaction on pyran-2-thiones</span></div><div class="casAuthors">Deodhar, K. D.; Kekare, M. B.; Pednekar, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">328-31</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Cyclization of pyranthiones I (Z = S, X = O) with RNH2 (R = H, PhCH2, p-ClC6H4, HO, H2N, PhNH, H2NCH2CH2) gave 47-86% pyridones I (Z = O, X = NR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv217rYbUdrrVg90H21EOLACvtfcHk0lgVAyJQfIqNpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlslCn&md5=20bceed23cb10cdda0cad268269e2fc9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-1985-31201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1985-31201%26sid%3Dliteratum%253Aachs%26aulast%3DDeodhar%26aufirst%3DK.%2BD.%26aulast%3DKekare%26aufirst%3DM.%2BB.%26aulast%3DPednekar%26aufirst%3DS.%2BR.%26atitle%3DA%2520Facile%2520Synthesis%2520of%25202-Pyridones%2520by%2520Nucleophilic%2520Reaction%2520on%2520Pyran2-thiones%26jtitle%3DSynthesis%26date%3D1985%26spage%3D328%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Batt, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraitis, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. R.</span><span> </span><span class="NLM_article-title">2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00163a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=360-370&author=D.+G.+Battauthor=G.+D.+Maynardauthor=J.+J.+Petraitisauthor=J.+E.+Shawauthor=W.+Galbraithauthor=R.+R.+Harris&title=2-Substituted-1-naphthols+as+potent+5-lipoxygenase+inhibitors+with+topical+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00163a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00163a058%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DMaynard%26aufirst%3DG.%2BD.%26aulast%3DPetraitis%26aufirst%3DJ.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%2BE.%26aulast%3DGalbraith%26aufirst%3DW.%26aulast%3DHarris%26aufirst%3DR.%2BR.%26atitle%3D2-Substituted-1-naphthols%2520as%2520potent%25205-lipoxygenase%2520inhibitors%2520with%2520topical%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D360%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, Makala Shakar Reddy, Lingala Vijaya Raghava Reddy, Subir Kumar Sadhukhan, Daniel P. Bradley, Brenda Moreira-Walsh, Tiffany C. Edwards, Austin T. O’Dea, John E. Tavis, Marvin J. Meyers, <span class="NLM_string-name hlFld-ContribAuthor">Maureen J. Donlin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (12)
                                     , 8477-8487. <a href="https://doi.org/10.1021/acsomega.1c00273" title="DOI URL">https://doi.org/10.1021/acsomega.1c00273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00273%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthetic%252BDerivatives%252Bof%252BCiclopirox%252Bare%252BEffective%252BInhibitors%252Bof%252BCryptococcus%252Bneoformans%26aulast%3DLin%26aufirst%3DJeffrey%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D09022021%26date%3D15032021%26volume%3D6%26issue%3D12%26spage%3D8477%26epage%3D8487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin A. Caravella, Jian Lin, R. Bruce Diebold, Ann-Marie Campbell, Anna Ericsson, Gary Gustafson, Zhongguo Wang, Jennifer Castro, Andrea Clarke, Deepali Gotur, Helen R. Josephine, Marie Katz, Mark Kershaw, Lili Yao, Angela V. Toms, Kenneth J. Barr, Christopher J. Dinsmore, Duncan Walker, Susan Ashwell, <span class="NLM_string-name hlFld-ContribAuthor">Wei Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1612-1623. <a href="https://doi.org/10.1021/acs.jmedchem.9b01423" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01423%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BIdentification%252Bof%252BFT-2102%252B%252528Olutasidenib%252529%25252C%252Ba%252BPotent%252BMutant-Selective%252BIDH1%252BInhibitor%26aulast%3DCaravella%26aufirst%3DJustin%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D03092019%26date%3D12022020%26date%3D23012020%26volume%3D63%26issue%3D4%26spage%3D1612%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Linghao Hu, Hongxuan Feng, Hongguang Zhang, Songda Yu, Qinyuan Zhao, Wei Wang, Fengxia Bao, Xun Ding, Jiajing Hu, Manjiong Wang, Yixiang Xu, Zengrui Wu, Xiaokang Li, Yun Tang, Fei Mao, Xiaoyan Chen, Haiyan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1051-1067. <a href="https://doi.org/10.1021/acs.jmedchem.9b01338" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01338%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%252BN-hydroxypyridone%252BDerivatives%252Bas%252BPotential%252BAnti-Ischemic%252BStroke%252BAgents%26aulast%3DHu%26aufirst%3DLinghao%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14082019%26date%3D22012020%26date%3D07012020%26volume%3D63%26issue%3D3%26spage%3D1051%26epage%3D1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jian Lin, Wei Lu, Justin A. Caravella, Ann Marie Campbell, R. Bruce Diebold, Anna Ericsson, Edward Fritzen, Gary R. Gustafson, David R. Lancia, Jr., Tatiana Shelekhin, Zhongguo Wang, Jennifer Castro, Andrea Clarke, Deepali Gotur, Helen R. Josephine, Marie Katz, Hien Diep, Mark Kershaw, Lili Yao, Goss Kauffman, Stephen E. Hubbs, George P. Luke, Angela V. Toms, Liann Wang, Kenneth W. Bair, Kenneth J. Barr, Christopher Dinsmore, Duncan Walker, <span class="NLM_string-name hlFld-ContribAuthor">Susan Ashwell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6575-6596. <a href="https://doi.org/10.1021/acs.jmedchem.9b00362" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00362%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BQuinolinone%252BDerivatives%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BMutant%252BIsocitrate%252BDehydrogenase%252B1%252B%252528mIDH1%252529%252BInhibitors%26aulast%3DLin%26aufirst%3DJian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07032019%26date%3D08072019%26date%3D14062019%26volume%3D62%26issue%3D14%26spage%3D6575%26epage%3D6596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoming Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 8981-9003. <a href="https://doi.org/10.1021/acs.jmedchem.8b00159" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00159%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BMutant%252BIsocitrate%252BDehydrogenases%252B1%252Band%252B2%252B%252528mIDH1%25252F2%252529%25253A%252BAn%252BUpdate%252Band%252BPerspective%26aulast%3DMa%26aufirst%3DTianfang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30012018%26date%3D18062018%26date%3D31052018%26volume%3D61%26issue%3D20%26spage%3D8981%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qian Zhao, James R. Manning, James Sutton, Abran Costales, Martin Sendzik, Cynthia M. Shafer, Julian R. Levell, Gang Liu, Thomas Caferro, Young Shin Cho, Mark Palermo, Gregg Chenail, Julia Dooley, Brian Villalba, Ali Farsidjani, Jinyun Chen, Stephanie Dodd, Ty Gould, Guiqing Liang, Kelly Slocum, Minying Pu, Brant Firestone, Joseph Growney, Tycho Heimbach, <span class="NLM_string-name hlFld-ContribAuthor">Raymond Pagliarini</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 746-751. <a href="https://doi.org/10.1021/acsmedchemlett.8b00182" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00182%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252B3-Pyrimidin-4-yl-oxazolidin-2-ones%252Bas%252BOrally%252BBioavailable%252Band%252BBrain%252BPenetrant%252BMutant%252BIDH1%252BInhibitors%26aulast%3DZhao%26aufirst%3DQian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16042018%26date%3D11062018%26date%3D15062018%26date%3D11062018%26volume%3D9%26issue%3D7%26spage%3D746%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Shin  Cho</span>, <span class="hlFld-ContribAuthor ">Julian R.  Levell</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  Caferro</span>, <span class="hlFld-ContribAuthor ">James  Sutton</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>, <span class="hlFld-ContribAuthor ">Abran  Costales</span>, <span class="hlFld-ContribAuthor ">James R.  Manning</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Martin  Sendzik</span>, <span class="hlFld-ContribAuthor ">Michael  Shultz</span>, <span class="hlFld-ContribAuthor ">Gregg  Chenail</span>, <span class="hlFld-ContribAuthor ">Julia  Dooley</span>, <span class="hlFld-ContribAuthor ">Brian  Villalba</span>, <span class="hlFld-ContribAuthor ">Ali  Farsidjani</span>, <span class="hlFld-ContribAuthor ">Jinyun  Chen</span>, <span class="hlFld-ContribAuthor ">Raviraj  Kulathila</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Xie</span>, <span class="hlFld-ContribAuthor ">Stephanie  Dodd</span>, <span class="hlFld-ContribAuthor ">Ty  Gould</span>, <span class="hlFld-ContribAuthor ">Guiqing  Liang</span>, <span class="hlFld-ContribAuthor ">Tycho  Heimbach</span>, <span class="hlFld-ContribAuthor ">Kelly  Slocum</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Minying  Pu</span>, <span class="hlFld-ContribAuthor ">Raymond  Pagliarini</span>, and <span class="hlFld-ContribAuthor ">Joseph D.  Growney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1116-1121. <a href="https://doi.org/10.1021/acsmedchemlett.7b00342" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00342%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BEvaluation%252Bof%252BClinical%252BCandidate%252BIDH305%25252C%252Ba%252BBrain%252BPenetrant%252BMutant%252BIDH1%252BInhibitor%26aulast%3DCho%26aufirst%3DYoung%2BShin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18082017%26date%3D17092017%26date%3D22092017%26date%3D12102017%26date%3D18092017%26volume%3D8%26issue%3D10%26spage%3D1116%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wai-Pong  To</span>, <span class="hlFld-ContribAuthor ">Glenna So Ming  Tong</span>, <span class="hlFld-ContribAuthor ">Chi-Wah  Cheung</span>, <span class="hlFld-ContribAuthor ">Chen  Yang</span>, <span class="hlFld-ContribAuthor ">Dongling  Zhou</span>, and <span class="hlFld-ContribAuthor ">Chi-Ming  Che</span>  . </span><span class="cited-content_cbyCitation_article-title">Luminescent Cyclometalated Gold(III) Alkyl Complexes: Photophysical and Photochemical Properties. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2017,</strong> <em>56 </em>
                                    (9)
                                     , 5046-5059. <a href="https://doi.org/10.1021/acs.inorgchem.7b00180" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.7b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.7b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.7b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DLuminescent%252BCyclometalated%252BGold%252528III%252529%252BAlkyl%252BComplexes%25253A%252BPhotophysical%252Band%252BPhotochemical%252BProperties%26aulast%3DTo%26aufirst%3DWai-Pong%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20012017%26date%3D13042017%26date%3D01052017%26volume%3D56%26issue%3D9%26spage%3D5046%26epage%3D5059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Daver</span>, <span class="hlFld-ContribAuthor ">Nicolas  Rodeville</span>, <span class="hlFld-ContribAuthor ">Francois  Pineau</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Arlabosse</span>, <span class="hlFld-ContribAuthor ">Christine  Moureou</span>, <span class="hlFld-ContribAuthor ">Franck  Muller</span>, <span class="hlFld-ContribAuthor ">Romain  Pierre</span>, <span class="hlFld-ContribAuthor ">Karinne  Bouquet</span>, <span class="hlFld-ContribAuthor ">Laurence  Dumais</span>, <span class="hlFld-ContribAuthor ">Jean-Guy  Boiteau</span>, and <span class="hlFld-ContribAuthor ">Isabelle  Cardinaud</span>  . </span><span class="cited-content_cbyCitation_article-title">Process Development and Crystallization in Oiling-Out System of a Novel Topical Antiandrogen. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (2)
                                     , 231-240. <a href="https://doi.org/10.1021/acs.oprd.6b00392" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Band%252BCrystallization%252Bin%252BOiling-Out%252BSystem%252Bof%252Ba%252BNovel%252BTopical%252BAntiandrogen%26aulast%3DDaver%26aufirst%3DS%25C3%25A9bastien%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23112016%26date%3D22012017%26date%3D17022017%26date%3D21122016%26volume%3D21%26issue%3D2%26spage%3D231%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian R.  Levell</span>, <span class="hlFld-ContribAuthor ">Thomas  Caferro</span>, <span class="hlFld-ContribAuthor ">Gregg  Chenail</span>, <span class="hlFld-ContribAuthor ">Ina  Dix</span>, <span class="hlFld-ContribAuthor ">Julia  Dooley</span>, <span class="hlFld-ContribAuthor ">Brant  Firestone</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Ty  Gould</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Growney</span>, <span class="hlFld-ContribAuthor ">Michael D.  Jones</span>, <span class="hlFld-ContribAuthor ">Raviraj  Kulathila</span>, <span class="hlFld-ContribAuthor ">Fallon  Lin</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Arne  Mueller</span>, <span class="hlFld-ContribAuthor ">Simon  van der Plas</span>, <span class="hlFld-ContribAuthor ">Kelly  Slocum</span>, <span class="hlFld-ContribAuthor ">Troy  Smith</span>, <span class="hlFld-ContribAuthor ">Remi  Terranova</span>, <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>, <span class="hlFld-ContribAuthor ">Viraj  Tyagi</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Fan S.  Yang</span>, <span class="hlFld-ContribAuthor ">Liping X.  Zhou</span>, <span class="hlFld-ContribAuthor ">Raymond  Pagliarini</span>, and <span class="hlFld-ContribAuthor ">Young Shin  Cho</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 151-156. <a href="https://doi.org/10.1021/acsmedchemlett.6b00334" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252B3-Pyrimidin-4-yl-oxazolidin-2-ones%252Bas%252BAllosteric%252Band%252BMutant%252BSpecific%252BInhibitors%252Bof%252BIDH1%26aulast%3DLevell%26aufirst%3DJulian%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D20082016%26date%3D16122016%26date%3D06012017%26date%3D09022017%26date%3D16122016%26volume%3D8%26issue%3D2%26spage%3D151%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Haudecoeur</span>, <span class="hlFld-ContribAuthor ">Marcello  Carotti</span>, <span class="hlFld-ContribAuthor ">Aurélie  Gouron</span>, <span class="hlFld-ContribAuthor ">Marc  Maresca</span>, <span class="hlFld-ContribAuthor ">Elina  Buitrago</span>, <span class="hlFld-ContribAuthor ">Renaud  Hardré</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bergantino</span>, <span class="hlFld-ContribAuthor ">Hélène  Jamet</span>, <span class="hlFld-ContribAuthor ">Catherine  Belle</span>, <span class="hlFld-ContribAuthor ">Marius  Réglier</span>, <span class="hlFld-ContribAuthor ">Luigi  Bubacco</span>, and <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>  . </span><span class="cited-content_cbyCitation_article-title">2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 55-60. <a href="https://doi.org/10.1021/acsmedchemlett.6b00369" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00369%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Hydroxypyridine-N-oxide-Embedded%252BAurones%252Bas%252BPotent%252BHuman%252BTyrosinase%252BInhibitors%26aulast%3DHaudecoeur%26aufirst%3DRomain%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22092016%26date%3D17112016%26date%3D22112016%26date%3D12012017%26date%3D17112016%26volume%3D8%26issue%3D1%26spage%3D55%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart  Jones</span>, <span class="hlFld-ContribAuthor ">Jonathan  Ahmet</span>, <span class="hlFld-ContribAuthor ">Kelly  Ayton</span>, <span class="hlFld-ContribAuthor ">Matthew  Ball</span>, <span class="hlFld-ContribAuthor ">Mark  Cockerill</span>, <span class="hlFld-ContribAuthor ">Emma  Fairweather</span>, <span class="hlFld-ContribAuthor ">Nicola  Hamilton</span>, <span class="hlFld-ContribAuthor ">Paul  Harper</span>, <span class="hlFld-ContribAuthor ">James  Hitchin</span>, <span class="hlFld-ContribAuthor ">Allan  Jordan</span>, <span class="hlFld-ContribAuthor ">Colin  Levy</span>, <span class="hlFld-ContribAuthor ">Ruth  Lopez</span>, <span class="hlFld-ContribAuthor ">Eddie  McKenzie</span>, <span class="hlFld-ContribAuthor ">Martin  Packer</span>, <span class="hlFld-ContribAuthor ">Darren  Plant</span>, <span class="hlFld-ContribAuthor ">Iain  Simpson</span>, <span class="hlFld-ContribAuthor ">Peter  Simpson</span>, <span class="hlFld-ContribAuthor ">Ian  Sinclair</span>, <span class="hlFld-ContribAuthor ">Tim C. P.  Somervaille</span>, <span class="hlFld-ContribAuthor ">Helen  Small</span>, <span class="hlFld-ContribAuthor ">Gary J.  Spencer</span>, <span class="hlFld-ContribAuthor ">Graeme  Thomson</span>, <span class="hlFld-ContribAuthor ">Michael  Tonge</span>, <span class="hlFld-ContribAuthor ">Ian  Waddell</span>, <span class="hlFld-ContribAuthor ">Jarrod  Walsh</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Mark  Wigglesworth</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Wiseman</span>, and <span class="hlFld-ContribAuthor ">Donald  Ogilvie</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 11120-11137. <a href="https://doi.org/10.1021/acs.jmedchem.6b01320" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01320%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BAllosteric%252BInhibitors%252Bof%252BMutant%252BIsocitrate%252BDehydrogenase%252B1%252B%252528R132H%252BIDH1%252529%252BDisplaying%252BActivity%252Bin%252BHuman%252BAcute%252BMyeloid%252BLeukemia%252BCells%26aulast%3DJones%26aufirst%3DStuart%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D27092016%26date%3D05122016%26date%3D22122016%26date%3D15112016%26volume%3D59%26issue%3D24%26spage%3D11120%26epage%3D11137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangrui  Wu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuan  Yao</span>, <span class="hlFld-ContribAuthor ">Liping  Wei</span>, <span class="hlFld-ContribAuthor ">Zizhen  Feng</span>, <span class="hlFld-ContribAuthor ">Lisheng  Deng</span>, and <span class="hlFld-ContribAuthor ">Yongcheng  Song</span>  . </span><span class="cited-content_cbyCitation_article-title">3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 253-263. <a href="https://doi.org/10.1021/acs.jmedchem.5b01361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-%252528Piperidin-4-ylmethoxy%252529pyridine%252BContaining%252BCompounds%252BAre%252BPotent%252BInhibitors%252Bof%252BLysine%252BSpecific%252BDemethylase%252B1%26aulast%3DWu%26aufirst%3DFangrui%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D03092015%26date%3D24122015%26date%3D14012016%26date%3D10122015%26volume%3D59%26issue%3D1%26spage%3D253%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangrui  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Jiang</span>, <span class="hlFld-ContribAuthor ">Baisong  Zheng</span>, <span class="hlFld-ContribAuthor ">Mari  Kogiso</span>, <span class="hlFld-ContribAuthor ">Yuan  Yao</span>, <span class="hlFld-ContribAuthor ">Chao  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao-Nan  Li</span>, and <span class="hlFld-ContribAuthor ">Yongcheng  Song</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6899-6908. <a href="https://doi.org/10.1021/acs.jmedchem.5b00684" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252BCancer-Associated%252BMutant%252BIsocitrate%252BDehydrogenases%252Bby%252B2-Thiohydantoin%252BCompounds%26aulast%3DWu%26aufirst%3DFangrui%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04052015%26date%3D26082015%26date%3D10092015%26date%3D17082015%26volume%3D58%26issue%3D17%26spage%3D6899%26epage%3D6908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Defny S.  Wewengkang</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Moe  Takahashi</span>, <span class="hlFld-ContribAuthor ">Toshiki  Togashi</span>, <span class="hlFld-ContribAuthor ">Henki  Rotinsulu</span>, <span class="hlFld-ContribAuthor ">Deiske A.  Sumilat</span>, <span class="hlFld-ContribAuthor ">Michio  Namikoshi</span>. </span><span class="cited-content_cbyCitation_article-title">Production of an α-pyrone metabolite and microbial transformation of isoflavones by an Indonesian
              Streptomyces
              sp.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Asian Natural Products Research</span><span> <strong>2020,</strong> <em>22 </em>
                                    (8)
                                     , 754-761. <a href="https://doi.org/10.1080/10286020.2019.1635588" title="DOI URL">https://doi.org/10.1080/10286020.2019.1635588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10286020.2019.1635588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10286020.2019.1635588%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Asian%2520Natural%2520Products%2520Research%26atitle%3DProduction%252Bof%252Ban%252B%2525CE%2525B1-pyrone%252Bmetabolite%252Band%252Bmicrobial%252Btransformation%252Bof%252Bisoflavones%252Bby%252Ban%252BIndonesian%252BStreptomyces%252Bsp.%26aulast%3DWewengkang%26aufirst%3DDefny%2BS.%26date%3D2020%26date%3D2019%26volume%3D22%26issue%3D8%26spage%3D754%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chujiao  Hu</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Jingqiu  Liu</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Weike  Liao</span>, <span class="hlFld-ContribAuthor ">Yongjun  Dang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Licochalcone A suppresses the proliferation of sarcoma HT-1080 cells, as a selective R132C mutant IDH1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126825. <a href="https://doi.org/10.1016/j.bmcl.2019.126825" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126825%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLicochalcone%252BA%252Bsuppresses%252Bthe%252Bproliferation%252Bof%252Bsarcoma%252BHT-1080%252Bcells%25252C%252Bas%252Ba%252Bselective%252BR132C%252Bmutant%252BIDH1%252Binhibitor%26aulast%3DHu%26aufirst%3DChujiao%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengcheng  Zheng</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Li</span>, <span class="hlFld-ContribAuthor ">Chengli  Mou</span>, <span class="hlFld-ContribAuthor ">Dingwu  Pan</span>, <span class="hlFld-ContribAuthor ">Shuquan  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Xue</span>, <span class="hlFld-ContribAuthor ">Zhichao  Jin</span>, <span class="hlFld-ContribAuthor ">Yonggui Robin  Chi</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Access to 2‐Pyrones via Carbene‐Catalyzed Oxidative [3+3] Reactions between Enals and Nitrogen Ylides. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (7)
                                     , 1067-1070. <a href="https://doi.org/10.1002/ajoc.201900153" title="DOI URL">https://doi.org/10.1002/ajoc.201900153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900153%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEfficient%252BAccess%252Bto%252B2%2525E2%252580%252590Pyrones%252Bvia%252BCarbene%2525E2%252580%252590Catalyzed%252BOxidative%252B%25255B3%25252B3%25255D%252BReactions%252Bbetween%252BEnals%252Band%252BNitrogen%252BYlides%26aulast%3DZheng%26aufirst%3DPengcheng%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D7%26spage%3D1067%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshinobu  Korenaga</span>, <span class="hlFld-ContribAuthor ">Takashi  Sakai</span>, <span class="hlFld-ContribAuthor ">Haobo  Pang</span>, <span class="hlFld-ContribAuthor ">Bo  Jin</span>, <span class="hlFld-ContribAuthor ">Bruce H.  Lipshutz</span>. </span><span class="cited-content_cbyCitation_article-title">Pentafluorophenylboronic Acid. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-10. <a href="https://doi.org/10.1002/047084289X.rn00751.pub2" title="DOI URL">https://doi.org/10.1002/047084289X.rn00751.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn00751.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn00751.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DPentafluorophenylboronic%252BAcid%26aulast%3DKorenaga%26aufirst%3DToshinobu%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D10%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqi  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Meng  Xu</span>, <span class="hlFld-ContribAuthor ">Lixin  Gao</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianrong  Gao</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-aryl-4-indolyl-maleimides as potent mutant isocitrate dehydrogenase-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 589-603. <a href="https://doi.org/10.1016/j.bmc.2018.12.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-aryl-4-indolyl-maleimides%252Bas%252Bpotent%252Bmutant%252Bisocitrate%252Bdehydrogenase-1%252Binhibitors%26aulast%3DLiu%26aufirst%3DXiaoqi%26date%3D2019%26volume%3D27%26issue%3D4%26spage%3D589%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Honghui  Liao</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Gaoya  Xu</span>, <span class="hlFld-ContribAuthor ">Lixin  Gao</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianrong  Gao</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">3-(7-Azaindolyl)-4-indolylmaleimides as a novel class of mutant isocitrate dehydrogenase-1 inhibitors: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (10)
                                     , 1800039. <a href="https://doi.org/10.1002/ardp.201800039" title="DOI URL">https://doi.org/10.1002/ardp.201800039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800039%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D3-%2525287-Azaindolyl%252529-4-indolylmaleimides%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase-1%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DHu%26aufirst%3DYuanyuan%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D10%26spage%3D1800039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Ruotian  Tang</span>, <span class="hlFld-ContribAuthor ">Yue  Deng</span>, <span class="hlFld-ContribAuthor ">Kaiyin  Yang</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Steroids from Ganoderma sinense as new natural inhibitors of cancer-associated mutant IDH1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>79 </em>, 89-97. <a href="https://doi.org/10.1016/j.bioorg.2018.04.016" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSteroids%252Bfrom%252BGanoderma%252Bsinense%252Bas%252Bnew%252Bnatural%252Binhibitors%252Bof%252Bcancer-associated%252Bmutant%252BIDH1%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2018%26volume%3D79%26spage%3D89%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanumantha  Madala</span>, <span class="hlFld-ContribAuthor ">Surendra  Punganuru</span>, <span class="hlFld-ContribAuthor ">Viswanath  Arutla</span>, <span class="hlFld-ContribAuthor ">Subhasis  Misra</span>, <span class="hlFld-ContribAuthor ">T.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kalkunte  Srivenugopal</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 49. <a href="https://doi.org/10.3390/cancers10020049" title="DOI URL">https://doi.org/10.3390/cancers10020049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10020049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10020049%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBeyond%252BBrooding%252Bon%252BOncometabolic%252BHavoc%252Bin%252BIDH-Mutant%252BGliomas%252Band%252BAML%25253A%252BCurrent%252Band%252BFuture%252BTherapeutic%252BStrategies%26aulast%3DMadala%26aufirst%3DHanumantha%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Bin  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Hou</span>, <span class="hlFld-ContribAuthor ">Hui  Lin</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Lin</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4
              H
              -pyran-4-one derivatives as antiglioma agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 471-476. <a href="https://doi.org/10.1039/C7MD00551B" title="DOI URL">https://doi.org/10.1039/C7MD00551B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00551B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00551B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B5-hydroxy-2-methyl-4%252BH%252B-pyran-4-one%252Bderivatives%252Bas%252Bantiglioma%252Bagents%26aulast%3DLi%26aufirst%3DYi-Bin%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Xianqiang  Sun</span>, <span class="hlFld-ContribAuthor ">Zhongming  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolan  Cheng</span>, <span class="hlFld-ContribAuthor ">Wuguang  Lu</span>, <span class="hlFld-ContribAuthor ">Xueting  Cai</span>, <span class="hlFld-ContribAuthor ">Chunping  Hu</span>, <span class="hlFld-ContribAuthor ">Xu  Shen</span>, <span class="hlFld-ContribAuthor ">Peng  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric inhibitor remotely modulates the conformation of the orthestric pockets in mutant IDH2/R140Q. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-16427-w" title="DOI URL">https://doi.org/10.1038/s41598-017-16427-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-16427-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-16427-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAllosteric%252Binhibitor%252Bremotely%252Bmodulates%252Bthe%252Bconformation%252Bof%252Bthe%252Borthestric%252Bpockets%252Bin%252Bmutant%252BIDH2%25252FR140Q%26aulast%3DChen%26aufirst%3DJiao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Weiguang  Sun</span>, <span class="hlFld-ContribAuthor ">Suyu  Gao</span>, <span class="hlFld-ContribAuthor ">Shanshan  Luan</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Renqi  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Jiangeng  Huang</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (27)
                                     , 44255-44265. <a href="https://doi.org/10.18632/oncotarget.17464" title="DOI URL">https://doi.org/10.18632/oncotarget.17464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.17464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.17464%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DStructure%252Bbased%252Bdiscovery%252Bof%252Bclomifene%252Bas%252Ba%252Bpotent%252Binhibitor%252Bof%252Bcancer-associated%252Bmutant%252BIDH1%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D27%26spage%3D44255%26epage%3D44265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  He</span>, <span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Qin  Li</span>, <span class="hlFld-ContribAuthor ">Zhengxi  Hu</span>, <span class="hlFld-ContribAuthor ">Hucheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Junjun  Liu</span>, <span class="hlFld-ContribAuthor ">Jianping  Wang</span>, <span class="hlFld-ContribAuthor ">Yongbo  Xue</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Asperspiropene A, a novel fungal metabolite as an inhibitor of cancer-associated mutant isocitrate dehydrogenase 1. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (6)
                                     , 1137-1144. <a href="https://doi.org/10.1039/C6QO00847J" title="DOI URL">https://doi.org/10.1039/C6QO00847J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6QO00847J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6QO00847J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAsperspiropene%252BA%25252C%252Ba%252Bnovel%252Bfungal%252Bmetabolite%252Bas%252Ban%252Binhibitor%252Bof%252Bcancer-associated%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%26aulast%3DHe%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D6%26spage%3D1137%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongcheng  Song</span>, <span class="hlFld-ContribAuthor ">Fangrui  Wu</span>, <span class="hlFld-ContribAuthor ">Jingyu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2016,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-016-0279-9" title="DOI URL">https://doi.org/10.1186/s13045-016-0279-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-016-0279-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-016-0279-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeting%252Bhistone%252Bmethylation%252Bfor%252Bcancer%252Btherapy%25253A%252Benzymes%25252C%252Binhibitors%25252C%252Bbiological%252Bactivity%252Band%252Bperspectives%26aulast%3DSong%26aufirst%3DYongcheng%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenya  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqun  Chang</span>, <span class="hlFld-ContribAuthor ">Yushui  Han</span>, <span class="hlFld-ContribAuthor ">Kangjia  Liu</span>, <span class="hlFld-ContribAuthor ">Jinsong  Hou</span>, <span class="hlFld-ContribAuthor ">Chengli  Dai</span>, <span class="hlFld-ContribAuthor ">Yuanhao  Zhai</span>, <span class="hlFld-ContribAuthor ">Jialiang  Guo</span>, <span class="hlFld-ContribAuthor ">Pinghua  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Lin</span>, <span class="hlFld-ContribAuthor ">Weimin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies on 1-hydroxypyridin-2-one compounds as mutant isocitrate dehydrogenase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2016,</strong> <em>1123 </em>, 335-343. <a href="https://doi.org/10.1016/j.molstruc.2016.06.044" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.06.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.06.044%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bon%252B1-hydroxypyridin-2-one%252Bcompounds%252Bas%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%252Binhibitors%26aulast%3DWang%26aufirst%3DZhenya%26date%3D2016%26volume%3D1123%26spage%3D335%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aristeidis E.  Boukouris</span>, <span class="hlFld-ContribAuthor ">Sotirios D.  Zervopoulos</span>, <span class="hlFld-ContribAuthor ">Evangelos D.  Michelakis</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. </span><span class="cited-content_cbyCitation_journal-name">Trends in Biochemical Sciences</span><span> <strong>2016,</strong> <em>41 </em>
                                    (8)
                                     , 712-730. <a href="https://doi.org/10.1016/j.tibs.2016.05.013" title="DOI URL">https://doi.org/10.1016/j.tibs.2016.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tibs.2016.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tibs.2016.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Biochemical%2520Sciences%26atitle%3DMetabolic%252BEnzymes%252BMoonlighting%252Bin%252Bthe%252BNucleus%25253A%252BMetabolic%252BRegulation%252Bof%252BGene%252BTranscription%26aulast%3DBoukouris%26aufirst%3DAristeidis%2BE.%26date%3D2016%26volume%3D41%26issue%3D8%26spage%3D712%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangxia  Zou</span>, <span class="hlFld-ContribAuthor ">Stefan  Pusch</span>, <span class="hlFld-ContribAuthor ">Jessica  Eisel</span>, <span class="hlFld-ContribAuthor ">Tianfang  Ma</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>, <span class="hlFld-ContribAuthor ">Dawei  Deng</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Andreas  von Deimling</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (99)
                                     , 96735-96742. <a href="https://doi.org/10.1039/C6RA21617J" title="DOI URL">https://doi.org/10.1039/C6RA21617J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA21617J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA21617J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252Bselective%252Binhibitor%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%252Bat%252Ballosteric%252Bsite%252Bby%252Bdocking-based%252Bvirtual%252Bscreening%26aulast%3DZou%26aufirst%3DFangxia%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D99%26spage%3D96735%26epage%3D96742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyo-Joon  Kim</span>, <span class="hlFld-ContribAuthor ">Xiang  Fei</span>, <span class="hlFld-ContribAuthor ">Seok-Cheol  Cho</span>, <span class="hlFld-ContribAuthor ">Bu Young  Choi</span>, <span class="hlFld-ContribAuthor ">Hee-Chul  Ahn</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Seung-Yong  Seo</span>, <span class="hlFld-ContribAuthor ">Young-Sam  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (23)
                                     , 5625-5631. <a href="https://doi.org/10.1016/j.bmcl.2015.10.034" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%2525CE%2525B1-mangostin%252Bas%252Ba%252Bnovel%252Bcompetitive%252Binhibitor%252Bagainst%252Bmutant%252Bisocitrate%252Bdehydrogenase-1%26aulast%3DKim%26aufirst%3DHyo-Joon%26date%3D2015%26volume%3D25%26issue%3D23%26spage%3D5625%26epage%3D5631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Sam  Keum</span>, <span class="hlFld-ContribAuthor ">Bu Young  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Isocitrate dehydrogenase mutations: new opportunities for translational research. </span><span class="cited-content_cbyCitation_journal-name">BMB Reports</span><span> <strong>2015,</strong> <em>48 </em>
                                    (5)
                                     , 266-270. <a href="https://doi.org/10.5483/BMBRep.2015.48.5.021" title="DOI URL">https://doi.org/10.5483/BMBRep.2015.48.5.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5483/BMBRep.2015.48.5.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5483%2FBMBRep.2015.48.5.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBMB%2520Reports%26atitle%3DIsocitrate%252Bdehydrogenase%252Bmutations%25253A%252Bnew%252Bopportunities%252Bfor%252Btranslational%252Bresearch%26aulast%3DKeum%26aufirst%3DYoung-Sam%26date%3D2015%26volume%3D48%26issue%3D5%26spage%3D266%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Reaction catalyzed by WT IDH enzymes in tricarboxylic acid cycle, (B) reaction catalyzed by mutant IDH enzymes, and (C) structures of current inhibitors of mutant IDH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures and <i>K</i><sub>i</sub> Values of Initial Inhibitors of IDH1(R132H)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Structures of <b>21</b>–<b>29</b> and Their <i>K</i><sub>i</sub> Values against IDH1(R132H)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal and docking structures of inhibitors of IDH1(R132H). (A) The close-up view of the active site of the crystal structure of IDH1(R132H)/<b>2</b>, with the backbone of one monomeric protein shown in blue lines and that of the other monomer in yellow. Compound <b>2</b> is shown as a ball and stick model. Only selected residues with the interactions with <b>2</b> are shown for clarity. (B) Ten docking structures of compound <b>30</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing that the 3-benzyl group of <b>30</b> is predicted to occupy an empty pocket. (C) Ten docking structures of compound <b>34</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing the 4-OH group of <b>34</b> is predicted to have favorable interactions with Thr77. (D) Ten docking structures of compound <b>39</b> (with C atoms in green), superimposed with the crystal structure of <b>2</b> (in yellow), showing the 6-(3-OMe-Ph) group of <b>39</b> is predicted to have favorable interactions with Arg109.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Correlations between inhibition of IDH1(R132C) and that of (A) IDH1(R132H) and (B) cellular production of D2HG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis for 4-Methyl-6-substituted 1-Hydroxypyridin-2-one and Related Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) AlCl<sub>3,</sub> CH<sub>2</sub>Cl<sub>2,</sub> reflux; (ii) H<sub>2</sub>SO<sub>4</sub>/HOAc; (iii) P<sub>4</sub>S<sub>10</sub>, benzene, reflux; (iv) NH<sub>2</sub>OH or NH<sub>2</sub>NH<sub>2</sub>, pyridine, reflux; (v) R-B(OH)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, dioxane, reflux.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/medium/jm-2014-00660f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis for Other Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-20/jm500660f/20151001/images/large/jm-2014-00660f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500660f&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) a Pd-catalyzed coupling reaction, for example, Suzuki or Heck reaction; (ii) 3-chloroperoxybenzoic acid; (iii) AcCl, reflux, then MeOH; (iv) POBr<sub>3</sub>, 130 °C, then MeOH; (v) NaBH<sub>4</sub>, reflux; (vi) MOMCl, Et<sub>3</sub>N; (vii) NaOMe, reflux; (viii) BuLi, −78 °C, then PhCHO, 25 °C; (ix) Et<sub>3</sub>SiH, trifluoroacetic acid, 50 °C; (x) 3 N HCl; (xi) NaOH; (xii) H<sub>2</sub>O<sub>2</sub>, TFA, reflux; (xiii) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>; 60 °C; (xiv) PBr<sub>3</sub>; (xv) NaOMe, MeOH/THF, 40 °C; (xvi) BnZnBr, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; (xvii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">33946</span><span class="NLM_x">–</span> <span class="NLM_lpage">33957</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1074%2Fjbc.M404298200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=15173171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33946-33957&author=X.+Xuauthor=J.+Zhaoauthor=Z.+Xuauthor=B.+Pengauthor=Q.+Huangauthor=E.+Arnoldauthor=J.+Ding&title=Structures+of+human+cytosolic+NADP-dependent+isocitrate+dehydrogenase+reveal+a+novel+self-regulatory+mechanism+of+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity</span></div><div class="casAuthors">Xu, Xiang; Zhao, Jingyue; Xu, Zhen; Peng, Baozhen; Huang, Qiuhua; Arnold, Eddy; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33946-33957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate, and regulation of the enzymic activity of IDHs is crucial for their biol. functions.  Bacterial IDHs are reversibly regulated by phosphorylation of a strictly conserved serine residue at the active site.  Eukaryotic NADP-dependent IDHs (NADP-IDHs) have been shown to have diverse important biol. functions; however, their regulatory mechanism remains unclear.  Structural studies of human cytosolic NADP-IDH (HcIDH) in complex with NADP and in complex with NADP, isocitrate, and Ca2+ reveal three biol. relevant conformational states of the enzyme that differ substantially in the structure of the active site and in the overall structure.  A structural segment at the active site that forms a conserved α-helix in all known NADP-IDH structures assumes a loop conformation in the open, inactive form of HcIDH; a partially unraveled α-helix in the semi-open, intermediate form; and an α-helix in the closed, active form.  The side chain of Asp279 of this segment occupies the isocitrate-binding site and forms hydrogen bonds with Ser94 (the equiv. of the phosphorylation site in bacterial IDHs) in the inactive form and chelates the metal ion in the active form.  The structural data led us to propose a novel self-regulatory mechanism for HcIDH that mimics the phosphorylation mechanism used by the bacterial homologs, consistent with biochem. and biol. data.  This mechanism might be applicable to other eukaryotic NADP-IDHs.  The results also provide insights into the recognition and specificity of substrate and cofactor by eukaryotic NADP-IDHs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJaUxoQoMZ7Vg90H21EOLACvtfcHk0lhoJI4nyLVkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D&md5=79474e467a8cca43c26551c86745b3e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404298200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520cytosolic%2520NADP-dependent%2520isocitrate%2520dehydrogenase%2520reveal%2520a%2520novel%2520self-regulatory%2520mechanism%2520of%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33946%26epage%3D33957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Haselbeck, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlister-Henn, L.</span><span> </span><span class="NLM_article-title">Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">12116</span><span class="NLM_x">–</span> <span class="NLM_lpage">12122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=12116-12122&author=R.+J.+Haselbeckauthor=L.+McAlister-Henn&title=Function+and+expression+of+yeast+mitochondrial+NAD-+and+NADP-specific+isocitrate+dehydrogenases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaselbeck%26aufirst%3DR.%2BJ.%26aulast%3DMcAlister-Henn%26aufirst%3DL.%26atitle%3DFunction%2520and%2520expression%2520of%2520yeast%2520mitochondrial%2520NAD-%2520and%2520NADP-specific%2520isocitrate%2520dehydrogenases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D12116%26epage%3D12122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jennings, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckey, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmelee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlister-Henn, L.</span><span> </span><span class="NLM_article-title">Cytosolic NADP(+)-dependent isocitrate dehydrogenase. Isolation of rat cDNA and study of tissue-specific and developmental expression of mRNA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2689</span><span class="NLM_x">, </span> <span class="NLM_fpage">23128</span><span class="NLM_x">–</span> <span class="NLM_lpage">23134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2689&publication_year=1994&pages=23128-23134&author=G.+T.+Jenningsauthor=S.+Sechiauthor=P.+M.+Stevensonauthor=R.+C.+Tuckeyauthor=D.+Parmeleeauthor=L.+McAlister-Henn&title=Cytosolic+NADP%28%2B%29-dependent+isocitrate+dehydrogenase.+Isolation+of+rat+cDNA+and+study+of+tissue-specific+and+developmental+expression+of+mRNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DG.%2BT.%26aulast%3DSechi%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DP.%2BM.%26aulast%3DTuckey%26aufirst%3DR.%2BC.%26aulast%3DParmelee%26aufirst%3DD.%26aulast%3DMcAlister-Henn%26aufirst%3DL.%26atitle%3DCytosolic%2520NADP%2528%252B%2529-dependent%2520isocitrate%2520dehydrogenase.%2520Isolation%2520of%2520rat%2520cDNA%2520and%2520study%2520of%2520tissue-specific%2520and%2520developmental%2520expression%2520of%2520mRNA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D2689%26spage%3D23128%26epage%3D23134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenendt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallia, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busam, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekleab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strausberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karchin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">An integrated genomic analysis of human glioblastoma multiforme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1126%2Fscience.1164382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=18772396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1807-1812&author=D.+W.+Parsonsauthor=S.+Jonesauthor=X.+Zhangauthor=J.+C.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=I.+M.+Siuauthor=G.+L.+Galliaauthor=A.+Oliviauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=S.+Keirauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=D.+A.+Busamauthor=H.+Tekleabauthor=L.+A.+Diazauthor=J.+Hartiganauthor=D.+R.+Smithauthor=R.+L.+Strausbergauthor=S.+K.+Marieauthor=S.+M.+Shinjoauthor=H.+Yanauthor=G.+J.+Rigginsauthor=D.+D.+Bignerauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=An+integrated+genomic+analysis+of+human+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrated genomic analysis of human glioblastoma multiforme</span></div><div class="casAuthors">Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Siu, I.-Mei; Gallia, Gary L.; Olivi, Alessandro; McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Nikolskaya, Tatiana; Nikolsky, Yuri; Busam, Dana A.; Tekleab, Hanna; Diaz, Luis A., Jr.; Hartigan, James; Smith, Doug R.; Strausberg, Robert L.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Yan, Hai; Riggins, Gregory J.; Bigner, Darell D.; Karchin, Rachel; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1807-1812</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review based on author's research.  Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer.  To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, detd. the presence of amplifications and deletions using high-d. oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples.  This comprehensive anal. led to the discovery of a variety of genes that were not known to be altered in GBMs.  Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients.  Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were assocd. with an increase in overall survival.  These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFSe-eB8psp7Vg90H21EOLACvtfcHk0lhtMBIdAXQ7-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE&md5=88c9e87c4b9dc8ebedcaa2b5d9f3ce13</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164382%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%2BC.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DOlivi%26aufirst%3DA.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DKeir%26aufirst%3DS.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DBusam%26aufirst%3DD.%2BA.%26aulast%3DTekleab%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DMarie%26aufirst%3DS.%2BK.%26aulast%3DShinjo%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAn%2520integrated%2520genomic%2520analysis%2520of%2520human%2520glioblastoma%2520multiforme%26jtitle%3DScience%26date%3D2008%26volume%3D321%26spage%3D1807%26epage%3D1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ccr.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=17-30&author=W.+Xuauthor=H.+Yangauthor=Y.+Liuauthor=Y.+Yangauthor=P.+Wangauthor=S.+H.+Kimauthor=S.+Itoauthor=C.+Yangauthor=M.+T.+Xiaoauthor=L.+X.+Liuauthor=W.+Q.+Jiangauthor=J.+Liuauthor=J.+Y.+Zhangauthor=B.+Wangauthor=S.+Fryeauthor=Y.+Zhangauthor=Y.+H.+Xuauthor=Q.+Y.+Leiauthor=K.+L.+Guanauthor=S.+M.+Zhaoauthor=Y.+Xiong&title=Oncometabolite+2-hydroxyglutarate+is+a+competitive+inhibitor+of+alpha-ketoglutarate-dependent+dioxygenases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases</span></div><div class="casAuthors">Xu, Wei; Yang, Hui; Liu, Ying; Yang, Ying; Wang, Ping; Kim, Se-Hee; Ito, Shinsuke; Yang, Chen; Wang, Pu; Xiao, Meng-Tao; Liu, Li-xia; Jiang, Wen-qing; Liu, Jing; Zhang, Jin-ye; Wang, Bin; Frye, Stephen; Zhang, Yi; Xu, Yan-hui; Lei, Qun-ying; Guan, Kun-Liang; Zhao, Shi-min; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: IDH1 and IDH2 mutations occur frequently in gliomas and acute myeloid leukemia, leading to simultaneous loss and gain of activities in the prodn. of α-ketoglutarate (α-KG) and 2-hydroxyglutarate (2-HG), resp.  Here we demonstrate that 2-HG is a competitive inhibitor of multiple α-KG-dependent dioxygenases, including histone demethylases and the TET family of 5-methylcytosine (5mC) hydroxylases. 2-HG occupies the same space as α-KG does in the active site of histone demethylases.  Ectopic expression of tumor-derived IDH1 and IDH2 mutants inhibits histone demethylation and 5mC hydroxylation.  In glioma, IDH1 mutations are assocd. with increased histone methylation and decreased 5-hydroxylmethylcytosine (5hmC).  Hence, tumor-derived IDH1 and IDH2 mutations reduce α-KG and accumulate an α-KG antagonist, 2-HG, leading to genome-wide histone and DNA methylation alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpry-WZlrav7Vg90H21EOLACvtfcHk0lhtMBIdAXQ7-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D&md5=27f1e2d50b9dc1dd30bcc576d6318662</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26aulast%3DJiang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFrye%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DLei%26aufirst%3DQ.%2BY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DOncometabolite%25202-hydroxyglutarate%2520is%2520a%2520competitive%2520inhibitor%2520of%2520alpha-ketoglutarate-dependent%2520dioxygenases%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D17%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0ljX8K32_MwUgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19554337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+A+study+of+1%2C010+diffuse+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span></div><div class="casAuthors">Hartmann Christian; Meyer Jochen; Balss Jorg; Capper David; Mueller Wolf; Christians Arne; Felsberg Jorg; Wolter Marietta; Mawrin Christian; Wick Wolfgang; Weller Michael; Herold-Mende Christel; Unterberg Andreas; Jeuken Judith W M; Wesseling Peter; Reifenberger Guido; von Deimling Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Somatic mutations in the IDH1 gene encoding cytosolic NADP+-dependent isocitrate dehydrogenase have been shown in the majority of astrocytomas, oligodendrogliomas and oligoastrocytomas of WHO grades II and III.  IDH2 encoding mitochondrial NADP+-dependent isocitrate dehydrogenase is also mutated in these tumors, albeit at much lower frequencies.  Preliminary data suggest an importance of IDH1 mutation for prognosis showing that patients with anaplastic astrocytomas, oligodendrogliomas and oligoastrocytomas harboring IDH1 mutations seem to fare much better than patients without this mutation in their tumors.  To determine mutation types and their frequencies, we examined 1,010 diffuse gliomas.  We detected 716 IDH1 mutations and 31 IDH2 mutations.  We found 165 IDH1 (72.7%) and 2 IDH2 mutations (0.9%) in 227 diffuse astrocytomas WHO grade II, 146 IDH1 (64.0%) and 2 IDH2 mutations (0.9%) in 228 anaplastic astrocytomas WHO grade III, 105 IDH1 (82.0%) and 6 IDH2 mutations (4.7%) in 128 oligodendrogliomas WHO grade II, 121 IDH1 (69.5%) and 9 IDH2 mutations (5.2%) in 174 anaplastic oligodendrogliomas WHO grade III, 62 IDH1 (81.6%) and 1 IDH2 mutations (1.3%) in 76 oligoastrocytomas WHO grade II and 117 IDH1 (66.1%) and 11 IDH2 mutations (6.2%) in 177 anaplastic oligoastrocytomas WHO grade III.  We report on an inverse association of IDH1 and IDH2 mutations in these gliomas and a non-random distribution of the mutation types within the tumor entities.  IDH1 mutations of the R132C type are strongly associated with astrocytoma, while IDH2 mutations predominantly occur in oligodendroglial tumors.  In addition, patients with anaplastic glioma harboring IDH1 mutations were on average 6 years younger than those without these alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtaE6XzJLN_6xYuD7tu2XfW6udTcc2eaw58X_uqDDpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D&md5=cf2e0709bbe2f6d49d466b7083f2e486</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520A%2520study%2520of%25201%252C010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Marcucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maharry, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radmacher, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrózek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margeson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzeler, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolitz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, C. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2348</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1200%2FJCO.2009.27.3730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20368543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=2348-2355&author=G.+Marcucciauthor=K.+Maharryauthor=Y.-Z.+Wuauthor=M.+D.+Radmacherauthor=K.+Mr%C3%B3zekauthor=D.+Margesonauthor=K.+B.+Hollandauthor=S.+P.+Whitmanauthor=H.+Beckerauthor=S.+Schwindauthor=K.+H.+Metzelerauthor=B.+L.+Powellauthor=T.+H.+Carterauthor=J.+E.+Kolitzauthor=M.+Wetzlerauthor=A.+J.+Carrollauthor=M.+R.+Baerauthor=M.+A.+Caligiuriauthor=R.+A.+Larsonauthor=C.+D.+Bloomfield&title=IDH1+and+IDH2+gene+mutations+identify+novel+molecular+subsets+within+de+novo+cytogenetically+normal+acute+myeloid+leukemia%3A+A+cancer+and+leukemia+group+B+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study</span></div><div class="casAuthors">Marcucci, Guido; Maharry, Kati; Wu, Yue-Zhong; Radmacher, Michael D.; Mrozek, Krzysztof; Margeson, Dean; Holland, Kelsi B.; Whitman, Susan P.; Becker, Heiko; Schwind, Sebastian; Metzeler, Klaus H.; Powell, Bayard L.; Carter, Thomas H.; Kolitz, Jonathan E.; Wetzler, Meir; Carroll, Andrew J.; Baer, Maria R.; Caligiuri, Michael A.; Larson, Richard A.; Bloomfield, Clara D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2348-2355</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To analyze the frequency and assocns. with prognostic markers and outcome of mutations in IDH genes encoding isocitrate dehydrogenases in adult de novo cytogenetically normal acute myeloid leukemia (CN-AML).  Patients and Methods: Diagnostic bone marrow or blood samples from 358 patients were analyzed for IDH1 and IDH2 mutations by DNA polymerase chain reaction amplification/sequencing.  FLT3, NPM1, CEBPA, WT1, and MLL mutational analyses and gene- and microRNA-expression profiling were performed centrally.  Results: IDH mutations were found in 33% of the patients.  IDH1 mutations were detected in 49 patients (14%; 47 with R132).  IDH2 mutations, previously unreported in AML, were detected in 69 patients (19%; 13 with R172 and 56 with R140).  R172 IDH2 mutations were mutually exclusive with all other prognostic mutations analyzed.  Younger age (< 60 years), mol. low-risk (NPM1-mutated/FLT3-internal tandem duplication-neg.) IDH1-mutated patients had shorter disease-free survival than mol. low-risk IDH1/IDH2-wild-type (wt) patients (P = .046).  R172 IDH2-mutated patients had lower complete remission rates than IDH1/IDH2wt patients (P = .007).  Distinctive microarray gene- and microRNA-expression profiles accurately predicted R172 IDH2 mutations.  The highest expressed gene and microRNAs in R172 IDH2-mutated patients compared with the IDH1/IDH2wt patients were APP (previously assocd. with complex karyotype AML) and miR-1 and miR-133 (involved in embryonal stem-cell differentiation), resp.  Conclusion: IDH1 and IDH2 mutations are recurrent in CN-AML and have an unfavorable impact on outcome.  The R172 IDH2 mutations, previously unreported in AML, characterize a novel subset of CN-AML patients lacking other prognostic mutations and assoc. with unique gene- and microRNA-expression profiles that may lead to the discovery of novel, therapeutically targetable leuke-mogenic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiEtSm6jNn6LVg90H21EOLACvtfcHk0lieZ7WZp-cqWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFOntr0%253D&md5=7f3d00b921e52fdc10e75ab2fbac3ae9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.3730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.3730%26sid%3Dliteratum%253Aachs%26aulast%3DMarcucci%26aufirst%3DG.%26aulast%3DMaharry%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.-Z.%26aulast%3DRadmacher%26aufirst%3DM.%2BD.%26aulast%3DMr%25C3%25B3zek%26aufirst%3DK.%26aulast%3DMargeson%26aufirst%3DD.%26aulast%3DHolland%26aufirst%3DK.%2BB.%26aulast%3DWhitman%26aufirst%3DS.%2BP.%26aulast%3DBecker%26aufirst%3DH.%26aulast%3DSchwind%26aufirst%3DS.%26aulast%3DMetzeler%26aufirst%3DK.%2BH.%26aulast%3DPowell%26aufirst%3DB.%2BL.%26aulast%3DCarter%26aufirst%3DT.%2BH.%26aulast%3DKolitz%26aufirst%3DJ.%2BE.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DA.%2BJ.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DBloomfield%26aufirst%3DC.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520gene%2520mutations%2520identify%2520novel%2520molecular%2520subsets%2520within%2520de%2520novo%2520cytogenetically%2520normal%2520acute%2520myeloid%2520leukemia%253A%2520A%2520cancer%2520and%2520leukemia%2520group%2520B%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D2348%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasanthakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paietta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löwenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span> </span><span class="NLM_article-title">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ccr.2010.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21130701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=553-567&author=M.+E.+Figueroaauthor=O.+Abdel-Wahabauthor=C.+Luauthor=P.+S.+Wardauthor=J.+Patelauthor=A.+Shihauthor=Y.+Liauthor=N.+Bhagwatauthor=A.+Vasanthakumarauthor=H.+F.+Fernandezauthor=M.+S.+Tallmanauthor=Z.+Sunauthor=K.+Wolniakauthor=J.+K.+Peetersauthor=W.+Liuauthor=S.+E.+Choeauthor=V.+R.+Fantinauthor=E.+Paiettaauthor=B.+L%C3%B6wenbergauthor=J.+D.+Lichtauthor=L.+A.+Godleyauthor=R.+Delwelauthor=P.+J.+Valkauthor=C.+B.+Thompsonauthor=R.+L.+Levineauthor=A.+Melnick&title=Leukemic+IDH1+and+IDH2+mutations+result+in+a+hypermethylation+phenotype%2C+disrupt+TET2+function%2C+and+impair+hematopoietic+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</span></div><div class="casAuthors">Figueroa, Maria E.; Abdel-Wahab, Omar; Lu, Chao; Ward, Patrick S.; Patel, Jay; Shih, Alan; Li, Yushan; Bhagwat, Neha; Vasanthakumar, Aparna; Fernandez, Hugo F.; Tallman, Martin S.; Sun, Zhuoxin; Wolniak, Kristy; Peeters, Justine K.; Liu, Wei; Choe, Sung E.; Fantin, Valeria R.; Paietta, Elisabeth; Loewenberg, Bob; Licht, Jonathan D.; Godley, Lucy A.; Delwel, Ruud; Valk, Peter J. M.; Thompson, Craig B.; Levine, Ross L.; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-567</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Cancer-assocd. IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate (2HG) prodn.  Mutational and epigenetic profiling of a large acute myeloid leukemia (AML) patient cohort revealed that IDH1/2-mutant AMLs display global DNA hypermethylation and a specific hypermethylation signature.  Furthermore, expression of 2HG-producing IDH alleles in cells induced global DNA hypermethylation.  In the AML cohort, IDH1/2 mutations were mutually exclusive with mutations in the α-ketoglutarate-dependent enzyme TET2, and TET2 loss-of-function mutations were assocd. with similar epigenetic defects as IDH1/2 mutants.  Consistent with these genetic and epigenetic data, expression of IDH mutants impaired TET2 catalytic function in cells.  Finally, either expression of mutant IDH1/2 or Tet2 depletion impaired hematopoietic differentiation and increased stem/progenitor cell marker expression, suggesting a shared proleukemogenic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5mMhJR64Z4rVg90H21EOLACvtfcHk0lieZ7WZp-cqWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvJ&md5=f058c7dbd2efd6a25f4044506b5a2ef3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBhagwat%26aufirst%3DN.%26aulast%3DVasanthakumar%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DH.%2BF.%26aulast%3DTallman%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DWolniak%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DJ.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChoe%26aufirst%3DS.%2BE.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DPaietta%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGodley%26aufirst%3DL.%2BA.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DValk%26aufirst%3DP.%2BJ.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DLeukemic%2520IDH1%2520and%2520IDH2%2520mutations%2520result%2520in%2520a%2520hypermethylation%2520phenotype%252C%2520disrupt%2520TET2%2520function%252C%2520and%2520impair%2520hematopoietic%2520differentiation%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D553%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Amary, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berisha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskandarpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogendoorn, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirabosco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, A. M.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1002%2Fpath.2913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21598255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2011&pages=334-343&author=M.+F.+Amaryauthor=K.+Bacsiauthor=F.+Maggianiauthor=S.+Damatoauthor=D.+Halaiauthor=F.+Berishaauthor=R.+Pollockauthor=P.+O%E2%80%99Donnellauthor=A.+Grigoriadisauthor=T.+Dissauthor=M.+Eskandarpourauthor=N.+Presneauauthor=P.+C.+Hogendoornauthor=A.+Futrealauthor=R.+Tiraboscoauthor=A.+M.+Flanagan&title=IDH1+and+IDH2+mutations+are+frequent+events+in+central+chondrosarcoma+and+central+and+periosteal+chondromas+but+not+in+other+mesenchymal+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumors</span></div><div class="casAuthors">Amary, M. Fernanda; Bacsi, Krisztian; Maggiani, Francesca; Damato, Stephen; Halai, Dina; Berisha, Fitim; Pollock, Robin; O'Donnell, Paul; Grigoriadis, Anita; Diss, Tim; Eskandarpour, Malihe; Presneau, Nadege; Hogendoorn, Pancras C.; Futreal, Andrew; Tirabosco, Roberto; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-343</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 occur in gliomas and acute myeloid leukemia (AML).  Since patients with multiple enchondromas have occasionally been reported to have these conditions, we hypothesized that the same mutations would occur in cartilaginous neoplasms.  Approx. 1200 mesenchymal tumors, including 220 cartilaginous tumors, 222 osteosarcomas and another ∼750 bone and soft tissue tumors, were screened for IDH1 R132 mutations, using Sequenom mass spectrometry.  Cartilaginous tumors and chondroblastic osteosarcomas, wild-type for IDH1 R132, were analyzed for IDH2 (R172, R140) mutations.  Validation was performed by capillary sequencing and restriction enzyme digestion.  Heterozygous somatic IDH1/IDH2 mutations, which result in the prodn. of a potential oncometabolite, 2-hydroxyglutarate, were only detected in central and periosteal cartilaginous tumors, and were found in at least 56% of these, ∼40% of which were represented by R132C.  IDH1 R132H mutations were confirmed by immunoreactivity for this mutant allele.  The ratio of IDH1:IDH2 mutation was 10.6 : 1.  No IDH2 R140 mutations were detected.  Mutations were detected in enchondromas through to conventional central and dedifferentiated chondrosarcomas, in patients with both solitary and multiple neoplasms.  No germline mutations were detected.  No mutations were detected in peripheral chondrosarcomas and osteochondromas.  In conclusion, IDH1 and IDH2 mutations represent the first common genetic abnormalities to be identified in conventional central and periosteal cartilaginous tumors.  As in gliomas and AML, the mutations appear to occur early in tumorigenesis.  We speculate that a mosaic pattern of IDH-mutation-bearing cells explains the reports of diverse tumors (gliomas, AML, multiple cartilaginous neoplasms, haemangiomas) occurring in the same patient.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnKlczQQ1mLVg90H21EOLACvtfcHk0lieZ7WZp-cqWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D&md5=59128645aa54d08a4251d8f763ccb28e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpath.2913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2913%26sid%3Dliteratum%253Aachs%26aulast%3DAmary%26aufirst%3DM.%2BF.%26aulast%3DBacsi%26aufirst%3DK.%26aulast%3DMaggiani%26aufirst%3DF.%26aulast%3DDamato%26aufirst%3DS.%26aulast%3DHalai%26aufirst%3DD.%26aulast%3DBerisha%26aufirst%3DF.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DDiss%26aufirst%3DT.%26aulast%3DEskandarpour%26aufirst%3DM.%26aulast%3DPresneau%26aufirst%3DN.%26aulast%3DHogendoorn%26aufirst%3DP.%2BC.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520events%2520in%2520central%2520chondrosarcoma%2520and%2520central%2520and%2520periosteal%2520chondromas%2520but%2520not%2520in%2520other%2520mesenchymal%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2011%26volume%3D224%26spage%3D334%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+van+der+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0lhgqH9RVlId3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3Dvan%2Bder%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coller, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=225-234&author=P.+S.+Wardauthor=J.+Patelauthor=D.+R.+Wiseauthor=O.+Abdel-Wahabauthor=B.+D.+Bennettauthor=H.+A.+Collerauthor=J.+R.+Crossauthor=V.+R.+Fantinauthor=C.+V.+Hedvatauthor=A.+E.+Perlauthor=J.+D.+Rabinowitzauthor=M.+Carrollauthor=S.+M.+Suauthor=K.+A.+Sharpauthor=R.+L.+Levineauthor=C.+B.+Thompson&title=The+common+feature+of+leukemia-associated+IDH1+and+IDH2+mutations+is+a+neomorphic+enzyme+activity+converting+alpha-ketoglutarate+to+2-hydroxyglutarate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DHedvat%26aufirst%3DC.%2BV.%26aulast%3DPerl%26aufirst%3DA.%2BE.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520common%2520feature%2520of%2520leukemia-associated%2520IDH1%2520and%2520IDH2%2520mutations%2520is%2520a%2520neomorphic%2520enzyme%2520activity%2520converting%2520alpha-ketoglutarate%2520to%25202-hydroxyglutarate%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D225%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Rourke, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnature10860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=22343901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=474-478&author=C.+Luauthor=P.+S.+Wardauthor=G.+S.+Kapoorauthor=D.+Rohleauthor=S.+Turcanauthor=O.+Abdel-Wahabauthor=C.+R.+Edwardsauthor=R.+Khaninauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=K.+E.+Wellenauthor=D.+M.+O%E2%80%99Rourkeauthor=S.+L.+Bergerauthor=T.+A.+Chanauthor=R.+L.+Levineauthor=I.+K.+Mellinghoffauthor=C.+B.+Thompson&title=IDH+mutation+impairs+histone+demethylation+and+results+in+a+block+to+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span></div><div class="casAuthors">Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">474-478</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukemias (AML) and chondrosarcomas, and share a novel enzymic property of producing 2-hydroxyglutarate (2HG) from α-ketoglutarate.  Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells.  In tumor samples from glioma patients, IDH mutations were assocd. with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was assocd. with increased histone methylation.  To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro.  Introduction of either mutant IDH or cell-permeable 2HG was assocd. with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation.  This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation.  Gliomas were found to have elevated levels of similar histone repressive marks.  Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation.  Of the marks examd., increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture.  Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation.  Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxj9sZYgiJH7Vg90H21EOLACvtfcHk0lhgqH9RVlId3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D&md5=d5bb18c8ef2bbd1d28540cf7dabc9b57</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature10860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10860%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DKhanin%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DD.%2BM.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DIDH%2520mutation%2520impairs%2520histone%2520demethylation%2520and%2520results%2520in%2520a%2520block%2520to%2520cell%2520differentiation%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D474%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yilmaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabius, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span> </span><span class="NLM_article-title">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=479-483&author=S.+Turcanauthor=D.+Rohleauthor=A.+Goenkaauthor=L.+A.+Walshauthor=F.+Fangauthor=E.+Yilmazauthor=C.+Camposauthor=A.+W.+Fabiusauthor=C.+Luauthor=P.+S.+Wardauthor=C.+B.+Thompsonauthor=A.+Kaufmanauthor=O.+Guryanovaauthor=R.+Levineauthor=A.+Heguyauthor=A.+Vialeauthor=L.+G.+Morrisauthor=J.+T.+Huseauthor=I.+K.+Mellinghoffauthor=T.+A.+Chan&title=IDH1+mutation+is+sufficient+to+establish+the+glioma+hypermethylator+phenotype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DGoenka%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DL.%2BA.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYilmaz%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DFabius%26aufirst%3DA.%2BW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKaufman%26aufirst%3DA.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DL.%2BG.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BA.%26atitle%3DIDH1%2520mutation%2520is%2520sufficient%2520to%2520establish%2520the%2520glioma%2520hypermethylator%2520phenotype%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Prensner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Metabolism unhinged: IDH mutations in cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fnm0311-291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=21383741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=291-293&author=J.+R.+Prensnerauthor=A.+M.+Chinnaiyan&title=Metabolism+unhinged%3A+IDH+mutations+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism unhinged: IDH mutations in cancer</span></div><div class="casAuthors">Prensner, John R.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-293</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently characterized IDH1 and IDH2 mutations in leukemia and glioblastoma have introduced a fascinating cancer-specific role for metabolic genes essential to cellular respiration.  Studies also link aberrant IDH1 and IDH2 activity to an altered metabolite profile, an observation that may have broad implications for both cancer epigenetics and clin. management of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopuegY-UsALVg90H21EOLACvtfcHk0lipfevJEbxtQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D&md5=6df1b41aab0341769974251276ba6dec</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm0311-291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0311-291%26sid%3Dliteratum%253Aachs%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMetabolism%2520unhinged%253A%2520IDH%2520mutations%2520in%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D291%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">IDH mutations in glioma and acute myeloid leukemia</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=387-397&author=L.+Dangauthor=S.+Jinauthor=S.+M.+Su&title=IDH+mutations+in+glioma+and+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DIDH%2520mutations%2520in%2520glioma%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1093%2Fjnci%2Fdjq262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20576929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=926-928&author=K.+Garber&title=Oncometabolite%3F+IDH1+discoveries+raise+possibility+of+new+metabolism+targets+in+brain+cancers+and+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite? IDH1 Discoveries Raise Possibility of New Metabolism Targets in Brain Cancers and Leukemia</span></div><div class="casAuthors">Garber, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">926-928</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Compared with normal cells, which primarily generate energy aerobically in mitochondria, most tumor cells rely more heavily on glycolysis (the anaerobic conversion of glucose to lactate) to generate energy.  Tumors also display other unique metabolic features.  But the discovery of a mutated metabolic enzyme was strong evidence that metabolic abnormalities play an important role in oncogenesis, and it set off a frantic effort to understand what the mutation was doing in such common and lethal cancers.  Answers have proven just as surprising as the initial discovery.  And the revelations, although incomplete and still controversial, are paving the way for drugs targeting mutant isocitrate dehydrogenase (IDH) and for diagnostic tests to identify patients likely to benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUWv5GxNnQqrVg90H21EOLACvtfcHk0lipfevJEbxtQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D&md5=66fe53c6c537f459144c907a59e47d90</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq262%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DOncometabolite%253F%2520IDH1%2520discoveries%2520raise%2520possibility%2520of%2520new%2520metabolism%2520targets%2520in%2520brain%2520cancers%2520and%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D926%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0liBKeV0wBxLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaskas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grommes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldrini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komisopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kernytsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0liBKeV0wBxLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anglin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0liBKeV0wBxLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundriyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-<span class="smallcaps smallerCapital">d</span>-xylulose-5-phosphate reductoisomerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6539</span><span class="NLM_x">–</span> <span class="NLM_lpage">6542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012592" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6539-6542&author=L.+Dengauthor=S.+Sundriyalauthor=V.+Rubioauthor=Z.+Shiauthor=Y.+Song&title=Coordination+chemistry+based+approach+to+lipophilic+inhibitors+of+1-deoxy-d-xylulose-5-phosphate+reductoisomerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm9012592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012592%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSundriyal%26aufirst%3DS.%26aulast%3DRubio%26aufirst%3DV.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCoordination%2520chemistry%2520based%2520approach%2520to%2520lipophilic%2520inhibitors%2520of%25201-deoxy-d-xylulose-5-phosphate%2520reductoisomerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6539%26epage%3D6542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Structures of 1-Deoxy-<span class="smallcaps smallerCapital">d</span>-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100243r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=165-170&author=L.+Dengauthor=K.+Endoauthor=M.+Katoauthor=G.+Chengauthor=S.+Yajimaauthor=Y.+Song&title=Structures+of+1-Deoxy-d-Xylulose-5-Phosphate+Reductoisomerase%2FLipophilic+Phosphonate+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml100243r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100243r%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DEndo%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DYajima%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DStructures%2520of%25201-Deoxy-d-Xylulose-5-Phosphate%2520Reductoisomerase%252FLipophilic%2520Phosphonate%2520Complexes%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D165%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300419r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=278-282&author=J.+Xueauthor=J.+Diaoauthor=G.+Caiauthor=L.+Dengauthor=B.+Zhengauthor=Y.+Yaoauthor=Y.+Song&title=Antimalarial+and+Structural+Studies+of+Pyridine-containing+Inhibitors+of+1-Deoxyxylulose-5-phosphate+Reductoisomerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300419r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300419r%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DDiao%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DG.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DAntimalarial%2520and%2520Structural%2520Studies%2520of%2520Pyridine-containing%2520Inhibitors%2520of%25201-Deoxyxylulose-5-phosphate%2520Reductoisomerase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D278%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of “off-on switch” of activities of human IDH1 by tumor-associated mutation R132H</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%9Coff-on+switch%E2%80%9D+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0lh_vnyV4R7GuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%259Coff-on%2520switch%25E2%2580%259D%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirozzi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasojevic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span> </span><span class="NLM_article-title">Mutant IDH1 is required for IDH1 mutated tumor cell growth</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=774-782&author=G.+Jinauthor=C.+J.+Pirozziauthor=L.+H.+Chenauthor=G.+Y.+Lopezauthor=C.+G.+Duncanauthor=J.+Fengauthor=I.+Spasojevicauthor=D.+D.+Bignerauthor=Y.+Heauthor=H.+Yan&title=Mutant+IDH1+is+required+for+IDH1+mutated+tumor+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DG.%26aulast%3DPirozzi%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DLopez%26aufirst%3DG.%2BY.%26aulast%3DDuncan%26aufirst%3DC.%2BG.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DH.%26atitle%3DMutant%2520IDH1%2520is%2520required%2520for%2520IDH1%2520mutated%2520tumor%2520cell%2520growth%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D774%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hellinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veszelka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duy, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vastag, M.</span><span> </span><span class="NLM_article-title">Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1016%2Fj.ejpb.2012.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=22906709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCiur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=340-351&author=E.+Hellingerauthor=S.+Veszelkaauthor=A.+E.+Tothauthor=F.+Walterauthor=A.+Kittelauthor=M.+L.+Bakkauthor=K.+Tihanyiauthor=V.+Hadaauthor=S.+Nakagawaauthor=T.+D.+Duyauthor=M.+Niwaauthor=M.+A.+Deliauthor=M.+Vastag&title=Comparison+of+brain+capillary+endothelial+cell-based+and+epithelial+%28MDCK-MDR1%2C+Caco-2%2C+and+VB-Caco-2%29+cell-based+surrogate+blood-brain+barrier+penetration+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models</span></div><div class="casAuthors">Hellinger, Eva; Veszelka, Szilvia; Toth, Andrea E.; Walter, Fruzsina; Kittel, Agnes; Bakk, Monika Laura; Tihanyi, Karoly; Hada, Viktor; Nakagawa, Shinsuke; Dinh Ha Duy, Thuy; Niwa, Masami; Deli, Maria A.; Vastag, Monika</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">340-351</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An accurate means of predicting blood-brain barrier (BBB) penetration and blood-brain partitioning of NCEs (new chem. entities) would fulfill a major need in pharmaceutical research.  Currently, an industry-std. BBB drug penetration model is not available.  Primary brain capillary endothelial cells, optionally co-cultured with astrocytes and/or pericytes, are the most valued models of BBB.  For routine use, establishing and maintaining a co-culture system is too costly and labor intensive.  Alternatively, non-cerebral cell lines such as MDCK-MDR1 are used, and most recently, the suitability of native and modified Caco-2 for predicting brain penetration has also come under investigation.  This study provides comparative data on the morphol. and functionality of the high integrity brain capillary endothelial BBB model (EPA: triple culture of brain capillary endothelial cells with pericytes and astrocytes) and the epithelial cell-based (native Caco-2, high P-glycoprotein expressing vinblastine-treated VB-Caco-2 and MDCK-MDR1) surrogate BBB models.  Using a panel of 10 compds. VB-Caco-2 and MDCK-MDR1 cell lines show restrictive paracellular pathway and BBB-like selective passive permeability that makes them comparable to the rat brain BBB model, which gave correlation with the highest r2 value with in vivo permeability data.  In bidirectional assay, the VB-Caco-2 and the MDCK-MDR1 models identified more P-glycoprotein drug substrates than the rat brain BBB model.  While the complexity and predictive value of the BBB model is the highest, for the screening of NCEs to det. whether they are efflux substrates or not, the VB-Caco-2 and the MDCK-MDR1 models may provide a simple and inexpensive tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPCN0_k1e4XrVg90H21EOLACvtfcHk0lh_vnyV4R7GuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCiur7F&md5=25215c5216a31136644eff7fe1cff273</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2012.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2012.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DHellinger%26aufirst%3DE.%26aulast%3DVeszelka%26aufirst%3DS.%26aulast%3DToth%26aufirst%3DA.%2BE.%26aulast%3DWalter%26aufirst%3DF.%26aulast%3DKittel%26aufirst%3DA.%26aulast%3DBakk%26aufirst%3DM.%2BL.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DHada%26aufirst%3DV.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DDuy%26aufirst%3DT.%2BD.%26aulast%3DNiwa%26aufirst%3DM.%26aulast%3DDeli%26aufirst%3DM.%2BA.%26aulast%3DVastag%26aufirst%3DM.%26atitle%3DComparison%2520of%2520brain%2520capillary%2520endothelial%2520cell-based%2520and%2520epithelial%2520%2528MDCK-MDR1%252C%2520Caco-2%252C%2520and%2520VB-Caco-2%2529%2520cell-based%2520surrogate%2520blood-brain%2520barrier%2520penetration%2520models%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2012%26volume%3D82%26spage%3D340%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetic-driven approach to screen candidate anticancer drugs for brain tumor chemotherapy</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=250-257&author=H.+Lvauthor=X.+Zhangauthor=J.+Sharmaauthor=M.+V.+R.+Reddyauthor=E.+P.+Reddyauthor=J.+M.+Gallo&title=Integrated+pharmacokinetic-driven+approach+to+screen+candidate+anticancer+drugs+for+brain+tumor+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSharma%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26atitle%3DIntegrated%2520pharmacokinetic-driven%2520approach%2520to%2520screen%2520candidate%2520anticancer%2520drugs%2520for%2520brain%2520tumor%2520chemotherapy%26jtitle%3DAAPS%2520J.%26date%3D2013%26volume%3D15%26spage%3D250%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Luchman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stechishin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnelong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weljie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S.</span><span> </span><span class="NLM_article-title">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=184-191&author=H.+A.+Luchmanauthor=O.+D.+Stechishinauthor=N.+H.+Dangauthor=M.+D.+Bloughauthor=C.+Chesnelongauthor=J.+J.+Kellyauthor=S.+A.+Nguyenauthor=J.+A.+Chanauthor=A.+M.+Weljieauthor=J.+G.+Cairncrossauthor=S.+Weiss&title=An+in+vivo+patient-derived+model+of+endogenous+IDH1-mutant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuchman%26aufirst%3DH.%2BA.%26aulast%3DStechishin%26aufirst%3DO.%2BD.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DBlough%26aufirst%3DM.%2BD.%26aulast%3DChesnelong%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DWeljie%26aufirst%3DA.%2BM.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%26atitle%3DAn%2520in%2520vivo%2520patient-derived%2520model%2520of%2520endogenous%2520IDH1-mutant%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2012%26volume%3D14%26spage%3D184%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antalffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauser, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1414</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1414-1424&author=Q.+Shuauthor=K.+K.+Wongauthor=J.+M.+Suauthor=A.+M.+Adesinaauthor=L.+T.+Yuauthor=Y.+T.+Tsangauthor=B.+C.+Antalffyauthor=P.+Baxterauthor=L.+Perlakyauthor=J.+Yangauthor=R.+C.+Dauserauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=C.+C.+Lauauthor=X.+N.+Li&title=Direct+orthotopic+transplantation+of+fresh+surgical+specimen+preserves+CD133%2B+tumor+cells+in+clinically+relevant+mouse+models+of+medulloblastoma+and+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DQ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DL.%2BT.%26aulast%3DTsang%26aufirst%3DY.%2BT.%26aulast%3DAntalffy%26aufirst%3DB.%2BC.%26aulast%3DBaxter%26aufirst%3DP.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DDauser%26aufirst%3DR.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DDirect%2520orthotopic%2520transplantation%2520of%2520fresh%2520surgical%2520specimen%2520preserves%2520CD133%252B%2520tumor%2520cells%2520in%2520clinically%2520relevant%2520mouse%2520models%2520of%2520medulloblastoma%2520and%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2008%26volume%3D26%26spage%3D1414%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idamakanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Police, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenbeck, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1173-1185&author=Z.+Liuauthor=X.+Zhaoauthor=H.+Maoauthor=P.+A.+Baxterauthor=Y.+Huangauthor=L.+Yuauthor=L.+Wadhwaauthor=J.+M.+Suauthor=A.+Adesinaauthor=L.+Perlakyauthor=M.+Hurwitzauthor=N.+Idamakantiauthor=S.+R.+Policeauthor=P.+L.+Hallenbeckauthor=R.+L.+Hurwitzauthor=C.+C.+Lauauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=X.+N.+Li&title=Intravenous+injection+of+oncolytic+picornavirus+SVV-001+prolongs+animal+survival+in+a+panel+of+primary+tumor-based+orthotopic+xenograft+mouse+models+of+pediatric+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWadhwa%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DHurwitz%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DPolice%26aufirst%3DS.%2BR.%26aulast%3DHallenbeck%26aufirst%3DP.%2BL.%26aulast%3DHurwitz%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DIntravenous%2520injection%2520of%2520oncolytic%2520picornavirus%2520SVV-001%2520prolongs%2520animal%2520survival%2520in%2520a%2520panel%2520of%2520primary%2520tumor-based%2520orthotopic%2520xenograft%2520mouse%2520models%2520of%2520pediatric%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2013%26volume%3D15%26spage%3D1173%26epage%3D1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, T.</span><span> </span><span class="NLM_article-title">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20331619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=877-889&author=F.+Wanauthor=S.+Zhangauthor=R.+Xieauthor=B.+Gaoauthor=B.+Camposauthor=C.+Herold-Mendeauthor=T.+Lei&title=The+utility+and+limitations+of+neurosphere+assay%2C+CD133+immunophenotyping+and+side+population+assay+in+glioma+stem+cell+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span></div><div class="casAuthors">Wan, Feng; Zhang, Suojun; Xie, Ruifan; Gao, Baocheng; Campos, Benito; Herold-Mende, Christel; Lei, Ting</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-889</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic "blueprints" of GSCs.  To identify the true "stemness" signatures, pure GSC populations are primarily needed.  Reliable in vitro methods enriching for GSCs and thereby identifying the key stem-like characteristics constitute the preliminary step forward.  We discuss in this review the current widely used methods for enriching and isolating GSCs, namely neurosphere assay, CD133 Immunophenotyping and side population assay, and detail their limitations and potential pitfalls that could complicate interpretation of corresponding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrleaZxkJUBc7Vg90H21EOLACvtfcHk0lghdDn7_nafgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN&md5=09f9ae3b110b21a2bb65baa0d831c09c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLei%26aufirst%3DT.%26atitle%3DThe%2520utility%2520and%2520limitations%2520of%2520neurosphere%2520assay%252C%2520CD133%2520immunophenotyping%2520and%2520side%2520population%2520assay%2520in%2520glioma%2520stem%2520cell%2520research%26jtitle%3DBrain%2520Pathol.%26date%3D2010%26volume%3D20%26spage%3D877%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterman-Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visnyei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenieux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazareff, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Neurosphere formation is an independent predictor of clinical outcome in malignant glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=980-987&author=D.+R.+Laksauthor=M.+Masterman-Smithauthor=K.+Visnyeiauthor=B.+Angenieuxauthor=N.+M.+Orozcoauthor=I.+Foranauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=L.+M.+Liauauthor=J.+A.+Lazareffauthor=P.+S.+Mischelauthor=T.+F.+Cloughesyauthor=S.+Horvathauthor=H.+I.+Kornblum&title=Neurosphere+formation+is+an+independent+predictor+of+clinical+outcome+in+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DMasterman-Smith%26aufirst%3DM.%26aulast%3DVisnyei%26aufirst%3DK.%26aulast%3DAngenieux%26aufirst%3DB.%26aulast%3DOrozco%26aufirst%3DN.%2BM.%26aulast%3DForan%26aufirst%3DI.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DLazareff%26aufirst%3DJ.%2BA.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DNeurosphere%2520formation%2520is%2520an%2520independent%2520predictor%2520of%2520clinical%2520outcome%2520in%2520malignant%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2009%26volume%3D27%26spage%3D980%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Chaichana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Berridi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara-Quintana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinones-Hinojosa, A.</span><span> </span><span class="NLM_article-title">Neurosphere assays: Growth factors and hormone differences in tumor and nontumor studies</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2851</span><span class="NLM_x">–</span> <span class="NLM_lpage">2857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2851-2857&author=K.+Chaichanaauthor=G.+Zamora-Berridiauthor=J.+Camara-Quintanaauthor=A.+Quinones-Hinojosa&title=Neurosphere+assays%3A+Growth+factors+and+hormone+differences+in+tumor+and+nontumor+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaichana%26aufirst%3DK.%26aulast%3DZamora-Berridi%26aufirst%3DG.%26aulast%3DCamara-Quintana%26aufirst%3DJ.%26aulast%3DQuinones-Hinojosa%26aufirst%3DA.%26atitle%3DNeurosphere%2520assays%253A%2520Growth%2520factors%2520and%2520hormone%2520differences%2520in%2520tumor%2520and%2520nontumor%2520studies%26jtitle%3DStem%2520Cells%26date%3D2006%26volume%3D24%26spage%3D2851%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voicu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurusiddappa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=580-594&author=L.+Yuauthor=P.+A.+Baxterauthor=H.+Voicuauthor=S.+Gurusiddappaauthor=Y.+Zhaoauthor=A.+Adesinaauthor=T.+K.+Manauthor=Q.+Shuauthor=Y.+J.+Zhangauthor=X.+M.+Zhaoauthor=J.+M.+Suauthor=L.+Perlakyauthor=R.+Dauserauthor=M.+Chintagumpalaauthor=C.+C.+Lauauthor=S.+M.+Blaneyauthor=P.+H.+Raoauthor=H.+C.+Leungauthor=X.+N.+Li&title=A+clinically+relevant+orthotopic+xenograft+model+of+ependymoma+that+maintains+the+genomic+signature+of+the+primary+tumor+and+preserves+cancer+stem+cells+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DVoicu%26aufirst%3DH.%26aulast%3DGurusiddappa%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DMan%26aufirst%3DT.%2BK.%26aulast%3DShu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BM.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DDauser%26aufirst%3DR.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DRao%26aufirst%3DP.%2BH.%26aulast%3DLeung%26aufirst%3DH.%2BC.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DA%2520clinically%2520relevant%2520orthotopic%2520xenograft%2520model%2520of%2520ependymoma%2520that%2520maintains%2520the%2520genomic%2520signature%2520of%2520the%2520primary%2520tumor%2520and%2520preserves%2520cancer%2520stem%2520cells%2520in%2520vivo%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D580%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vormoor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres-Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span> </span><span class="NLM_article-title">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=645-648&author=T.+Lapidotauthor=C.+Sirardauthor=J.+Vormoorauthor=B.+Murdochauthor=T.+Hoangauthor=J.+Caceres-Cortesauthor=M.+Mindenauthor=B.+Patersonauthor=M.+A.+Caligiuriauthor=J.+E.+Dick&title=A+cell+initiating+human+acute+myeloid+leukaemia+after+transplantation+into+SCID+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DB.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DPaterson%26aufirst%3DB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26atitle%3DA%2520cell%2520initiating%2520human%2520acute%2520myeloid%2520leukaemia%2520after%2520transplantation%2520into%2520SCID%2520mice%26jtitle%3DNature%26date%3D1994%26volume%3D367%26spage%3D645%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Al Hajj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, M. F.</span><span> </span><span class="NLM_article-title">Therapeutic implications of cancer stem cells</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=43-47&author=M.+Al+Hajjauthor=M.+W.+Beckerauthor=M.+Wichaauthor=I.+Weissmanauthor=M.+F.+Clarke&title=Therapeutic+implications+of+cancer+stem+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BHajj%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DM.%2BW.%26aulast%3DWicha%26aufirst%3DM.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DClarke%26aufirst%3DM.%2BF.%26atitle%3DTherapeutic%2520implications%2520of%2520cancer%2520stem%2520cells%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2004%26volume%3D14%26spage%3D43%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">The antitumor activity of the fungicide ciclopirox</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1002%2Fijc.25255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500660f&amp;key=20225320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=2467-2477&author=H.+Zhouauthor=T.+Shenauthor=Y.+Luoauthor=L.+Liuauthor=W.+Chenauthor=B.+Xuauthor=X.+Hanauthor=J.+Pangauthor=C.+A.+Riveraauthor=S.+Huang&title=The+antitumor+activity+of+the+fungicide+ciclopirox"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The antitumor activity of the fungicide ciclopirox</span></div><div class="casAuthors">Zhou, Hongyu; Shen, Tao; Luo, Yan; Liu, Lei; Chen, Wenxing; Xu, Baoshan; Han, Xiuzhen; Pang, Jia; Rivera, Chantal A.; Huang, Shile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2467-2477</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Ciclopirox olamine (CPX) is a synthetic antifungal agent clin. used to treat mycoses of the skin and nails.  Here, we show that CPX inhibited tumor growth in human breast cancer MDA-MB-231 xenografts.  To unveil the underlying mechanism, we further studied the antitumor activity of CPX in cell culture.  The results indicate that CPX inhibited cell proliferation and induced apoptosis in human rhabdomyosarcoma (Rh30), breast carcinoma (MDA-MB231) and colon adenocarcinoma (HT-29) cells in a concn.-dependent manner.  By cell cycle anal., CPX induced accumulation of cells in G1/G0 phase of the cell cycle.  Concurrently, CPX downregulated cellular protein expression of cyclins (A, B1, D1 and E) and cyclin-dependent kinases (CDK2 and CDK4) and upregulated expression of the CDK inhibitor p21Cip1, leading to hypophosphorylation of retinoblastoma protein.  CPX also downregulated protein expression of Bcl-xL and survivin and enhanced cleavages of Bcl-2.  Z-VAD-FMK, a pan-caspase inhibitor, partially prevented CPX-induced cell death, suggesting that CPX-induced apoptosis of cancer cells is mediated at least in part through caspase-dependent mechanism.  The results indicate that CPX is a potential antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4oPUHIyDErVg90H21EOLACvtfcHk0lj2y3AmQCHY4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GqtLnN&md5=b470936945d36addb288929e0da4162a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fijc.25255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25255%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DC.%2BA.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DThe%2520antitumor%2520activity%2520of%2520the%2520fungicide%2520ciclopirox%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D127%26spage%3D2467%26epage%3D2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Eberhard, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurren, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antholine, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">3064</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eberhard%2C+Y.%3B+McDermott%2C+S.+P.%3B+Wang%2C+X.%3B+Gronda%2C+M.%3B+Venugopal%2C+A.%3B+Wood%2C+T.+E.%3B+Hurren%2C+R.%3B+Datti%2C+A.%3B+Batey%2C+R.+A.%3B+Wrana%2C+J.%3B+Antholine%2C+W.+E.%3B+Dick%2C+J.+E.%3B+Schimmer%2C+A.+D.Blood+2009%2C+114%2C+3064%E2%80%933073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEberhard%26aufirst%3DY.%26aulast%3DMcDermott%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGronda%26aufirst%3DM.%26aulast%3DVenugopal%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DT.%2BE.%26aulast%3DHurren%26aufirst%3DR.%26aulast%3DDatti%26aufirst%3DA.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DWrana%26aufirst%3DJ.%26aulast%3DAntholine%26aufirst%3DW.%2BE.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D3064%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Deodhar, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kekare, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pednekar, S. R.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of 2-Pyridones by Nucleophilic Reaction on Pyran2-thiones</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500660f&amp;key=10.1055%2Fs-1985-31201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500660f&amp;key=1%3ACAS%3A528%3ADyaL28XlslCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=328-331&author=K.+D.+Deodharauthor=M.+B.+Kekareauthor=S.+R.+Pednekar&title=A+Facile+Synthesis+of+2-Pyridones+by+Nucleophilic+Reaction+on+Pyran2-thiones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of 2-pyridones by nucleophilic reaction on pyran-2-thiones</span></div><div class="casAuthors">Deodhar, K. D.; Kekare, M. B.; Pednekar, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">328-31</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Cyclization of pyranthiones I (Z = S, X = O) with RNH2 (R = H, PhCH2, p-ClC6H4, HO, H2N, PhNH, H2NCH2CH2) gave 47-86% pyridones I (Z = O, X = NR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv217rYbUdrrVg90H21EOLACvtfcHk0lh1Dqlu_9GzSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlslCn&md5=20bceed23cb10cdda0cad268269e2fc9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-1985-31201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1985-31201%26sid%3Dliteratum%253Aachs%26aulast%3DDeodhar%26aufirst%3DK.%2BD.%26aulast%3DKekare%26aufirst%3DM.%2BB.%26aulast%3DPednekar%26aufirst%3DS.%2BR.%26atitle%3DA%2520Facile%2520Synthesis%2520of%25202-Pyridones%2520by%2520Nucleophilic%2520Reaction%2520on%2520Pyran2-thiones%26jtitle%3DSynthesis%26date%3D1985%26spage%3D328%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Batt, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraitis, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. R.</span><span> </span><span class="NLM_article-title">2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00163a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=360-370&author=D.+G.+Battauthor=G.+D.+Maynardauthor=J.+J.+Petraitisauthor=J.+E.+Shawauthor=W.+Galbraithauthor=R.+R.+Harris&title=2-Substituted-1-naphthols+as+potent+5-lipoxygenase+inhibitors+with+topical+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00163a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00163a058%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DMaynard%26aufirst%3DG.%2BD.%26aulast%3DPetraitis%26aufirst%3DJ.%2BJ.%26aulast%3DShaw%26aufirst%3DJ.%2BE.%26aulast%3DGalbraith%26aufirst%3DW.%26aulast%3DHarris%26aufirst%3DR.%2BR.%26atitle%3D2-Substituted-1-naphthols%2520as%2520potent%25205-lipoxygenase%2520inhibitors%2520with%2520topical%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D360%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I3L','PDB','4I3L'); return false;">PDB: 4I3L</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/jm500660f">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_10137"></div></div></div></div></div><hr /></hr><p class="last">Alignments of crystal structures of IDH1 forms bound to substrates and inhibitors and experimental procedures providing details of compound synthesis and characterization. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500660f/suppl_file/jm500660f_si_001.pdf">jm500660f_si_001.pdf (834.35 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500660f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-20%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm500660f%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500660f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a87b4acaa3d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
